KinKin的个人主页 - 老虎社区

KinKin

KinKin

暂无个人介绍

IP属地：未知

507关注

14粉丝

0主题

0勋章

2021-05-07

Pls like & comment Thank you

抱歉，原内容已删除

2021-04-27

Boom.!

Tesla posts record net income of $438 million, revenue surges by 74%<blockquote>特斯拉净利润创历史新高 4.38 亿美元，收入激增 74%</blockquote>

2021-06-18

Get your post featured? What’s that means.?

Dow drops 400 points at the open, extending losses in its worst week since January<blockquote>道琼斯指数开盘下跌 400 点，扩大自 1 月份以来最糟糕的一周跌幅</blockquote>

2021-05-14

Buy buy buy

抱歉，原内容已删除

2021-04-29

Need ur like & comment

NIO Q1 2021 Earnings Report Preview: What to Look For<blockquote>蔚来 2021 年第一季度收益报告预览：看点</blockquote>

2021-11-29

Hi

Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify 股票：逢低买入至 10 月初水平？</blockquote>

2021-09-28

Hi

Cannabis stocks jumped in Monday morning trading<blockquote>周一早盘交易中大麻股票上涨</blockquote>

2021-05-15

Pls like & comment

Why AMC Entertainment Stock Jumped Again Friday<blockquote>为什么AMC院线股价周五再次上涨</blockquote>

2021-06-08

Pls comment. Thank you

抱歉，原内容已删除

2021-05-15

Pls like & comment

Delta Mandates All New Employees Must Have COVID-19 Vaccinations<blockquote>达美航空要求所有新员工必须接种 COVID-19 疫苗</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3574428256060280","uuid":"3574428256060280","gmtCreate":1611334232605,"gmtModify":1613355334024,"name":"KinKin","pinyin":"kinkin","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":14,"headSize":507,"tweetSize":277,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.07.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.57%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":693007445,"gmtCreate":1639920441087,"gmtModify":1639920441277,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693007445","repostId":"2192035909","repostType":4,"isVote":1,"tweetType":1,"viewCount":4678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690219638,"gmtCreate":1639668882052,"gmtModify":1639669004700,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690219638","repostId":"2191453039","repostType":4,"isVote":1,"tweetType":1,"viewCount":4449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605853928,"gmtCreate":1639147282871,"gmtModify":1639147283089,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605853928","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohunote.com/m/news/1148141788?lang=zh_CN&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘交易中下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p><p><blockquote>疫苗股在早盘交易中下跌。Moderna、BioNTech 和 Novavax 下跌 2% 至 11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading<blockquote>疫苗股早盘交易中下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading<blockquote>疫苗股早盘交易中下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-10 22:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p><p><blockquote>疫苗股在早盘交易中下跌。Moderna、BioNTech 和 Novavax 下跌 2% 至 11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1,"symbols_score_info":{"NVAX":0.9,"BNTX":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":4087,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601457892,"gmtCreate":1638550394827,"gmtModify":1638550394958,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Ho","listText":"Ho","text":"Ho","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601457892","repostId":"1158981658","repostType":4,"isVote":1,"tweetType":1,"viewCount":3876,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600765168,"gmtCreate":1638198782315,"gmtModify":1638198822415,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600765168","repostId":"1180693909","repostType":4,"repost":{"id":"1180693909","kind":"news","pubTimestamp":1638198357,"share":"https://www.laohunote.com/m/news/1180693909?lang=zh_CN&edition=full","pubTime":"2021-11-29 23:05","market":"us","language":"en","title":"Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify 股票：逢低买入至 10 月初水平？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1180693909","media":"TheStreet","summary":"Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the","content":"<p>Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.</p><p><blockquote>继第三季度后盈利飙升后，Spotify 股价在 11 月份大幅下跌。一些人可能认为这一举动是看跌的，而另一些人则可能认为这是一个以更低价格购买现货的机会。</blockquote></p><p> In late October, Spotify&nbsp;announced third quarter results. The numbers excited investors and sent Spotify stock&nbsp;up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.</p><p><blockquote>10月下旬，Spotify公布了第三季度业绩。这些数字让投资者兴奋不已，Spotify 股价迅速上涨近 15%。支撑乐观情绪的关键指标是该平台的 MAU（月活跃用户）比上一年大幅增长，随后收入同比增长近 30%。</blockquote></p><p> However, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.</p><p><blockquote>然而，在财报公布近一个月后，股价下跌了10%，回到了10月初的水平。如今，MavenFlix 试图了解 SPOT 的情况，并讨论最近的下跌是否可以被视为买入机会。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1a76b6dc048e3702eb0b6ef48bbc0409\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Spotify app icon.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Spotify应用程序图标。</span></p></blockquote></p><p> <b>Recent downfall and a future opportunity</b></p><p><blockquote><b>最近的失败和未来的机会</b></blockquote></p><p> SPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.</p><p><blockquote>SPOT 在 8 月份触及每股 205 美元，此后开始强劲看涨，升至六个月高点。然而，11 月，在该公司第三季度业绩公布后不久，Spotify 股价从 300 美元的高点跌至 250 美元以下。</blockquote></p><p> One of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.</p><p><blockquote>这种下降的可能原因之一是获利了结。如果是这样的话，对于那些喜欢该公司基本面的人来说，可能存在逢低买入的机会，但认为该现货可能过于昂贵或被高估。如今，Spotify 的交易价格为过去 3 个月来的最低价格。</blockquote></p><p> <b>Podcast growth and ad revenue</b></p><p><blockquote><b>播客增长和广告收入</b></blockquote></p><p> Unlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.</p><p><blockquote>与许多人的想法不同，Spotify不仅仅是一个音乐平台，而是一个音频平台。因此，在计算股票的公允价值时，人们不应只考虑音乐流媒体领域的增长。</blockquote></p><p> As we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&amp;L in the foreseeable future.</p><p><blockquote>正如我们在 “Spotify 财报： 为什么第三季度业绩导致股价飙升 ”中讨论的那样，播客是当今 Spotify 最相关的增长动力之一。流媒体音频的这一细分市场正在快速扩张，并可能在可预见的未来成为公司损益的重要组成部分。</blockquote></p><p> With ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.</p><p><blockquote>随着广告支持的帐户以与付费用户相同的速度增长，播客货币化是Spotify下一步的关键。我们认为这可能是推动 Spotify 股价在未来走高的催化剂——即使不是在未来几周或几个月内。</blockquote></p><p> <b>Spotify dominates audio streaming</b></p><p><blockquote><b>Spotify 主导音频流媒体</b></blockquote></p><p> Spotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.</p><p><blockquote>Spotify拥有最大的音乐库之一。然而，我们并不认为这使该公司有别于竞争对手。例如，苹果和亚马逊也在继续投入大量现金，以提高其平台的内容产品。</blockquote></p><p> What makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.</p><p><blockquote>在我们看来，让Spotify脱颖而出的是它在音频流媒体领域的足迹。尽管有增长前景，但市场仍然集中在少数参与者手中，这与视频流不同。如下图所示，Spotify 拥有明显的市场主导地位。</blockquote></p><p> The investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.</p><p><blockquote>对播客的投资只会帮助Spotify在未来几年确立自己的领先地位。目前，该平台上大约有260万个播客标题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab561adf751b756fe06b8fa8d2bff0ee\" tg-width=\"609\" tg-height=\"458\" width=\"100%\" height=\"auto\"><span>Figure 2: Music streaming market share.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：音乐流媒体市场份额。</span></p></blockquote></p><p> <b>Our view</b></p><p><blockquote><b>我们的观点</b></blockquote></p><p> After Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.</p><p><blockquote>自 11 月初以来，Spotify 股价下跌超过 10%，对于那些欣赏 Spotify 商业模式的人来说，机会之窗可能已经打开。然而，今天购买现货可能只会被证明是一个好的长期策略，因为短期内的波动性不太可能消退。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify 股票：逢低买入至 10 月初水平？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify 股票：逢低买入至 10 月初水平？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-11-29 23:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.</p><p><blockquote>继第三季度后盈利飙升后，Spotify 股价在 11 月份大幅下跌。一些人可能认为这一举动是看跌的，而另一些人则可能认为这是一个以更低价格购买现货的机会。</blockquote></p><p> In late October, Spotify&nbsp;announced third quarter results. The numbers excited investors and sent Spotify stock&nbsp;up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.</p><p><blockquote>10月下旬，Spotify公布了第三季度业绩。这些数字让投资者兴奋不已，Spotify 股价迅速上涨近 15%。支撑乐观情绪的关键指标是该平台的 MAU（月活跃用户）比上一年大幅增长，随后收入同比增长近 30%。</blockquote></p><p> However, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.</p><p><blockquote>然而，在财报公布近一个月后，股价下跌了10%，回到了10月初的水平。如今，MavenFlix 试图了解 SPOT 的情况，并讨论最近的下跌是否可以被视为买入机会。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1a76b6dc048e3702eb0b6ef48bbc0409\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Spotify app icon.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Spotify应用程序图标。</span></p></blockquote></p><p> <b>Recent downfall and a future opportunity</b></p><p><blockquote><b>最近的失败和未来的机会</b></blockquote></p><p> SPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.</p><p><blockquote>SPOT 在 8 月份触及每股 205 美元，此后开始强劲看涨，升至六个月高点。然而，11 月，在该公司第三季度业绩公布后不久，Spotify 股价从 300 美元的高点跌至 250 美元以下。</blockquote></p><p> One of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.</p><p><blockquote>这种下降的可能原因之一是获利了结。如果是这样的话，对于那些喜欢该公司基本面的人来说，可能存在逢低买入的机会，但认为该现货可能过于昂贵或被高估。如今，Spotify 的交易价格为过去 3 个月来的最低价格。</blockquote></p><p> <b>Podcast growth and ad revenue</b></p><p><blockquote><b>播客增长和广告收入</b></blockquote></p><p> Unlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.</p><p><blockquote>与许多人的想法不同，Spotify不仅仅是一个音乐平台，而是一个音频平台。因此，在计算股票的公允价值时，人们不应只考虑音乐流媒体领域的增长。</blockquote></p><p> As we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&amp;L in the foreseeable future.</p><p><blockquote>正如我们在 “Spotify 财报： 为什么第三季度业绩导致股价飙升 ”中讨论的那样，播客是当今 Spotify 最相关的增长动力之一。流媒体音频的这一细分市场正在快速扩张，并可能在可预见的未来成为公司损益的重要组成部分。</blockquote></p><p> With ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.</p><p><blockquote>随着广告支持的帐户以与付费用户相同的速度增长，播客货币化是Spotify下一步的关键。我们认为这可能是推动 Spotify 股价在未来走高的催化剂——即使不是在未来几周或几个月内。</blockquote></p><p> <b>Spotify dominates audio streaming</b></p><p><blockquote><b>Spotify 主导音频流媒体</b></blockquote></p><p> Spotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.</p><p><blockquote>Spotify拥有最大的音乐库之一。然而，我们并不认为这使该公司有别于竞争对手。例如，苹果和亚马逊也在继续投入大量现金，以提高其平台的内容产品。</blockquote></p><p> What makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.</p><p><blockquote>在我们看来，让Spotify脱颖而出的是它在音频流媒体领域的足迹。尽管有增长前景，但市场仍然集中在少数参与者手中，这与视频流不同。如下图所示，Spotify 拥有明显的市场主导地位。</blockquote></p><p> The investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.</p><p><blockquote>对播客的投资只会帮助Spotify在未来几年确立自己的领先地位。目前，该平台上大约有260万个播客标题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab561adf751b756fe06b8fa8d2bff0ee\" tg-width=\"609\" tg-height=\"458\" width=\"100%\" height=\"auto\"><span>Figure 2: Music streaming market share.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：音乐流媒体市场份额。</span></p></blockquote></p><p> <b>Our view</b></p><p><blockquote><b>我们的观点</b></blockquote></p><p> After Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.</p><p><blockquote>自 11 月初以来，Spotify 股价下跌超过 10%，对于那些欣赏 Spotify 商业模式的人来说，机会之窗可能已经打开。然而，今天购买现货可能只会被证明是一个好的长期策略，因为短期内的波动性不太可能消退。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/streaming/spot/buy-spotify-stock-at-pre-q3-earnings-levels\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPOT":"Spotify Technology S.A."},"source_url":"https://www.thestreet.com/streaming/spot/buy-spotify-stock-at-pre-q3-earnings-levels","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180693909","content_text":"Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.\nIn late October, Spotify announced third quarter results. The numbers excited investors and sent Spotify stock up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.\nHowever, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.\nFigure 1: Spotify app icon.\nRecent downfall and a future opportunity\nSPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.\nOne of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.\nPodcast growth and ad revenue\nUnlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.\nAs we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&L in the foreseeable future.\nWith ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.\nSpotify dominates audio streaming\nSpotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.\nWhat makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.\nThe investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.\nFigure 2: Music streaming market share.\nOur view\nAfter Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.","news_type":1,"symbols_score_info":{"SPOT":0.9}},"isVote":1,"tweetType":1,"viewCount":4999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877598648,"gmtCreate":1637940510618,"gmtModify":1637940510696,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877598648","repostId":"1158420182","repostType":4,"repost":{"id":"1158420182","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637939738,"share":"https://www.laohunote.com/m/news/1158420182?lang=zh_CN&edition=full","pubTime":"2021-11-26 23:15","market":"fut","language":"en","title":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%，至每桶71.28美元，布伦特原油下跌8.16%。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158420182","media":"Tiger Newspress","summary":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.","content":"<p>WTI crude tumbled&nbsp;9.02% to $71.28 a barrel,&nbsp;Brent&nbsp;fell&nbsp;8.16%.<img src=\"https://static.tigerbbs.com/6e118e6a5e909412e48ca104b2c37b30\" tg-width=\"884\" tg-height=\"611\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/1ac1680f3b9d8085d5fd9b6a868ce9c3\" tg-width=\"870\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote>WTI原油下跌9.02%，至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%，至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.<blockquote>WTI原油下跌9.02%，至每桶71.28美元，布伦特原油下跌8.16%。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-26 23:15</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>WTI crude tumbled&nbsp;9.02% to $71.28 a barrel,&nbsp;Brent&nbsp;fell&nbsp;8.16%.<img src=\"https://static.tigerbbs.com/6e118e6a5e909412e48ca104b2c37b30\" tg-width=\"884\" tg-height=\"611\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/1ac1680f3b9d8085d5fd9b6a868ce9c3\" tg-width=\"870\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote>WTI原油下跌9.02%，至每桶71.28美元，布伦特原油下跌8.16%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158420182","content_text":"WTI crude tumbled 9.02% to $71.28 a barrel, Brent fell 8.16%.","news_type":1,"symbols_score_info":{"BZmain":0.9,"CLmain":0.9}},"isVote":1,"tweetType":1,"viewCount":3957,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877912421,"gmtCreate":1637863611074,"gmtModify":1637863611159,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877912421","repostId":"1122037796","repostType":4,"repost":{"id":"1122037796","kind":"news","pubTimestamp":1637849010,"share":"https://www.laohunote.com/m/news/1122037796?lang=zh_CN&edition=full","pubTime":"2021-11-25 22:03","market":"us","language":"en","title":"7 stocks with the most Thanksgiving exposure, according to Bank of America<blockquote>根据美国银行的数据，感恩节风险敞口最大的 7 只股票</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122037796","media":"finance.yahoo","summary":"Thanksgiving feasts will likely draw larger crowds than last year and incur higher costs.\nA recent B","content":"<p>Thanksgiving feasts will likely draw larger crowds than last year and&nbsp;incur higher costs.</p><p><blockquote>感恩节盛宴可能会吸引比去年更多的人群，并产生更高的成本。</blockquote></p><p> A recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid supply chain bottlenecks, inflation, lingering COVID concerns, low inventories, and evolving consumer behaviors.</p><p><blockquote>美国银行最近的一份报告详细介绍了在供应链瓶颈、通货膨胀、挥之不去的新冠疫情担忧、低库存和不断变化的消费者行为的情况下，哪些公司最有可能接触到顶级节日菜肴。</blockquote></p><p> Those companies are Campbell's Soup Company (CPB), General Mills (GIS), The Kraft Heinz Company (KHC), Conagra Brands (CAG), Hormel Foods Corporation (HRL), McCormick &amp; Company (MKC), and The Duckhorn Portfolio, Inc. (NAPA).</p><p><blockquote>这些公司是金宝汤公司 (CPB)、通用磨坊 (GIS)、卡夫亨氏公司 (KHC)、康尼格拉品牌 (CAG)、荷美尔食品公司 (HRL)、麦考密克公司 (MKC) 和鸭角投资组合公司 (NAPA)。</blockquote></p><p> \"We looked at companies’ exposure to the top Thanksgiving dishes: turkey, stuffing, dinner rolls, gravy, green bean casserole, potatoes, mac &amp; cheese dessert and wine,\" the analysts stated. \"Overall CPB, GIS, KHC, CAG, MKC, HRL and NAPA are the most exposed. KHC and NAPA are our favorite stocks in this group.\"</p><p><blockquote>“分析师们说：”我们调查了各公司对感恩节顶级菜肴的接触情况： 火鸡、馅料、晚餐卷、肉汁、四季豆砂锅、土豆、通心粉和奶酪甜点和葡萄酒。“总体而言，CPB、GIS、KHC、CAG、MKC、HRL 和 NAPA 是暴露最多的。KHC 和 NAPA 是我们在该组中最喜欢的股票。”</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/39aa902f366c0bd07e076520c33cdf52\" tg-width=\"705\" tg-height=\"409\" width=\"100%\" height=\"auto\"><span>Key companies exposed to Thanksgiving meal trends. (Source: BofA)Thanksgiving 'center of the plate' items see more pricing power</span></p><p><blockquote><p class=\"t-img-caption\"><span>暴露于感恩节大餐趋势的主要公司。（资料来源：美国银行）感恩节“盘子中心”项目看到更多定价权</span></p></blockquote></p><p> People appear to be gathering around the table again, the analysts stated, as data from social media conversations found mentions of \"vaccines\" on the rise while mentions of \"FaceTime,\" \"social distancing,\" and \"canceled\" declined. (\"Friendsgiving\" and \"day drinking\" also saw increases.)</p><p><blockquote>分析师表示，人们似乎再次聚集在桌子周围，因为社交媒体对话的数据发现，提及“疫苗”的人数有所增加，而提及“FaceTime”、“社交距离”和“取消”的人数有所下降。（“朋友聚会”和“白天喝酒”也有所增加。）</blockquote></p><p> And whether consumers opt for turkey or ham, mashed potatoes or marshmallow-topped sweet potatoes, traditional orplant-based options, they're likely to pay more with inflation hitting food prices.</p><p><blockquote>无论消费者选择火鸡还是火腿、土豆泥还是棉花糖甘薯，传统的还是基于植物的选择，他们都可能在通货膨胀冲击食品价格的情况下支付更多费用。</blockquote></p><p> The&nbsp;American Farm Bureau Thanksgiving cost index&nbsp;projects a 14% year-over-year increase for 2021, led by a 24% increase in turkey prices.</p><p><blockquote>美国农业局感恩节成本指数预计2021年将同比增长14%，其中火鸡价格上涨24%。</blockquote></p><p> “When you look at more of the center of the plate sort of food items, typically, there has not historically been a lot of pricing power,” Bryan Spillane, a senior food and beverage analyst at BofA Global Research, told Yahoo Finance Live (video above). “But what's unusual this year is that there has been. Food companies, in particular, began raising prices the middle of the year, and there's virtually been no elasticity.”</p><p><blockquote>“美国银行全球研究部（BofA Global Research）高级食品和饮料分析师布莱恩-斯皮兰（Bryan Spillane）告诉雅虎财经直播（上图视频）：”通常情况下，当你看到更多的盘子中央类型的食品时，历史上并没有太大的定价权。“但今年不同寻常的是，出现了这种情况。尤其是食品公司，在年中就开始提价，而且几乎没有弹性。”</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8e60ff60917eb4db45a68c41bd19a337\" tg-width=\"705\" tg-height=\"529\" width=\"100%\" height=\"auto\"><span>Frozen turkeys in Philadelphia, Wednesday, Nov. 17, 2021. (AP Photo/Matt Rourke)</span></p><p><blockquote><p class=\"t-img-caption\"><span>2021年11月17日，星期三，费城的冷冻火鸡。（美联社照片/马特·洛克）</span></p></blockquote></p><p> That said, Spillane added, consumer behavior is expected to change at some point.</p><p><blockquote>尽管如此，斯皮兰补充说，消费者行为预计会在某个时候发生变化。</blockquote></p><p> “Something that we're really watching as we move into next year is: At what point does the consumer begin to push back and do we begin to see some trading down or other behavior that demonstrates that consumers are feeling that pinch?” Spillane said.</p><p><blockquote>“进入明年，我们真正关注的是：消费者在什么时候开始反击，我们是否开始看到一些降价或其他行为，表明消费者感受到了这种压力？”斯皮兰说。</blockquote></p><p> Investor appetite for food and beverage companies</p><p><blockquote>投资者对食品饮料公司的胃口</blockquote></p><p> The top company with the most upside or downside potential is Campbell's, which BofA gave an \"underperform\" rating.</p><p><blockquote>最具上行或下行潜力的顶级公司是金宝公司，美国银行给予其“跑输大盘”评级。</blockquote></p><p> “Campbell's struggling from a few issues,” Spillane said. “One is they are experiencing a material amount of inflation. They have a product portfolio that's a little bit more skewed… to kind of middle and low-income households. So, that's, maybe, an area where there may be some sensitivity around passing those prices through.”</p><p><blockquote>“斯皮兰说：”坎贝尔在几个问题上苦苦挣扎。“一是他们正在经历大量的通货膨胀。他们的产品组合有点偏向.中低收入家庭。因此，这可能是一个在传递这些价格方面存在一些敏感性的领域”。</blockquote></p><p> The iconic soup company also has a lot of direct and indirect exposure to labor shortages and higher labor costs, Spillane added.</p><p><blockquote>斯皮兰补充说，这家标志性的汤品公司也直接和间接地面临着劳动力短缺和劳动力成本上升的问题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/be1718627f49a5fcc29f52e9e322313f\" tg-width=\"705\" tg-height=\"470\" width=\"100%\" height=\"auto\"><span>Cans of Campbell's Soup are displayed in a supermarket in New York City, U.S. February 15, 2017. REUTERS/Brendan McDermid</span></p><p><blockquote><p class=\"t-img-caption\"><span>2017年2月15日，美国纽约市一家超市里陈列着罐装金宝汤。路透社/布伦丹·麦克德米德</span></p></blockquote></p><p> BofA also gave seasoning-maker McCormick &amp; Company an \"underperform\" rating, with an $84 price target.</p><p><blockquote>美国银行还给予调味品制造商麦考密克公司“跑输大盘”评级，目标价为 84 美元。</blockquote></p><p> McCormick is “still trading at a premium valuation,” Spillane said, adding that while it has benefitted from people having cooked at home more in the last 18 months, “at some point, as things moderate, you're going to see less of that cooking at home behavior. And that's going to create an overhang for McCormick.”</p><p><blockquote>斯皮兰说，麦考密克 “仍在以溢价进行交易”，他补充说，虽然在过去的 18 个月里，人们在家做饭的次数增加了，但 “在某个时候，随着情况的缓和，你会看到更少的在家做饭的行为。这将给麦考密克带来悬念”。</blockquote></p><p> On the flip side, “Hershey [HSY] is well-positioned,” Spillane said, especially when it comes to the inflationary environment.</p><p><blockquote>另一方面，“好时 [HSY] 处于有利地位，”斯皮兰说，尤其是在通胀环境下。</blockquote></p><p> “The combination of a category that's still growing very strongly where there's still a lot of product innovation and where there's been demonstrated pricing power, we think that Hershey is set up really well to be able to maybe even more than protect margins, maybe potentially grow margins as we cycle through some of this inflation,” he explained.</p><p><blockquote>“他解释说：”好时是一个仍在强劲增长的品类，仍然有很多产品创新，而且定价权也得到了证明，我们认为好时已经做好了充分准备，也许不仅仅是保护利润率，也许还能在我们经历一些通货膨胀的过程中提高利润率。</blockquote></p><p> BofA also awarded Stove Top stuffing-maker Kraft Heinz a buy rating with a $46 price objective.</p><p><blockquote>美国银行还给予炉顶填料制造商卡夫亨氏买入评级，目标价为 46 美元。</blockquote></p><p></p><p> “We believe this is justified based our view that KHC is well positioned to capture growth associated with changing consumer demand patterns related to recessions and pantry stocking offset by higher than average debt levels,” the analysts wrote.</p><p><blockquote>“分析师写道：”我们认为这是合理的，因为我们认为，KHC 已做好充分准备，可以抓住与经济衰退和食品储藏室库存相关的不断变化的消费者需求模式，而高于平均水平的债务水平抵消了这些变化。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 stocks with the most Thanksgiving exposure, according to Bank of America<blockquote>根据美国银行的数据，感恩节风险敞口最大的 7 只股票</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 stocks with the most Thanksgiving exposure, according to Bank of America<blockquote>根据美国银行的数据，感恩节风险敞口最大的 7 只股票</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">finance.yahoo</strong><span class=\"h-time small\">2021-11-25 22:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Thanksgiving feasts will likely draw larger crowds than last year and&nbsp;incur higher costs.</p><p><blockquote>感恩节盛宴可能会吸引比去年更多的人群，并产生更高的成本。</blockquote></p><p> A recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid supply chain bottlenecks, inflation, lingering COVID concerns, low inventories, and evolving consumer behaviors.</p><p><blockquote>美国银行最近的一份报告详细介绍了在供应链瓶颈、通货膨胀、挥之不去的新冠疫情担忧、低库存和不断变化的消费者行为的情况下，哪些公司最有可能接触到顶级节日菜肴。</blockquote></p><p> Those companies are Campbell's Soup Company (CPB), General Mills (GIS), The Kraft Heinz Company (KHC), Conagra Brands (CAG), Hormel Foods Corporation (HRL), McCormick &amp; Company (MKC), and The Duckhorn Portfolio, Inc. (NAPA).</p><p><blockquote>这些公司是金宝汤公司 (CPB)、通用磨坊 (GIS)、卡夫亨氏公司 (KHC)、康尼格拉品牌 (CAG)、荷美尔食品公司 (HRL)、麦考密克公司 (MKC) 和鸭角投资组合公司 (NAPA)。</blockquote></p><p> \"We looked at companies’ exposure to the top Thanksgiving dishes: turkey, stuffing, dinner rolls, gravy, green bean casserole, potatoes, mac &amp; cheese dessert and wine,\" the analysts stated. \"Overall CPB, GIS, KHC, CAG, MKC, HRL and NAPA are the most exposed. KHC and NAPA are our favorite stocks in this group.\"</p><p><blockquote>“分析师们说：”我们调查了各公司对感恩节顶级菜肴的接触情况： 火鸡、馅料、晚餐卷、肉汁、四季豆砂锅、土豆、通心粉和奶酪甜点和葡萄酒。“总体而言，CPB、GIS、KHC、CAG、MKC、HRL 和 NAPA 是暴露最多的。KHC 和 NAPA 是我们在该组中最喜欢的股票。”</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/39aa902f366c0bd07e076520c33cdf52\" tg-width=\"705\" tg-height=\"409\" width=\"100%\" height=\"auto\"><span>Key companies exposed to Thanksgiving meal trends. (Source: BofA)Thanksgiving 'center of the plate' items see more pricing power</span></p><p><blockquote><p class=\"t-img-caption\"><span>暴露于感恩节大餐趋势的主要公司。（资料来源：美国银行）感恩节“盘子中心”项目看到更多定价权</span></p></blockquote></p><p> People appear to be gathering around the table again, the analysts stated, as data from social media conversations found mentions of \"vaccines\" on the rise while mentions of \"FaceTime,\" \"social distancing,\" and \"canceled\" declined. (\"Friendsgiving\" and \"day drinking\" also saw increases.)</p><p><blockquote>分析师表示，人们似乎再次聚集在桌子周围，因为社交媒体对话的数据发现，提及“疫苗”的人数有所增加，而提及“FaceTime”、“社交距离”和“取消”的人数有所下降。（“朋友聚会”和“白天喝酒”也有所增加。）</blockquote></p><p> And whether consumers opt for turkey or ham, mashed potatoes or marshmallow-topped sweet potatoes, traditional orplant-based options, they're likely to pay more with inflation hitting food prices.</p><p><blockquote>无论消费者选择火鸡还是火腿、土豆泥还是棉花糖甘薯，传统的还是基于植物的选择，他们都可能在通货膨胀冲击食品价格的情况下支付更多费用。</blockquote></p><p> The&nbsp;American Farm Bureau Thanksgiving cost index&nbsp;projects a 14% year-over-year increase for 2021, led by a 24% increase in turkey prices.</p><p><blockquote>美国农业局感恩节成本指数预计2021年将同比增长14%，其中火鸡价格上涨24%。</blockquote></p><p> “When you look at more of the center of the plate sort of food items, typically, there has not historically been a lot of pricing power,” Bryan Spillane, a senior food and beverage analyst at BofA Global Research, told Yahoo Finance Live (video above). “But what's unusual this year is that there has been. Food companies, in particular, began raising prices the middle of the year, and there's virtually been no elasticity.”</p><p><blockquote>“美国银行全球研究部（BofA Global Research）高级食品和饮料分析师布莱恩-斯皮兰（Bryan Spillane）告诉雅虎财经直播（上图视频）：”通常情况下，当你看到更多的盘子中央类型的食品时，历史上并没有太大的定价权。“但今年不同寻常的是，出现了这种情况。尤其是食品公司，在年中就开始提价，而且几乎没有弹性。”</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8e60ff60917eb4db45a68c41bd19a337\" tg-width=\"705\" tg-height=\"529\" width=\"100%\" height=\"auto\"><span>Frozen turkeys in Philadelphia, Wednesday, Nov. 17, 2021. (AP Photo/Matt Rourke)</span></p><p><blockquote><p class=\"t-img-caption\"><span>2021年11月17日，星期三，费城的冷冻火鸡。（美联社照片/马特·洛克）</span></p></blockquote></p><p> That said, Spillane added, consumer behavior is expected to change at some point.</p><p><blockquote>尽管如此，斯皮兰补充说，消费者行为预计会在某个时候发生变化。</blockquote></p><p> “Something that we're really watching as we move into next year is: At what point does the consumer begin to push back and do we begin to see some trading down or other behavior that demonstrates that consumers are feeling that pinch?” Spillane said.</p><p><blockquote>“进入明年，我们真正关注的是：消费者在什么时候开始反击，我们是否开始看到一些降价或其他行为，表明消费者感受到了这种压力？”斯皮兰说。</blockquote></p><p> Investor appetite for food and beverage companies</p><p><blockquote>投资者对食品饮料公司的胃口</blockquote></p><p> The top company with the most upside or downside potential is Campbell's, which BofA gave an \"underperform\" rating.</p><p><blockquote>最具上行或下行潜力的顶级公司是金宝公司，美国银行给予其“跑输大盘”评级。</blockquote></p><p> “Campbell's struggling from a few issues,” Spillane said. “One is they are experiencing a material amount of inflation. They have a product portfolio that's a little bit more skewed… to kind of middle and low-income households. So, that's, maybe, an area where there may be some sensitivity around passing those prices through.”</p><p><blockquote>“斯皮兰说：”坎贝尔在几个问题上苦苦挣扎。“一是他们正在经历大量的通货膨胀。他们的产品组合有点偏向.中低收入家庭。因此，这可能是一个在传递这些价格方面存在一些敏感性的领域”。</blockquote></p><p> The iconic soup company also has a lot of direct and indirect exposure to labor shortages and higher labor costs, Spillane added.</p><p><blockquote>斯皮兰补充说，这家标志性的汤品公司也直接和间接地面临着劳动力短缺和劳动力成本上升的问题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/be1718627f49a5fcc29f52e9e322313f\" tg-width=\"705\" tg-height=\"470\" width=\"100%\" height=\"auto\"><span>Cans of Campbell's Soup are displayed in a supermarket in New York City, U.S. February 15, 2017. REUTERS/Brendan McDermid</span></p><p><blockquote><p class=\"t-img-caption\"><span>2017年2月15日，美国纽约市一家超市里陈列着罐装金宝汤。路透社/布伦丹·麦克德米德</span></p></blockquote></p><p> BofA also gave seasoning-maker McCormick &amp; Company an \"underperform\" rating, with an $84 price target.</p><p><blockquote>美国银行还给予调味品制造商麦考密克公司“跑输大盘”评级，目标价为 84 美元。</blockquote></p><p> McCormick is “still trading at a premium valuation,” Spillane said, adding that while it has benefitted from people having cooked at home more in the last 18 months, “at some point, as things moderate, you're going to see less of that cooking at home behavior. And that's going to create an overhang for McCormick.”</p><p><blockquote>斯皮兰说，麦考密克 “仍在以溢价进行交易”，他补充说，虽然在过去的 18 个月里，人们在家做饭的次数增加了，但 “在某个时候，随着情况的缓和，你会看到更少的在家做饭的行为。这将给麦考密克带来悬念”。</blockquote></p><p> On the flip side, “Hershey [HSY] is well-positioned,” Spillane said, especially when it comes to the inflationary environment.</p><p><blockquote>另一方面，“好时 [HSY] 处于有利地位，”斯皮兰说，尤其是在通胀环境下。</blockquote></p><p> “The combination of a category that's still growing very strongly where there's still a lot of product innovation and where there's been demonstrated pricing power, we think that Hershey is set up really well to be able to maybe even more than protect margins, maybe potentially grow margins as we cycle through some of this inflation,” he explained.</p><p><blockquote>“他解释说：”好时是一个仍在强劲增长的品类，仍然有很多产品创新，而且定价权也得到了证明，我们认为好时已经做好了充分准备，也许不仅仅是保护利润率，也许还能在我们经历一些通货膨胀的过程中提高利润率。</blockquote></p><p> BofA also awarded Stove Top stuffing-maker Kraft Heinz a buy rating with a $46 price objective.</p><p><blockquote>美国银行还给予炉顶填料制造商卡夫亨氏买入评级，目标价为 46 美元。</blockquote></p><p></p><p> “We believe this is justified based our view that KHC is well positioned to capture growth associated with changing consumer demand patterns related to recessions and pantry stocking offset by higher than average debt levels,” the analysts wrote.</p><p><blockquote>“分析师写道：”我们认为这是合理的，因为我们认为，KHC 已做好充分准备，可以抓住与经济衰退和食品储藏室库存相关的不断变化的消费者需求模式，而高于平均水平的债务水平抵消了这些变化。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/7-stocks-thanksgiving-exposure-bank-of-america-134505457.html\">finance.yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GIS":"通用磨坊","CAG":"康尼格拉","MKC":"味好美","KHC":"卡夫亨氏","HRL":"荷美尔","CPB":"金宝汤"},"source_url":"https://finance.yahoo.com/news/7-stocks-thanksgiving-exposure-bank-of-america-134505457.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122037796","content_text":"Thanksgiving feasts will likely draw larger crowds than last year and incur higher costs.\nA recent Bank of America note detailed which companies have the most exposure to the top holiday dishes amid supply chain bottlenecks, inflation, lingering COVID concerns, low inventories, and evolving consumer behaviors.\nThose companies are Campbell's Soup Company (CPB), General Mills (GIS), The Kraft Heinz Company (KHC), Conagra Brands (CAG), Hormel Foods Corporation (HRL), McCormick & Company (MKC), and The Duckhorn Portfolio, Inc. (NAPA).\n\"We looked at companies’ exposure to the top Thanksgiving dishes: turkey, stuffing, dinner rolls, gravy, green bean casserole, potatoes, mac & cheese dessert and wine,\" the analysts stated. \"Overall CPB, GIS, KHC, CAG, MKC, HRL and NAPA are the most exposed. KHC and NAPA are our favorite stocks in this group.\"\nKey companies exposed to Thanksgiving meal trends. (Source: BofA)Thanksgiving 'center of the plate' items see more pricing power\nPeople appear to be gathering around the table again, the analysts stated, as data from social media conversations found mentions of \"vaccines\" on the rise while mentions of \"FaceTime,\" \"social distancing,\" and \"canceled\" declined. (\"Friendsgiving\" and \"day drinking\" also saw increases.)\nAnd whether consumers opt for turkey or ham, mashed potatoes or marshmallow-topped sweet potatoes, traditional orplant-based options, they're likely to pay more with inflation hitting food prices.\nThe American Farm Bureau Thanksgiving cost index projects a 14% year-over-year increase for 2021, led by a 24% increase in turkey prices.\n“When you look at more of the center of the plate sort of food items, typically, there has not historically been a lot of pricing power,” Bryan Spillane, a senior food and beverage analyst at BofA Global Research, told Yahoo Finance Live (video above). “But what's unusual this year is that there has been. Food companies, in particular, began raising prices the middle of the year, and there's virtually been no elasticity.”\nFrozen turkeys in Philadelphia, Wednesday, Nov. 17, 2021. (AP Photo/Matt Rourke)\nThat said, Spillane added, consumer behavior is expected to change at some point.\n“Something that we're really watching as we move into next year is: At what point does the consumer begin to push back and do we begin to see some trading down or other behavior that demonstrates that consumers are feeling that pinch?” Spillane said.\nInvestor appetite for food and beverage companies\nThe top company with the most upside or downside potential is Campbell's, which BofA gave an \"underperform\" rating.\n“Campbell's struggling from a few issues,” Spillane said. “One is they are experiencing a material amount of inflation. They have a product portfolio that's a little bit more skewed… to kind of middle and low-income households. So, that's, maybe, an area where there may be some sensitivity around passing those prices through.”\nThe iconic soup company also has a lot of direct and indirect exposure to labor shortages and higher labor costs, Spillane added.\nCans of Campbell's Soup are displayed in a supermarket in New York City, U.S. February 15, 2017. REUTERS/Brendan McDermid\nBofA also gave seasoning-maker McCormick & Company an \"underperform\" rating, with an $84 price target.\nMcCormick is “still trading at a premium valuation,” Spillane said, adding that while it has benefitted from people having cooked at home more in the last 18 months, “at some point, as things moderate, you're going to see less of that cooking at home behavior. And that's going to create an overhang for McCormick.”\nOn the flip side, “Hershey [HSY] is well-positioned,” Spillane said, especially when it comes to the inflationary environment.\n“The combination of a category that's still growing very strongly where there's still a lot of product innovation and where there's been demonstrated pricing power, we think that Hershey is set up really well to be able to maybe even more than protect margins, maybe potentially grow margins as we cycle through some of this inflation,” he explained.\nBofA also awarded Stove Top stuffing-maker Kraft Heinz a buy rating with a $46 price objective.\n“We believe this is justified based our view that KHC is well positioned to capture growth associated with changing consumer demand patterns related to recessions and pantry stocking offset by higher than average debt levels,” the analysts wrote.","news_type":1,"symbols_score_info":{"CPB":0.9,"GIS":0.9,"MKC":0.9,"KHC":0.9,"NAPA":0.9,"HRL":0.9,"CAG":0.9}},"isVote":1,"tweetType":1,"viewCount":4710,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875457018,"gmtCreate":1637680850959,"gmtModify":1637680851037,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/875457018","repostId":"1119603099","repostType":4,"repost":{"id":"1119603099","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637680476,"share":"https://www.laohunote.com/m/news/1119603099?lang=zh_CN&edition=full","pubTime":"2021-11-23 23:14","market":"us","language":"en","title":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%<blockquote>BioNTech 股价早盘下跌近 7%，Moderna 股价下跌 3%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119603099","media":"Tiger Newspress","summary":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%.The U.S. government asked","content":"<p>BioNTech&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;7%&nbsp;in&nbsp;early&nbsp;trading&nbsp;and&nbsp;Moderna&nbsp;shares&nbsp;slid&nbsp;3%.<img src=\"https://static.tigerbbs.com/89a99816fada5bf2c2120b3cda678cb6\" tg-width=\"871\" tg-height=\"599\" width=\"100%\" height=\"auto\">The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.</p><p><blockquote>BioNTech 股价早盘下跌近 7%，Moderna 股价下跌 3%。根据一份法庭文件，美国政府要求联邦上诉法院立即解除法院下令暂停全面工作场所新冠肺炎疫苗规则的禁令，以避免对公共健康造成“巨大”损害，或者允许掩蔽和检测要求。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%<blockquote>BioNTech 股价早盘下跌近 7%，Moderna 股价下跌 3%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%<blockquote>BioNTech 股价早盘下跌近 7%，Moderna 股价下跌 3%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-23 23:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioNTech&nbsp;shares&nbsp;fell&nbsp;nearly&nbsp;7%&nbsp;in&nbsp;early&nbsp;trading&nbsp;and&nbsp;Moderna&nbsp;shares&nbsp;slid&nbsp;3%.<img src=\"https://static.tigerbbs.com/89a99816fada5bf2c2120b3cda678cb6\" tg-width=\"871\" tg-height=\"599\" width=\"100%\" height=\"auto\">The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.</p><p><blockquote>BioNTech 股价早盘下跌近 7%，Moderna 股价下跌 3%。根据一份法庭文件，美国政府要求联邦上诉法院立即解除法院下令暂停全面工作场所新冠肺炎疫苗规则的禁令，以避免对公共健康造成“巨大”损害，或者允许掩蔽和检测要求。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119603099","content_text":"BioNTech shares fell nearly 7% in early trading and Moderna shares slid 3%.The U.S. government asked a federal appeals court to immediately lift a court-ordered stay on a sweeping workplace COVID-19 vaccine rule to avoid \"enormous\" harm to public health, or alternatively to allow a masking-and-testing requirement, according to a court filing.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":4692,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875076570,"gmtCreate":1637592414989,"gmtModify":1637592415086,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875076570","repostId":"2185872821","repostType":4,"isVote":1,"tweetType":1,"viewCount":4743,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876907118,"gmtCreate":1637247684222,"gmtModify":1637247684325,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876907118","repostId":"1171650346","repostType":4,"repost":{"id":"1171650346","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637247556,"share":"https://www.laohunote.com/m/news/1171650346?lang=zh_CN&edition=full","pubTime":"2021-11-18 22:59","market":"us","language":"en","title":"Semiconductor stocks climbed in morning trading<blockquote>半导体股早盘上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1171650346","media":"Tiger Newspress","summary":"Semiconductor stocks climbed in morning trading.Nvidia,AMD,GlobalFoundries,TSMC,ASML,Micron Technolo","content":"<p>Semiconductor stocks climbed in morning trading.Nvidia,AMD,GlobalFoundries,TSMC,ASML,Micron Technology&nbsp;and&nbsp;Qualcomm&nbsp;rose&nbsp;between 2% and 11%.</p><p><blockquote>半导体股早盘攀升.英伟达、AMD、GlobalFoundries、台积电、ASML、美光科技和高通上涨2%至11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/299bd7bc3695657a76434e3d339f30ad\" tg-width=\"409\" tg-height=\"425\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Nvidia reported record sales and beat on earnings again;</p><p><blockquote>英伟达公布销售额创历史新高，盈利再次超出预期；</blockquote></p><p> Ford explores buying chips directly from GlobalFoundries to offset shortage;</p><p><blockquote>福特探索直接从全球代工厂购买芯片以弥补短缺；</blockquote></p><p> ASML sees around $2.27 bln in sales in China in 2021, 2022 - CFO.</p><p><blockquote>ASML 预计 2021 年和 2022 年在中国的销售额约为 22.7 亿美元 - 首席财务官。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks climbed in morning trading<blockquote>半导体股早盘上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks climbed in morning trading<blockquote>半导体股早盘上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-18 22:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Semiconductor stocks climbed in morning trading.Nvidia,AMD,GlobalFoundries,TSMC,ASML,Micron Technology&nbsp;and&nbsp;Qualcomm&nbsp;rose&nbsp;between 2% and 11%.</p><p><blockquote>半导体股早盘攀升.英伟达、AMD、GlobalFoundries、台积电、ASML、美光科技和高通上涨2%至11%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/299bd7bc3695657a76434e3d339f30ad\" tg-width=\"409\" tg-height=\"425\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Nvidia reported record sales and beat on earnings again;</p><p><blockquote>英伟达公布销售额创历史新高，盈利再次超出预期；</blockquote></p><p> Ford explores buying chips directly from GlobalFoundries to offset shortage;</p><p><blockquote>福特探索直接从全球代工厂购买芯片以弥补短缺；</blockquote></p><p> ASML sees around $2.27 bln in sales in China in 2021, 2022 - CFO.</p><p><blockquote>ASML 预计 2021 年和 2022 年在中国的销售额约为 22.7 亿美元 - 首席财务官。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","QCOM":"高通","ASML":"阿斯麦","GFS":"GLOBALFOUNDRIES Inc.","AMD":"美国超微公司","MU":"美光科技","TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171650346","content_text":"Semiconductor stocks climbed in morning trading.Nvidia,AMD,GlobalFoundries,TSMC,ASML,Micron Technology and Qualcomm rose between 2% and 11%.\n\nNvidia reported record sales and beat on earnings again;\nFord explores buying chips directly from GlobalFoundries to offset shortage;\nASML sees around $2.27 bln in sales in China in 2021, 2022 - CFO.","news_type":1,"symbols_score_info":{"ASML":0.9,"AMD":0.9,"GFS":0.9,"TSM":0.9,"MU":0.9,"NVDA":0.9,"QCOM":0.9}},"isVote":1,"tweetType":1,"viewCount":4098,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870727475,"gmtCreate":1636651299506,"gmtModify":1636651299710,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870727475","repostId":"1138997737","repostType":4,"isVote":1,"tweetType":1,"viewCount":1210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841959209,"gmtCreate":1635870072754,"gmtModify":1635870072826,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Come n play","listText":"Come n play","text":"Come n play","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841959209","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"36984908995200","authorIdStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841924826,"gmtCreate":1635869865994,"gmtModify":1635869866103,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841924826","repostId":"850756569","repostType":1,"repost":{"id":850756569,"gmtCreate":1634631211448,"gmtModify":1635853120757,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"36984908995200","authorIdStr":"36984908995200"},"themes":[],"title":"[Halloween Game] Trade or Treat!","htmlText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","listText":"Hello, dear Tigers!&nbsp; Happy&nbsp;Halloween!&nbsp;🎃🎃🎃&nbsp;&nbsp; <a href=\"https://www.tigerbrokers.com.sg/activity/market/2021/halloween/?lang=en_US#/\" target=\"_blank\">Tap&nbsp;here&nbsp;to&nbsp;play the Halloween game,&nbsp;and&nbsp;you&nbsp;stand&nbsp;a&nbsp;chance&nbsp;to win various rewards!&nbsp;</a> Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1.&nbsp;How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'.&nbsp; 2.&nbsp;How to collect points? Each player has 30 seconds to catch falling candies while av","text":"Hello, dear Tigers! Happy Halloween! 🎃🎃🎃 Tap here to play the Halloween game, and you stand a chance to win various rewards! Promotion Period: October 27, 2021 18:00 - November 9, 2021 18:00 (SGT) 1. How to Participate? All Tiger clients may collect points which can be used to redeem rewards by taking part in the Trade or Treating Game. All existing Tiger clients will have 2 game attempts. Clients can get more game attempts by completing different tasks, such as 'Invite a friend' or 'Share Halloween Game'. 2. How to collect points? Each player has 30 seconds to catch falling candies while av","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/850756569","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":932,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855838513,"gmtCreate":1635347993685,"gmtModify":1635347993873,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855838513","repostId":"2178239526","repostType":4,"isVote":1,"tweetType":1,"viewCount":1021,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823236464,"gmtCreate":1633625179113,"gmtModify":1633625179333,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/823236464","repostId":"1123346561","repostType":4,"repost":{"id":"1123346561","kind":"news","pubTimestamp":1633612422,"share":"https://www.laohunote.com/m/news/1123346561?lang=zh_CN&edition=full","pubTime":"2021-10-07 21:13","market":"us","language":"en","title":"Lordstown Motors Is the Poster Child for Blank-Check Firms<blockquote>洛兹敦汽车公司是空白支票公司的典范</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1123346561","media":"InvestorPlace","summary":"RIDE stock confirms the importance of due diligence.\n\nA few months ago, I expressed some concerns ab","content":"<p><div> RIDE stock confirms the importance of due diligence.  A few months ago, I expressed some concerns about Lordstown Motors Corp. stock and suffice to say, it was not well received. Source: Postmodern ...</p><p><blockquote><div>RIDE stock证实了尽职调查的重要性。几个月前，我对 Lordstown Motors Corp. 的股票表达了一些担忧，可以说，它并没有受到好评。来源：后现代……</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">网页连接</a></blockquote></p><p></p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lordstown Motors Is the Poster Child for Blank-Check Firms<blockquote>洛兹敦汽车公司是空白支票公司的典范</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLordstown Motors Is the Poster Child for Blank-Check Firms<blockquote>洛兹敦汽车公司是空白支票公司的典范</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestorPlace</strong><span class=\"h-time small\">2021-10-07 21:13</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> RIDE stock confirms the importance of due diligence.  A few months ago, I expressed some concerns about Lordstown Motors Corp. stock and suffice to say, it was not well received. Source: Postmodern ...</p><p><blockquote><div>RIDE stock证实了尽职调查的重要性。几个月前，我对 Lordstown Motors Corp. 的股票表达了一些担忧，可以说，它并没有受到好评。来源：后现代……</div></blockquote></p><p>  <a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/\">InvestorPlace</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/10/ride-stock-poster-child-for-spacs/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123346561","content_text":"RIDE stock confirms the importance of due diligence.\n\nA few months ago, I expressed some concerns about Lordstown Motors Corp. stock and suffice to say, it was not well received.\nSource: Postmodern Studio / Shutterstock.com\nI could understand why. Even though the criticisms I received regarding my take on RIDE stock did not involve this admission, the reality is that no one likes losing money on a deal.\nHow often have we fretted over losing out on a negotiation rather than the joys that we accrued through victories in other areas. According to an NPR report, this concept has a name,loss aversion. “People care more about losing a dollar than gaining a dollar.” So, I get the anger over losing money from banking on RIDE stock.\nIf it makes anyone feel any better, I’ve put my money down on plenty of clunkers. All I can tell you is that you got to stay in the game through smart money management.\nBut there’s also another point here and that’s the value of due diligence. At the end of September, theNew York Times revealed thatHon Hai Precision Industry Co.(OTCMKTS:HNHPF) – better known as Foxconn – reached an agreement in principle to develop Lordstown’s electric vehicles. Also, it’s quite possible that the EV maker could sell its Ohio factory to Foxconn.\nAdding more woes to stakeholders of RIDE stock, Lordstown “said it would continue to use the factory to make the Endurance by leasing back space from Foxconn if the sale was completed. Foxconn would then offer employment contracts to some Lordstown manufacturing employees. Troubled companies often resort to sale-lease back deals as a way to raise cash.”\nThat’s not all. Under the terms of the agreement, “Foxconn agreed to buy $50 million worth of Lordstown shares at a price of $6.89.” At time of writing, RIDE stock closed at $5.85.\nBlank-Check Fever Was the Blessing and Curse of RIDE Stock\nWith so much attention focused on EVs in light of the massive paradigm shift from the novel coronavirus, it’s easy to forget that RIDE stock came to us via a merger with a special purpose acquisition company. Over the trailing year, SPACs have been the talk of town. But at the end of this period, this distinct manner of an initial public offering has come under scrutiny.\nFor one thing, RIDE stock isn’t an anomaly among post-merger business combinations. True, the hideousness of the losses – down 10% on Oct. 4, down 31% in the trailing five days and down 74% year-to-date – are a bit extreme, even for SPACs. However, SPACs overall have beenunderperforming benchmark indicesso far this year.\nNow, I don’t want to hit on SPACs (with an “S” in front) without providing some balanced context. One of the key benefits of these shell companies is that they open opportunities that would otherwise not be publicly available. Also, for the fullest of full disclosures, I make moneyanalyzing SPACs, so there’s that angle.\nBut the positives of blank-check firms don’t exempt one from conducting due diligence. You just got to do it, especially when you’re betting blind on pre-merger-announcement SPACs.\nBut what really struck me about RIDE stock is that it appears that at least with some SPACs, even their backers haven’t conducted a thorough examination. AnotherNew York Timesarticle describes how the scrutiny of a key architect of the SPAC that merged with Lordstown “was most likely far lessthan the inspection that a company undergoes in a conventional initial public offering.”\n“In an I.P.O., a company is held to strict reporting standards about its finances and prospects. By contrast, SPAC mergers give companies that would find it challenging to go public on their own an easier path to the public markets.”\nBe Careful Out There\nI’m not about to tell you not to buy SPACs – that would be SPAC-ist. Because let’s be real, even traditional IPOs can suffer from questionable antics. Otherwise, the filmThe Wolf of Wall Streetwouldn’t be as colorful as it was.\nBut the takeaway is that SPACs do seem to tempt the worst of behaviors from sponsors that seem to have their own interest in mind rather than the long-term viability of the deals they’re quarterbacking.\nPerhaps that’s the legacy of RIDE stock if this equity unit doesn’t make it out of this mess. Don’t be too comfortable flying with SPAC Air: there might not be anyone in the cockpit.","news_type":1,"symbols_score_info":{"RIDE":0.9}},"isVote":1,"tweetType":1,"viewCount":1285,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829445986,"gmtCreate":1633538342129,"gmtModify":1633538342340,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829445986","repostId":"2173091050","repostType":4,"isVote":1,"tweetType":1,"viewCount":862,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820152447,"gmtCreate":1633360994670,"gmtModify":1633361053911,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820152447","repostId":"1185304471","repostType":4,"repost":{"id":"1185304471","kind":"news","pubTimestamp":1633360698,"share":"https://www.laohunote.com/m/news/1185304471?lang=zh_CN&edition=full","pubTime":"2021-10-04 23:18","market":"us","language":"en","title":"Fed's Bullard: U.S. businesses having no problems raising prices<blockquote>美联储布拉德：美国企业提价没有问题</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1185304471","media":"finance.yahoo","summary":"(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time i","content":"<p>(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.</p><p><blockquote>（路透社） - 圣路易斯联邦储备银行行长詹姆斯·布拉德周一表示，美国企业多年来首次提高客户价格几乎没有问题，他警告称，由于担心更高的预期变得根深蒂固，通胀可能在未来一段时间内保持在高位。</blockquote></p><p> Bullard's business contacts in his Fed district and around the country \"typically say 'don't worry my company's going to be profitable because I am going to raise prices and we've had no difficulty raising prices in this environment,'\" Bullard said during an event held by the International Economic Forum of the Americas.</p><p><blockquote>布拉德在美联储辖区和全国各地的商业联系人“通常会说‘别担心我的公司会盈利，因为我会提高价格，而且我们在这种环境下提高价格没有任何困难’，”布拉德在美洲国际经济论坛举办的一次活动中说道。</blockquote></p><p> Bullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.</p><p><blockquote>布拉德是美联储采取积极措施应对高于预期的通胀的最强烈倡导者之一，他认为 2022 年需要两次加息。自2020年初新冠肺炎疫情爆发以来，利率目前仍接近于零。</blockquote></p><p> \"I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that's not been the case,\" Bullard added.</p><p><blockquote>“我想说，我担心的是经济中围绕价格的心态变化，以及企业认为可以轻松地将增加的成本转嫁给客户的相对自由。多年来，情况并非如此，”布拉德补充道。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed's Bullard: U.S. businesses having no problems raising prices<blockquote>美联储布拉德：美国企业提价没有问题</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed's Bullard: U.S. businesses having no problems raising prices<blockquote>美联储布拉德：美国企业提价没有问题</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">finance.yahoo</strong><span class=\"h-time small\">2021-10-04 23:18</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.</p><p><blockquote>（路透社） - 圣路易斯联邦储备银行行长詹姆斯·布拉德周一表示，美国企业多年来首次提高客户价格几乎没有问题，他警告称，由于担心更高的预期变得根深蒂固，通胀可能在未来一段时间内保持在高位。</blockquote></p><p> Bullard's business contacts in his Fed district and around the country \"typically say 'don't worry my company's going to be profitable because I am going to raise prices and we've had no difficulty raising prices in this environment,'\" Bullard said during an event held by the International Economic Forum of the Americas.</p><p><blockquote>布拉德在美联储辖区和全国各地的商业联系人“通常会说‘别担心我的公司会盈利，因为我会提高价格，而且我们在这种环境下提高价格没有任何困难’，”布拉德在美洲国际经济论坛举办的一次活动中说道。</blockquote></p><p> Bullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.</p><p><blockquote>布拉德是美联储采取积极措施应对高于预期的通胀的最强烈倡导者之一，他认为 2022 年需要两次加息。自2020年初新冠肺炎疫情爆发以来，利率目前仍接近于零。</blockquote></p><p> \"I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that's not been the case,\" Bullard added.</p><p><blockquote>“我想说，我担心的是经济中围绕价格的心态变化，以及企业认为可以轻松地将增加的成本转嫁给客户的相对自由。多年来，情况并非如此，”布拉德补充道。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/feds-bullard-u-businesses-having-151026032.html\">finance.yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/feds-bullard-u-businesses-having-151026032.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185304471","content_text":"(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.\nBullard's business contacts in his Fed district and around the country \"typically say 'don't worry my company's going to be profitable because I am going to raise prices and we've had no difficulty raising prices in this environment,'\" Bullard said during an event held by the International Economic Forum of the Americas.\nBullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.\n\"I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that's not been the case,\" Bullard added.","news_type":1,"symbols_score_info":{".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":1424,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867919618,"gmtCreate":1633184557310,"gmtModify":1633184557600,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867919618","repostId":"1134305481","repostType":4,"repost":{"id":"1134305481","kind":"news","pubTimestamp":1633152909,"share":"https://www.laohunote.com/m/news/1134305481?lang=zh_CN&edition=full","pubTime":"2021-10-02 13:35","market":"sh","language":"en","title":"3 Stocks That Can Double Again in the Fourth Quarter<blockquote>3只股票第四季度可能再次翻倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1134305481","media":"The motley fool","summary":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this mo","content":"<p>Key Points</p><p><blockquote>要点</blockquote></p><p> <ul>  <li>Crocs has jacked up its guidance every quarter this year. It reports again later this month.</li>  <li>AMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.</li>  <li>Upstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.</li> </ul> </p><p><blockquote><ul><li>Crocs 今年每个季度都上调了指引。它将于本月晚些时候再次报道。</li><li>AMC 必须从这里开始翻倍才能重返 6 月份的高点。查看即将到来的影院上映名单，了解为什么电影院会变得更好。</li><li>Upstart 正在彻底改变消费贷款中确定信用度的方式，并且一路嘲笑银行。</li></ul></blockquote></p><p> It's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?</p><p><blockquote>对于股市来说，这是动荡的一年，但自然有些投资比其他投资表现更好。2021 年，超过 300 只股票的股价上涨了一倍多。如果许多获胜的投资能够在今年的最后三个月保持这些收益，他们将是幸运的，但那些有可能再次翻倍的名字呢？</blockquote></p><p> <b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>AMC Entertainment</b>(NYSE:AMC), and<b>Upstart</b>&nbsp;(NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.</p><p><blockquote><b>洞洞鞋</b>（纳斯达克股票代码：CROX）<b>AMC院线</b>（纽约证券交易所代码：AMC），以及<b>暴发户</b>（纳斯达克股票代码：UPST）2021 年前 9 个月的价值增长了一倍多。让我们看看为什么他们有能力在第四季度重复这一壮举。</blockquote></p><p> 1. Crocs</p><p><blockquote>1. 洞洞鞋</blockquote></p><p> Remember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.</p><p><blockquote>还记得那些有洞的明亮橡胶鞋吗？他们又回来了。自疫情爆发以来，Crocs 的销量一直在蓬勃发展，2021 年前 9 个月，该股也随之上涨了 129%。</blockquote></p><p> The comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.</p><p><blockquote>在 COVID-19 危机之前，舒适的树脂鞋已经卷土重来，2019 年实现了两位数的收入增长，然后在 2020 年再次实现这一壮举。2021年，动力才是真正让Crocs更上一层楼的原因。</blockquote></p><p> The year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?</p><p><blockquote>今年年初，这家鞋类制造商在 2 月份预计全年营收增长 20% 至 25%。接下来的一个季度，指引上调至 40% 至 50% 之间。今年夏天，这种情况再次发生，Crocs 现在的目标是 2021 年全年收入增长 60% 至 65%。您认为如果在本月晚些时候公布第三季度业绩时这些目标被推得更高，会发生什么？</blockquote></p><p> Despite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.</p><p><blockquote>尽管该股自 2019 年初以来已上涨近六倍，但考虑到其加速增长，Crocs 的定价还是合理的。该公司的交易价格是今年市盈率的 21 倍，而明年目标仅为 17 倍。显然还有增加这些倍数的空间，华尔街终于对 Crocs 作为一项投资感到满意，就像其客户对 Crocs 的看法一样。</blockquote></p><p> 2. AMC Entertainment</p><p><blockquote>2.AMC院线</blockquote></p><p> You may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.</p><p><blockquote>你可能会惊讶地发现这个国家领先的多厅影院运营商出现在这个名单上，但情节转折是电影如此出色的原因。AMC院线确实已经升值——无论是股价还是流通股的五倍爆炸式增长——到了其估值相对于同行来说已经失控的地步。如果你想对电影院行业的复苏进行纯粹的投资，你会发现价格更具吸引力的股票。</blockquote></p><p> However, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?</p><p><blockquote>然而，作为 ameme 股票和文化现象，很难反驳 AMC 在复苏过程中将其在散户投资者中的受欢迎程度转化为合法的市场份额抢占所做的事情。今年没有一家公司的市值像 AMC 那样膨胀，但这也是一只进入第四季度的股票，其股价仅为 6 月份峰值时的一半多一点。简而言之，它必须从这里翻倍才能重新创下历史高点——但对于 2021 年动量股票的海报儿童来说，这不总是可能的吗？</blockquote></p><p> Fundamentally speaking, the catalysts are also there.<i>Shang-Chi and the Legend of the Ten Rings</i>shattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.</p><p><blockquote>从根本上说，催化剂也在那里。<i>尚气与十环传说</i>劳动节周末打破了票房记录，但当随后的周末表现糟糕时，最初的兴奋就消失了。然而，这都是关于管道的。当德尔塔变异毒株导致新冠肺炎病例激增时，电影公司将9月份的上映推迟到10月份及以后。我们现在看到备受期待的电影开始回归，从下周末的新詹姆斯·邦德电影开始。第四季度对该行业来说应该比反对者想象的要强劲得多，如果 AMC 股价回到 6 月初的水平（这次基本上是盈利的），它将不得不从这里翻一番。</blockquote></p><p> 3. Upstart</p><p><blockquote>3. 新贵</blockquote></p><p> I love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.</p><p><blockquote>我喜欢颠覆时机成熟的行业被颠覆，这就是 Upstart 对贷款行业所做的事情。Upstart 使用人工智能和机器学习来更好地评级，为那些通常无法获得消费贷款批准的人评估风险状况和信用度。</blockquote></p><p> Growth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.</p><p><blockquote>增长是疯狂的。收入似乎急剧放缓，过去三年增长速度分别放缓了 89%、52% 和 27%。现在，消费者开始意识到Upstart是发薪日贷款和其他掠夺性贷款产品的更好替代品，业务正在飙升。第一季度收入增长 90%，但在最新报告中却猛增 1,018%。不，那不是错别字。</blockquote></p><p></p><p> With Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.</p><p><blockquote>随着Upstart现在扩展到汽车贷款市场，其更好的替代乏味信用评分的潜力才刚刚开始。2021 年前三个季度，该股上涨了七袋，但这架颠覆性喷气式飞机的跑道还很长。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Can Double Again in the Fourth Quarter<blockquote>3只股票第四季度可能再次翻倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Can Double Again in the Fourth Quarter<blockquote>3只股票第四季度可能再次翻倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The motley fool</strong><span class=\"h-time small\">2021-10-02 13:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Key Points</p><p><blockquote>要点</blockquote></p><p> <ul>  <li>Crocs has jacked up its guidance every quarter this year. It reports again later this month.</li>  <li>AMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.</li>  <li>Upstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.</li> </ul> </p><p><blockquote><ul><li>Crocs 今年每个季度都上调了指引。它将于本月晚些时候再次报道。</li><li>AMC 必须从这里开始翻倍才能重返 6 月份的高点。查看即将到来的影院上映名单，了解为什么电影院会变得更好。</li><li>Upstart 正在彻底改变消费贷款中确定信用度的方式，并且一路嘲笑银行。</li></ul></blockquote></p><p> It's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?</p><p><blockquote>对于股市来说，这是动荡的一年，但自然有些投资比其他投资表现更好。2021 年，超过 300 只股票的股价上涨了一倍多。如果许多获胜的投资能够在今年的最后三个月保持这些收益，他们将是幸运的，但那些有可能再次翻倍的名字呢？</blockquote></p><p> <b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>AMC Entertainment</b>(NYSE:AMC), and<b>Upstart</b>&nbsp;(NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.</p><p><blockquote><b>洞洞鞋</b>（纳斯达克股票代码：CROX）<b>AMC院线</b>（纽约证券交易所代码：AMC），以及<b>暴发户</b>（纳斯达克股票代码：UPST）2021 年前 9 个月的价值增长了一倍多。让我们看看为什么他们有能力在第四季度重复这一壮举。</blockquote></p><p> 1. Crocs</p><p><blockquote>1. 洞洞鞋</blockquote></p><p> Remember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.</p><p><blockquote>还记得那些有洞的明亮橡胶鞋吗？他们又回来了。自疫情爆发以来，Crocs 的销量一直在蓬勃发展，2021 年前 9 个月，该股也随之上涨了 129%。</blockquote></p><p> The comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.</p><p><blockquote>在 COVID-19 危机之前，舒适的树脂鞋已经卷土重来，2019 年实现了两位数的收入增长，然后在 2020 年再次实现这一壮举。2021年，动力才是真正让Crocs更上一层楼的原因。</blockquote></p><p> The year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?</p><p><blockquote>今年年初，这家鞋类制造商在 2 月份预计全年营收增长 20% 至 25%。接下来的一个季度，指引上调至 40% 至 50% 之间。今年夏天，这种情况再次发生，Crocs 现在的目标是 2021 年全年收入增长 60% 至 65%。您认为如果在本月晚些时候公布第三季度业绩时这些目标被推得更高，会发生什么？</blockquote></p><p> Despite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.</p><p><blockquote>尽管该股自 2019 年初以来已上涨近六倍，但考虑到其加速增长，Crocs 的定价还是合理的。该公司的交易价格是今年市盈率的 21 倍，而明年目标仅为 17 倍。显然还有增加这些倍数的空间，华尔街终于对 Crocs 作为一项投资感到满意，就像其客户对 Crocs 的看法一样。</blockquote></p><p> 2. AMC Entertainment</p><p><blockquote>2.AMC院线</blockquote></p><p> You may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.</p><p><blockquote>你可能会惊讶地发现这个国家领先的多厅影院运营商出现在这个名单上，但情节转折是电影如此出色的原因。AMC院线确实已经升值——无论是股价还是流通股的五倍爆炸式增长——到了其估值相对于同行来说已经失控的地步。如果你想对电影院行业的复苏进行纯粹的投资，你会发现价格更具吸引力的股票。</blockquote></p><p> However, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?</p><p><blockquote>然而，作为 ameme 股票和文化现象，很难反驳 AMC 在复苏过程中将其在散户投资者中的受欢迎程度转化为合法的市场份额抢占所做的事情。今年没有一家公司的市值像 AMC 那样膨胀，但这也是一只进入第四季度的股票，其股价仅为 6 月份峰值时的一半多一点。简而言之，它必须从这里翻倍才能重新创下历史高点——但对于 2021 年动量股票的海报儿童来说，这不总是可能的吗？</blockquote></p><p> Fundamentally speaking, the catalysts are also there.<i>Shang-Chi and the Legend of the Ten Rings</i>shattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.</p><p><blockquote>从根本上说，催化剂也在那里。<i>尚气与十环传说</i>劳动节周末打破了票房记录，但当随后的周末表现糟糕时，最初的兴奋就消失了。然而，这都是关于管道的。当德尔塔变异毒株导致新冠肺炎病例激增时，电影公司将9月份的上映推迟到10月份及以后。我们现在看到备受期待的电影开始回归，从下周末的新詹姆斯·邦德电影开始。第四季度对该行业来说应该比反对者想象的要强劲得多，如果 AMC 股价回到 6 月初的水平（这次基本上是盈利的），它将不得不从这里翻一番。</blockquote></p><p> 3. Upstart</p><p><blockquote>3. 新贵</blockquote></p><p> I love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.</p><p><blockquote>我喜欢颠覆时机成熟的行业被颠覆，这就是 Upstart 对贷款行业所做的事情。Upstart 使用人工智能和机器学习来更好地评级，为那些通常无法获得消费贷款批准的人评估风险状况和信用度。</blockquote></p><p> Growth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.</p><p><blockquote>增长是疯狂的。收入似乎急剧放缓，过去三年增长速度分别放缓了 89%、52% 和 27%。现在，消费者开始意识到Upstart是发薪日贷款和其他掠夺性贷款产品的更好替代品，业务正在飙升。第一季度收入增长 90%，但在最新报告中却猛增 1,018%。不，那不是错别字。</blockquote></p><p></p><p> With Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.</p><p><blockquote>随着Upstart现在扩展到汽车贷款市场，其更好的替代乏味信用评分的潜力才刚刚开始。2021 年前三个季度，该股上涨了七袋，但这架颠覆性喷气式飞机的跑道还很长。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/\">The motley fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CROX":"卡骆驰","UPST":"Upstart Holdings, Inc.","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134305481","content_text":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this month.\nAMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.\nUpstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.\n\n\nIt's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?\nCrocs (NASDAQ:CROX),AMC Entertainment(NYSE:AMC), andUpstart (NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.\n1. Crocs\nRemember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.\nThe comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.\nThe year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?\nDespite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.\n2. AMC Entertainment\nYou may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.\nHowever, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?\nFundamentally speaking, the catalysts are also there.Shang-Chi and the Legend of the Ten Ringsshattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.\n3. Upstart\nI love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.\nGrowth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.\nWith Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.","news_type":1,"symbols_score_info":{"CROX":0.9,"AMC":0.9,"UPST":0.9}},"isVote":1,"tweetType":1,"viewCount":1302,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865442253,"gmtCreate":1633013712650,"gmtModify":1633013712887,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865442253","repostId":"1149815025","repostType":4,"repost":{"id":"1149815025","kind":"news","pubTimestamp":1633013380,"share":"https://www.laohunote.com/m/news/1149815025?lang=zh_CN&edition=full","pubTime":"2021-09-30 22:49","market":"us","language":"en","title":"BioNTech: Stock Price Buoyancy Depends On Comirnaty Sales, But Long Term Value On Pipeline<blockquote>BioNTech：股价上涨取决于 Comirnaty 销售，但长期价值仍在酝酿之中</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1149815025","media":"Seeking Alpha","summary":"Summary\n\nBioNTech has been a phenomenal success story for investors, delivering a ~1,900% gain on in","content":"<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>BioNTech has been a phenomenal success story for investors, delivering a ~1,900% gain on investment since its 2019 IPO.</li>  <li>Sales of its mRNA vaccine Comirnaty will earn the company in excess of $18bn in 2021, management believes - firmly ahead of expectations.</li>  <li>These revenues are likely not sustainable, however - I expect them to dip below $10bn from 2022.</li>  <li>Nevertheless, BioNTech has never been about a single vaccine and the pipeline excites.</li>  <li>mRNA technology is here to stay and BioNTech's pipeline will soon become the key measure for valuing the company. It may take time but a triple-digit billion valuation is a distinct possibility in my view.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d4c2347e8f25525b37a93f78e0d8ba65\" tg-width=\"1536\" tg-height=\"1092\" width=\"100%\" height=\"auto\"><span>PM Images/DigitalVision via Getty Images</span></p><p><blockquote><ul><li>BioNTech 对于投资者来说是一个非凡的成功故事，自 2019 年 IPO 以来，投资收益约为 1,900%。</li><li>管理层认为，其 mRNA 疫苗 Comirnaty 的销售将在 2021 年为该公司带来超过 180 亿美元的收入，远远超出预期。</li><li>然而，这些收入可能不可持续——我预计从 2022 年起将降至 100 亿美元以下。</li><li>尽管如此，BioNTech 从来都不是关于单一疫苗，而且该管道令人兴奋。</li><li>mRNA 技术将继续存在，BioNTech 的产品线将很快成为评估该公司价值的关键衡量标准。这可能需要时间，但在我看来，三位数十亿的估值是一种明显的可能性。</li></ul><p class=\"t-img-caption\"><span>PM Images/DigitalVision via Getty Images</span></p></blockquote></p><p> <b>Investment Thesis</b></p><p><blockquote><b>投资论文</b></blockquote></p><p> BioNTech (BNTX) shareholders who backed the messenger-RNA pioneer at the time of the Germany based company's IPO, which raised ~$150m at a price of $15, can be well satisfied with a &gt;1,900% gain on investment to date - but is the company still worth backing at current price of $277 per share?</p><p><blockquote>BioNTech (BNTX) 的股东在这家德国公司 IPO 时支持了这家信使 RNA 先驱，该公司以 15 美元的价格筹集了约 1.5 亿美元，他们对迄今为止超过 1,900% 的投资收益感到非常满意 - 但该公司目前每股 277 美元的价格仍然值得支持吗？</blockquote></p><p> When I&nbsp;last covered BioNTech&nbsp;back in February, I set a share price forecast of ~$200 for BioNTech stock, but that was based on sales of its Comirnaty COVID vaccine - jointly developed with Pfizer (PFE) - reaching ~$7.5bn in 2021.</p><p><blockquote>当我上次在 2 月份报道 BioNTech 时，我对 BioNTech 股票的股价预测约为 200 美元，但这是基于其与辉瑞 (PFE) 联合开发的 Comirnaty COVID 疫苗的销售额在 2021 年达到约 75 亿美元。</blockquote></p><p> Releasing its&nbsp;Q2'21 results&nbsp;in early August, the company reported 6-month revenues of $8.56bn - shattering my expectations - and its share price reached a stunning peak of $388.</p><p><blockquote>该公司于 8 月初发布了 2021 年第二季度业绩，报告 6 个月收入为 85.6 亿美元，超出了我的预期，其股价达到了 388 美元的惊人峰值。</blockquote></p><p> At the time of writing, shares have fallen back to a price of $277 - discounted by ~29% from their August peak, but with full-year revenues forecast by management to be in the region of $18.5bn, and net profits perhaps reaching &gt;$13.5bn (if we take 6-month net profit figure of $6.8bn and double it), investors will likely look at a forward price to sales ratio of 4x, and forward price to earnings ratio of ~5x, and feel that BioNTech stock continues to look great value.</p><p><blockquote>截至撰写本文时，股价已回落至 277 美元，较 8 月份的峰值折价约 29%，但管理层预测全年收入约为 185 亿美元，净利润可能达到 135 亿美元以上（如果我们取 6 个月净利润数字 68 亿美元并翻倍），投资者可能会看到 4 倍的远期市销率和约 5 倍的远期市盈率，并认为 BioNTech 股票继续看起来很有价值。</blockquote></p><p> Essentially, two factors will determine whether BioNTech shares are worth buying at current price, and also how long investors should think about holding them.</p><p><blockquote>从本质上讲，有两个因素将决定 BioNTech 股票以当前价格是否值得购买，以及投资者应该考虑持有它们多长时间。</blockquote></p><p> The first is the scale of ongoing demand for its COVID vaccine Comirnaty. Sadly, revenues from this source have probably exceeded the market's wildest expectations, with the pandemic refusing to die down, and with booster shots now&nbsp;approved&nbsp;to be administered to over-65's in the US, and to over-50's in the UK, and&nbsp;under consideration&nbsp;for all people over the age of 16 in Europe, there appears to be no set limit to how many Comirnaty shots BioNTech will eventually sell.</p><p><blockquote>首先是对其COVID疫苗Comirnaty的持续需求规模。可悲的是，来自这一来源的收入可能已经超出了市场最疯狂的预期，因为疫情拒绝消亡，而且现在美国批准对 65 岁以上的人和英国 50 岁以上的人进行加强注射，并且正在考虑对欧洲所有 16 岁以上的人进行加强注射，BioNTech 最终销售的 Comirnaty 注射数量似乎没有设定限制。</blockquote></p><p> The second is the migration of the use of messenger-RNA technologies into other therapeutic modalities, to target a broad range of diseases, where it can potentially challenge current standards of care on efficacy and safety.</p><p><blockquote>第二个是信使-RNA技术的使用迁移到其他治疗模式，以针对广泛的疾病，这可能会在疗效和安全性方面挑战当前的护理标准。</blockquote></p><p> Only in a nightmare scenario will vaccine demand remain at current levels beyond the next 2-3 years, and therefore BioNTech's revenues will not remain at 2021 levels over the long term, unless it can launch new vaccine products targeting e.g. other infectious diseases, oncology, auto-immune, inflammation, regenerative medicines, etc.</p><p><blockquote>只有在噩梦般的情况下，疫苗需求才会在未来2-3年内保持在当前水平，因此BioNTech的收入从长远来看不会保持在2021年的水平，除非它能够推出针对其他传染病、肿瘤学、自身免疫、炎症、再生医学等的新疫苗产品。</blockquote></p><p> To that end, BioNTech recently released a&nbsp;70-slide presentation&nbsp;highlighting its development pipeline, and reporting progress across all the above treatment fields. Not one single mention of its COVID vaccine can be found, illustrating that BioNTech has never, and will never think of itself as a pure COVID vaccine company.</p><p><blockquote>为此，BioNTech 最近发布了一份 70 张幻灯片的演示文稿，重点介绍了其开发管道，并报告了上述所有治疗领域的进展。没有一个提到它的COVID疫苗，这说明BioNTech从来没有，也永远不会认为自己是一家纯粹的COVID疫苗公司。</blockquote></p><p> Even so, it will take time to successfully develop new mRNA therapies in other indications, and success is not guaranteed.</p><p><blockquote>即便如此，要在其他适应症中成功开发新的mRNA疗法还需要时间，而且也不能保证成功。</blockquote></p><p> New challengers are emerging in the mRNA field, with strong investor backing and ambitious goals - China-based pharma Abogen Biosciences, for example,recently raised&nbsp;&gt;&nbsp;$700m of funding to develop an mRNA COVID vaccine whilst Sanofi (SNY), the French Pharma company with a &gt;$120bn market cap valuation recently&nbsp;splashed out&nbsp;$3.2bn to acquire Translate Bio, and its messenger RNA Technology targeting Cystic Fibrosis and other genetic diseases.</p><p><blockquote>mRNA 领域正在出现新的挑战者，拥有强大的投资者支持和雄心勃勃的目标 - 例如，总部位于中国的制药公司 Abogen Biosciences 最近筹集了超过 7 亿美元的资金来开发 mRNA COVID 疫苗，而法国制药公司赛诺菲 (SNY) 市值超过 1200 亿美元最近斥资 32 亿美元收购了 Translate Bio 及其针对囊性纤维化和其他遗传疾病的信使 RNA 技术。</blockquote></p><p> 6 months ago, Moderna (MRNA), BioNTech and CureVac were probably considered the \"Big 3\" mRNA pioneers, but CureVac's failure to successfully develop a COVID vaccine has wiped &gt;50% off of its market value whilst Moderna stock has realized unprecedented highs, trading at a price of $390 at the time of writing, with a market valuation of $157bn.</p><p><blockquote>6个月前，Moderna (mRNA)、BioNTech 和 CureVac 可能被认为是“三大”mRNA 先驱，但 CureVac 未能成功开发新冠疫苗，其市值蒸发了 50% 以上，而 Moderna 股票则实现了前所未有的高点，截至撰写本文时，交易价格为 390 美元，市值为 1570 亿美元。</blockquote></p><p></p><p> That is a staggeringly high valuation, but as I argued in my last post on BioNTech and in&nbsp;other posts on Moderna&nbsp;itself, that valuation could potentially double again if the company can prove that mRNA technology will work in any therapeutic setting - as it is striving to do.</p><p><blockquote>这是一个惊人的高估值，但正如我在上一篇关于 BioNTech 的帖子和其他关于 Moderna 本身的帖子中所说，如果该公司能够证明 mRNA 技术可以在任何治疗环境中发挥作用，那么估值可能会再次翻倍——正如它正在努力做到的那样。</blockquote></p><p> I would certainly argue that BioNTech has more in common with Moderna than it does with CureVac - the company will earn a similar volume of revenues in FY21 as Moderna, and yet its market cap of $75bn is half that of Moderna's.</p><p><blockquote>我当然认为 BioNTech 与 Moderna 的共同点比与 CureVac 的共同点更多——该公司在 2021 财年将获得与 Moderna 相似的收入，但其 750 亿美元的市值是 Moderna 的一半。</blockquote></p><p> That may be due firstly to the market's perception that BioNTech owes much of its success to Pfizer, whilst Moderna is not reliant on a Big Pharma partner, and secondly on the strength of Moderna's non-COVID programs.</p><p><blockquote>这可能首先是由于市场认为 BioNTech 的成功很大程度上归功于辉瑞，而 Moderna 并不依赖大型制药合作伙伴，其次是由于 Moderna 非新冠项目的实力。</blockquote></p><p> In the rest of this post I will take a closer look at BioNTech's Covid earnings, and its longer-term development pipeline in order to highlight the short and long-term investment cases.</p><p><blockquote>在这篇文章的其余部分，我将仔细研究 BioNTech 的 Covid 收益及其长期发展管道，以突出短期和长期投资案例。</blockquote></p><p> My thesis is that BioNTech is not worth less than half Moderna, and that Moderna itself is potentially undervalued relative to its opportunities to develop mRNA vaccines and therapies in other therapeutic modalities.</p><p><blockquote>我的论点是，BioNTech 的价值不低于 Moderna 的一半，而且 Moderna 本身相对于其开发 mRNA 疫苗和其他治疗模式疗法的机会可能被低估。</blockquote></p><p> As such, my feeling is that investors can pick up BioNTech stock at current price and be optimistic of ~30% near-term upside, based on recent developments with Comirnaty, and the introduction of booster shots.</p><p><blockquote>因此，我的感觉是，根据 Comirnaty 的最新进展以及加强注射的引入，投资者可以以当前价格买入 BioNTech 股票，并对近期约 30% 的上涨空间持乐观态度。</blockquote></p><p> A dip may follow if COVID revenues begin to slide after 2022, which I expect to happen, and be pronounced, but this ought to be offset by pipeline progress, which suggests to me that BioNTech could maintain a &gt;$100bn market cap, which may even be at the lower end of expectations.</p><p><blockquote>如果 2022 年后 COVID 收入开始下滑（我预计这种情况会发生），并且很明显，那么接下来可能会出现下滑，但这应该会被管道进展所抵消，这表明 BioNTech 可以保持超过 1000 亿美元的市值，甚至可能处于预期的低端。</blockquote></p><p> <b>Outlook for Comirnaty</b></p><p><blockquote><b>Comirnaty 展望</b></blockquote></p><p> Pfizer/BioNTech'sCovid vaccine - now known as Comirnaty, is fully approved by the FDA, and used in &gt;130 countries in the fight against Coronavirus.</p><p><blockquote>辉瑞/BioNTech的COVID疫苗——现在被称为Comirnaty，得到了FDA的完全批准，并在130多个国家用于抗击冠状病毒。</blockquote></p><p> In the first 6 months of 2021, BioNTech and Pfizer shipped &gt;1bn doses of Comirnaty, signed supply contracts to deliver another 2.2bn doses by the end of the year, and committed to supply a further 2bn doses to low and middle-income nations, according to a summation in BioNTech's Q2'21&nbsp;earnings presentation.</p><p><blockquote>2021 年前 6 个月，BioNTech 和辉瑞运送了超过 10 亿剂 Comirnaty，签署了供应合同，将在年底前再交付 22 亿剂，并承诺再向低收入和中等收入国家供应 20 亿剂。 BioNTech 21 年第二季度收益报告中的总结。</blockquote></p><p> Alongside an agreement signed with the EU to provide 900m doses, and potentially another 900m - doses that had been earmarked for fulfilment by CureVac before its vaccine&nbsp;failed to achieve&nbsp;the required efficacy in its pivotal trial, with just 47% versus Pfizer / BioNTech's &gt;95% - there are 90m doses going to the US, and potentially 90m more in 2022.</p><p><blockquote>除了与欧盟签署的提供 9 亿剂疫苗的协议外，CureVac 还可能提供另外 9 亿剂疫苗，这些疫苗在其关键试验中未能达到所需的功效（仅达到 47%，而辉瑞/BioNTech 的功效超过 95%）还有 9000 万剂疫苗将运往美国，2022 年可能还会有 9000 万剂疫苗。</blockquote></p><p> Since August, however, Comirnaty has&nbsp;received&nbsp;an Emergency Use Authorisation (\"EUA\") for use as a booster vaccine, for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups, based on data suggesting that the vaccine \"elicits high neutralization titers against SARS-CoV-2 and all currently tested variants\".</p><p><blockquote>然而，自8月以来，Comirnaty已获得紧急使用授权（“EUA”），可用作加强疫苗，用于65岁及以上的个人以及某些高危人群中18至64岁的个人，其依据是该疫苗“对新型冠状病毒和所有当前测试的变种产生高中和滴度”。</blockquote></p><p> Covid is simply refusing to go away, with a significant spike in infections, hospitalizations and deaths reported across the past 2 months, according to data from the&nbsp;New York Times.</p><p><blockquote>根据《纽约时报》的数据，Covid只是拒绝消失，过去两个月报告的感染、住院和死亡人数大幅增加。</blockquote></p><p> Just as it was the first vaccine approved in the US for COVID, Comirnaty is now the first to be approved as a booster shot, and it seems logical that, in time, booster shots will be extended to the entire US population, and populations worldwide. Looking further ahead, it also seems likely that annual or biannual shots will be required as COVID becomes an endemic disease.</p><p><blockquote>正如它是美国批准的第一个COVID疫苗一样，Comirnaty现在是第一个被批准作为加强注射的疫苗，随着时间的推移，加强注射将扩展到整个美国人口和世界各地的人口，这似乎是合乎逻辑的。展望未来，随着COVID成为地方病，似乎也可能需要每年或每两年注射一次。</blockquote></p><p> With that said, I would argue that it is unlikely that BioNTech will replicate its $18bn of sales - which works out at just under 1bn doses - in 2021 in future years.</p><p><blockquote>话虽如此，我认为 BioNTech 在未来几年不太可能在 2021 年复制其 180 亿美元的销售额（相当于略低于 10 亿剂）。</blockquote></p><p> At maximum capacity, Pfizer/BioNTech can manufacture ~2bn doses per annum, so we can be fairly sure that each firms' sales are capped at &gt;$20bn per annum, but it is also likely that both companies average selling price will decrease after 2021, as the vaccine rollout switches from developed, to developing nations.</p><p><blockquote>辉瑞/BioNTech 在最大产能下每年可以生产约 20 亿剂疫苗，因此我们可以相当肯定每家公司的年销售额上限都在 200 亿美元以上，但两家公司的平均销售价格也有可能在 2021 年后下降，随着疫苗的推出从发达国家转向发展中国家。</blockquote></p><p> Arguably, if every global citizen receives 2 vaccinations per annum, there is demand for ~16bn doses per annum, and as a key supplier, BioNTech would have no issues selling 1bn doses per annum. The deals recently done with the EU are not far short of such figures, but they may not be repeatable, and logistically speaking there is little or no chance that any population globally will be able to achieve &gt;50% population vaccination in a single year in my view.</p><p><blockquote>可以说，如果每个全球公民每年接种两次疫苗，每年的需求约为160亿剂，作为主要供应商，BioNTech每年销售10亿剂疫苗不会有问题。最近与欧盟达成的协议与这样的数字相差不远，但它们可能不可重复，从逻辑上讲，在我看来，全球任何人口都不太可能在一年内实现超过50%的人口疫苗接种率。</blockquote></p><p> As such, I would not expect to see BioNTech earn double-digit billions from Comirnaty sales in any year after 2021, and its profit margins may well narrow after this year - the near 80% profit margin achieved across the first 6 months of 2021 is also simply unsustainable from an economic or ethical viewpoint.</p><p><blockquote>因此，我预计 BioNTech 在 2021 年之后的任何一年都不会从 Comirnaty 销售中赚取两位数的数十亿美元，而且今年之后其利润率很可能会缩小——2021 年前 6 个月实现的近 80% 的利润率从经济或道德角度来看也是根本不可持续的。</blockquote></p><p> I would put forward an average figure of ~$8bn per annum for BioNTech's earnings from Comirnaty between 2022 - 2025, for the reasons discussed above, and a profit margin average of ~50%.</p><p><blockquote>出于上述原因，我预计 2022 年至 2025 年间 BioNTech 从 Comirnaty 获得的平均收入约为 80 亿美元，平均利润率约为 50%。</blockquote></p><p></p><p> That gives me a price to sales ratio of ~9.4x and price to earnings ratio of ~19x - not especially attractive, but realistic, and for a company with as much promise as BioNTech, perhaps a strong value proposition, given what may come from its pipeline.</p><p><blockquote>这给我的市销率约为 9.4 倍，市盈率约为 19 倍——这不是特别有吸引力，但很现实，对于一家像 BioNTech 这样有前途的公司来说，考虑到它的产品线，也许是一个强大的价值主张。</blockquote></p><p> <b>Outlook for Pipeline</b></p><p><blockquote><b>管道展望</b></blockquote></p><p> When we think about the fact that neither BioNTech nor Moderna can realistically rely on revenues or profit margins from its COVID vaccine sales being sustained over the long term at current levels, their valuations - $75bn and $153bn respectively - may look too high.</p><p><blockquote>当我们考虑到 BioNTech 和 Moderna 都无法现实地依赖其 COVID 疫苗销售的收入或利润率长期维持在当前水平时，它们的估值（分别为 750 亿美元和 1530 亿美元）可能看起来太高了。</blockquote></p><p> But believers in mRNA technology - and why wouldn't anyone be excited by a technology as powerful as mRNA, which can effectively instruct cells to manufacture literally any protein - may feel that both companies are significantly undervalued.</p><p><blockquote>但 mRNA 技术的信徒——以及为什么没有人会对像 mRNA 这样强大的技术感到兴奋，这种技术可以有效地指导细胞制造任何蛋白质——可能会觉得这两家公司都被严重低估了。</blockquote></p><p> The key question, however, is whether each company is able to deliver the hoped for revolution in medicine - personalized vaccines for many/all disease types, tailored to the patients' specific genetic profile - how long it will take, what the risk of failure is, and what will happen to each company's share price in the interim period.</p><p><blockquote>然而，关键问题是每家公司是否能够提供人们所希望的医学革命——针对许多/所有疾病类型的个性化疫苗，根据患者的特定基因特征量身定制——需要多长时间，失败的风险是多少，以及在过渡时期内，每家公司的股价会发生什么变化。</blockquote></p><p> The first and most obvious targets are infectious diseases - then oncology, CAR-T cell therapy, immuno-therapies, and then expansion into multiple modalities, covering most disease types that any investor can care to think of.</p><p><blockquote>第一个也是最明显的目标是传染病——然后是肿瘤学、CAR-T细胞疗法、免疫疗法，然后扩展到多种模式，涵盖任何投资者都能想到的大多数疾病类型。</blockquote></p><p> 12 months ago even, BioNTech's infectious disease pipeline went largely under the radar but emboldened by its success with Comirnaty, BioNTech now boasts vaccines in development for Malaria, Tuberculosis and HIV, 10 mRNA vaccines in clinical development targeting infectious diseases, and an influenza vaccine, jointly developed with Pfizer, which implies that the 2 companies are willing to work together over the long term - perhaps a merger is even a possibility.</p><p><blockquote>甚至在 12 个月前，BioNTech 的传染病产品线在很大程度上还不为人知，但受到 Comirnaty 成功的鼓舞，BioNTech 现在拥有正在开发的疟疾、结核病和艾滋病毒疫苗、正在临床开发的 10 种针对传染病的 mRNA 疫苗，以及与辉瑞联合开发的流感疫苗，这意味着两家公司愿意长期合作——也许合并甚至是一种可能性。</blockquote></p><p> By the end of this year, BioNTech will deliver 5 trial updates from vaccines targeting solid tumors, leveraging bi-specifics, CD40, and CAR-T cell therapy, and largely targeting solid tumors, initiate 3 Phase 2 trials, targeting melanoma, head and neck cancer, and colorectal cancer, as well as 7 Phase 1 trials, including its influenza vaccine program.</p><p><blockquote>到今年年底，BioNTech 将提供 5 项针对实体瘤的疫苗试验更新，利用双特异性、CD40 和 CAR-T 细胞疗法，主要针对实体瘤，启动 3 项针对黑色素瘤、头颈癌和结直肠癌的 2 期试验，以及 7 项 1 期试验，包括其流感疫苗计划。</blockquote></p><p> All of the company's plans are laid out in its latest&nbsp;investor presentation- collaborations with Pharma powerhouses such as Regeneron (REGN), Genentech (a Roche subsidiary), and Sanofi, as well as Pfizer.</p><p><blockquote>该公司的所有计划都在其最新的投资者演示中有所阐述——与再生元（REGN）、基因泰克（罗氏子公司）、赛诺菲以及辉瑞等制药巨头合作。</blockquote></p><p> There are 15 oncology programs in total, 6 infectious disease vaccines (admittedly still at the preclinical stage), therapies targeting PD-1 / PDL1, the targets of cancer blockbuster drugs such as Bristol Myers Squibb's (BMY) Opdivo and Merck's (MRK) Keytruda, cell therapies, and cytokine inhibitors.</p><p><blockquote>共有15个肿瘤学项目，6个传染病疫苗（公认仍处于临床前阶段），靶向PD-1/PDL1的疗法，百时美施贵宝（BMY）的Opdivo和默沙东（MRK）的Keytruda等癌症重磅药物的靶点，细胞疗法，以及细胞因子抑制剂。</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p> My point in relation to both BioNTech and Moderna is that both are increasingly beginning to behave more and more like Big Pharma firms - anticipating that their revenue-generating assets may not have a lengthy shelf life, and understanding that they must deliver new medicines in order to support current valuations over the longer term.</p><p><blockquote>我对 BioNTech 和 Moderna 的看法是，两家公司的行为越来越像大型制药公司——预计它们的创收资产可能不会有很长的保质期，并且明白它们必须提供新药以支持当前的长期估值。</blockquote></p><p> Reviewing BioNtech's latest investor presentation - which I encourage all prospective investors to do - I was struck by the amount of progress BioNTech has made in a single year, and not just from a development perspective - the company has always had grand ambitions - but from an organisational, and PR perspective also.</p><p><blockquote>回顾 BioNTech 最新的投资者演示（我鼓励所有潜在投资者这样做），我对 BioNTech 在一年内取得的巨大进步感到震惊，不仅仅是从发展的角度来看——该公司一直有远大的抱负——但从组织和公关的角度来看也是如此。</blockquote></p><p> There's no question in my mind that the market still values BioNTech as if it were a pure COVID vaccine play, and any company with a single, $18bn per annum selling asset is highly unlikely to be able to distract investor's attention away from that asset.</p><p><blockquote>在我看来，毫无疑问，市场仍然将 BioNTech 视为纯粹的新冠疫苗，任何每年出售 180 亿美元资产的公司都不太可能将投资者的注意力从该资产上转移开。</blockquote></p><p> But BioNtech and its management team are smarter than most, in my view, just like their technology, and it is planning for the long term.</p><p><blockquote>但在我看来，BioNtech 及其管理团队比大多数人都聪明，就像他们的技术一样，而且它正在进行长远规划。</blockquote></p><p> Data readouts in oncology - and there ought to be 5 before the end of this year - and progress towards commercialisation of a new infectious disease vaccine - will rapidly become the key yardsticks for assessing the true value of BioNTech shares.</p><p><blockquote>肿瘤学领域的数据读数（今年年底前应该有 5 个）以及新传染病疫苗商业化的进展将迅速成为评估 BioNTech 股票真实价值的关键标准。</blockquote></p><p> There is currently no need for investors to be concerned about BioNtech's share price crashing on negative data readouts from these programs - when there are double-digit billion annual revenues in play - but these programs will increasingly replace Comirnaty sales as the stock markets' weighing machine, and that ought to be good news for fans of mRNA science - of which I am one.</p><p><blockquote>目前，投资者无需担心 BioNtech 的股价因这些项目的负面数据读数而暴跌——当时年收入达到了两位数十亿美元——但这些项目将越来越多地取代 Comirnaty 销售成为股市的称重机器，这对于 mRNA 科学的粉丝来说应该是个好消息——我就是其中之一。</blockquote></p><p> It may take time, but BioNTech represents an exciting buy and hold opportunity for biotech enthusiasts, in my view.</p><p><blockquote>这可能需要时间，但在我看来，BioNTech 代表着生物技术爱好者令人兴奋的买入和持有机会。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech: Stock Price Buoyancy Depends On Comirnaty Sales, But Long Term Value On Pipeline<blockquote>BioNTech：股价上涨取决于 Comirnaty 销售，但长期价值仍在酝酿之中</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech: Stock Price Buoyancy Depends On Comirnaty Sales, But Long Term Value On Pipeline<blockquote>BioNTech：股价上涨取决于 Comirnaty 销售，但长期价值仍在酝酿之中</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-09-30 22:49</span>\n</p>\n</h4>\n</header>\n<article>\n<p><b>Summary</b></p><p><blockquote><b>总结</b></blockquote></p><p> <ul>  <li>BioNTech has been a phenomenal success story for investors, delivering a ~1,900% gain on investment since its 2019 IPO.</li>  <li>Sales of its mRNA vaccine Comirnaty will earn the company in excess of $18bn in 2021, management believes - firmly ahead of expectations.</li>  <li>These revenues are likely not sustainable, however - I expect them to dip below $10bn from 2022.</li>  <li>Nevertheless, BioNTech has never been about a single vaccine and the pipeline excites.</li>  <li>mRNA technology is here to stay and BioNTech's pipeline will soon become the key measure for valuing the company. It may take time but a triple-digit billion valuation is a distinct possibility in my view.</li> </ul> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d4c2347e8f25525b37a93f78e0d8ba65\" tg-width=\"1536\" tg-height=\"1092\" width=\"100%\" height=\"auto\"><span>PM Images/DigitalVision via Getty Images</span></p><p><blockquote><ul><li>BioNTech 对于投资者来说是一个非凡的成功故事，自 2019 年 IPO 以来，投资收益约为 1,900%。</li><li>管理层认为，其 mRNA 疫苗 Comirnaty 的销售将在 2021 年为该公司带来超过 180 亿美元的收入，远远超出预期。</li><li>然而，这些收入可能不可持续——我预计从 2022 年起将降至 100 亿美元以下。</li><li>尽管如此，BioNTech 从来都不是关于单一疫苗，而且该管道令人兴奋。</li><li>mRNA 技术将继续存在，BioNTech 的产品线将很快成为评估该公司价值的关键衡量标准。这可能需要时间，但在我看来，三位数十亿的估值是一种明显的可能性。</li></ul><p class=\"t-img-caption\"><span>PM Images/DigitalVision via Getty Images</span></p></blockquote></p><p> <b>Investment Thesis</b></p><p><blockquote><b>投资论文</b></blockquote></p><p> BioNTech (BNTX) shareholders who backed the messenger-RNA pioneer at the time of the Germany based company's IPO, which raised ~$150m at a price of $15, can be well satisfied with a &gt;1,900% gain on investment to date - but is the company still worth backing at current price of $277 per share?</p><p><blockquote>BioNTech (BNTX) 的股东在这家德国公司 IPO 时支持了这家信使 RNA 先驱，该公司以 15 美元的价格筹集了约 1.5 亿美元，他们对迄今为止超过 1,900% 的投资收益感到非常满意 - 但该公司目前每股 277 美元的价格仍然值得支持吗？</blockquote></p><p> When I&nbsp;last covered BioNTech&nbsp;back in February, I set a share price forecast of ~$200 for BioNTech stock, but that was based on sales of its Comirnaty COVID vaccine - jointly developed with Pfizer (PFE) - reaching ~$7.5bn in 2021.</p><p><blockquote>当我上次在 2 月份报道 BioNTech 时，我对 BioNTech 股票的股价预测约为 200 美元，但这是基于其与辉瑞 (PFE) 联合开发的 Comirnaty COVID 疫苗的销售额在 2021 年达到约 75 亿美元。</blockquote></p><p> Releasing its&nbsp;Q2'21 results&nbsp;in early August, the company reported 6-month revenues of $8.56bn - shattering my expectations - and its share price reached a stunning peak of $388.</p><p><blockquote>该公司于 8 月初发布了 2021 年第二季度业绩，报告 6 个月收入为 85.6 亿美元，超出了我的预期，其股价达到了 388 美元的惊人峰值。</blockquote></p><p> At the time of writing, shares have fallen back to a price of $277 - discounted by ~29% from their August peak, but with full-year revenues forecast by management to be in the region of $18.5bn, and net profits perhaps reaching &gt;$13.5bn (if we take 6-month net profit figure of $6.8bn and double it), investors will likely look at a forward price to sales ratio of 4x, and forward price to earnings ratio of ~5x, and feel that BioNTech stock continues to look great value.</p><p><blockquote>截至撰写本文时，股价已回落至 277 美元，较 8 月份的峰值折价约 29%，但管理层预测全年收入约为 185 亿美元，净利润可能达到 135 亿美元以上（如果我们取 6 个月净利润数字 68 亿美元并翻倍），投资者可能会看到 4 倍的远期市销率和约 5 倍的远期市盈率，并认为 BioNTech 股票继续看起来很有价值。</blockquote></p><p> Essentially, two factors will determine whether BioNTech shares are worth buying at current price, and also how long investors should think about holding them.</p><p><blockquote>从本质上讲，有两个因素将决定 BioNTech 股票以当前价格是否值得购买，以及投资者应该考虑持有它们多长时间。</blockquote></p><p> The first is the scale of ongoing demand for its COVID vaccine Comirnaty. Sadly, revenues from this source have probably exceeded the market's wildest expectations, with the pandemic refusing to die down, and with booster shots now&nbsp;approved&nbsp;to be administered to over-65's in the US, and to over-50's in the UK, and&nbsp;under consideration&nbsp;for all people over the age of 16 in Europe, there appears to be no set limit to how many Comirnaty shots BioNTech will eventually sell.</p><p><blockquote>首先是对其COVID疫苗Comirnaty的持续需求规模。可悲的是，来自这一来源的收入可能已经超出了市场最疯狂的预期，因为疫情拒绝消亡，而且现在美国批准对 65 岁以上的人和英国 50 岁以上的人进行加强注射，并且正在考虑对欧洲所有 16 岁以上的人进行加强注射，BioNTech 最终销售的 Comirnaty 注射数量似乎没有设定限制。</blockquote></p><p> The second is the migration of the use of messenger-RNA technologies into other therapeutic modalities, to target a broad range of diseases, where it can potentially challenge current standards of care on efficacy and safety.</p><p><blockquote>第二个是信使-RNA技术的使用迁移到其他治疗模式，以针对广泛的疾病，这可能会在疗效和安全性方面挑战当前的护理标准。</blockquote></p><p> Only in a nightmare scenario will vaccine demand remain at current levels beyond the next 2-3 years, and therefore BioNTech's revenues will not remain at 2021 levels over the long term, unless it can launch new vaccine products targeting e.g. other infectious diseases, oncology, auto-immune, inflammation, regenerative medicines, etc.</p><p><blockquote>只有在噩梦般的情况下，疫苗需求才会在未来2-3年内保持在当前水平，因此BioNTech的收入从长远来看不会保持在2021年的水平，除非它能够推出针对其他传染病、肿瘤学、自身免疫、炎症、再生医学等的新疫苗产品。</blockquote></p><p> To that end, BioNTech recently released a&nbsp;70-slide presentation&nbsp;highlighting its development pipeline, and reporting progress across all the above treatment fields. Not one single mention of its COVID vaccine can be found, illustrating that BioNTech has never, and will never think of itself as a pure COVID vaccine company.</p><p><blockquote>为此，BioNTech 最近发布了一份 70 张幻灯片的演示文稿，重点介绍了其开发管道，并报告了上述所有治疗领域的进展。没有一个提到它的COVID疫苗，这说明BioNTech从来没有，也永远不会认为自己是一家纯粹的COVID疫苗公司。</blockquote></p><p> Even so, it will take time to successfully develop new mRNA therapies in other indications, and success is not guaranteed.</p><p><blockquote>即便如此，要在其他适应症中成功开发新的mRNA疗法还需要时间，而且也不能保证成功。</blockquote></p><p> New challengers are emerging in the mRNA field, with strong investor backing and ambitious goals - China-based pharma Abogen Biosciences, for example,recently raised&nbsp;&gt;&nbsp;$700m of funding to develop an mRNA COVID vaccine whilst Sanofi (SNY), the French Pharma company with a &gt;$120bn market cap valuation recently&nbsp;splashed out&nbsp;$3.2bn to acquire Translate Bio, and its messenger RNA Technology targeting Cystic Fibrosis and other genetic diseases.</p><p><blockquote>mRNA 领域正在出现新的挑战者，拥有强大的投资者支持和雄心勃勃的目标 - 例如，总部位于中国的制药公司 Abogen Biosciences 最近筹集了超过 7 亿美元的资金来开发 mRNA COVID 疫苗，而法国制药公司赛诺菲 (SNY) 市值超过 1200 亿美元最近斥资 32 亿美元收购了 Translate Bio 及其针对囊性纤维化和其他遗传疾病的信使 RNA 技术。</blockquote></p><p> 6 months ago, Moderna (MRNA), BioNTech and CureVac were probably considered the \"Big 3\" mRNA pioneers, but CureVac's failure to successfully develop a COVID vaccine has wiped &gt;50% off of its market value whilst Moderna stock has realized unprecedented highs, trading at a price of $390 at the time of writing, with a market valuation of $157bn.</p><p><blockquote>6个月前，Moderna (mRNA)、BioNTech 和 CureVac 可能被认为是“三大”mRNA 先驱，但 CureVac 未能成功开发新冠疫苗，其市值蒸发了 50% 以上，而 Moderna 股票则实现了前所未有的高点，截至撰写本文时，交易价格为 390 美元，市值为 1570 亿美元。</blockquote></p><p></p><p> That is a staggeringly high valuation, but as I argued in my last post on BioNTech and in&nbsp;other posts on Moderna&nbsp;itself, that valuation could potentially double again if the company can prove that mRNA technology will work in any therapeutic setting - as it is striving to do.</p><p><blockquote>这是一个惊人的高估值，但正如我在上一篇关于 BioNTech 的帖子和其他关于 Moderna 本身的帖子中所说，如果该公司能够证明 mRNA 技术可以在任何治疗环境中发挥作用，那么估值可能会再次翻倍——正如它正在努力做到的那样。</blockquote></p><p> I would certainly argue that BioNTech has more in common with Moderna than it does with CureVac - the company will earn a similar volume of revenues in FY21 as Moderna, and yet its market cap of $75bn is half that of Moderna's.</p><p><blockquote>我当然认为 BioNTech 与 Moderna 的共同点比与 CureVac 的共同点更多——该公司在 2021 财年将获得与 Moderna 相似的收入，但其 750 亿美元的市值是 Moderna 的一半。</blockquote></p><p> That may be due firstly to the market's perception that BioNTech owes much of its success to Pfizer, whilst Moderna is not reliant on a Big Pharma partner, and secondly on the strength of Moderna's non-COVID programs.</p><p><blockquote>这可能首先是由于市场认为 BioNTech 的成功很大程度上归功于辉瑞，而 Moderna 并不依赖大型制药合作伙伴，其次是由于 Moderna 非新冠项目的实力。</blockquote></p><p> In the rest of this post I will take a closer look at BioNTech's Covid earnings, and its longer-term development pipeline in order to highlight the short and long-term investment cases.</p><p><blockquote>在这篇文章的其余部分，我将仔细研究 BioNTech 的 Covid 收益及其长期发展管道，以突出短期和长期投资案例。</blockquote></p><p> My thesis is that BioNTech is not worth less than half Moderna, and that Moderna itself is potentially undervalued relative to its opportunities to develop mRNA vaccines and therapies in other therapeutic modalities.</p><p><blockquote>我的论点是，BioNTech 的价值不低于 Moderna 的一半，而且 Moderna 本身相对于其开发 mRNA 疫苗和其他治疗模式疗法的机会可能被低估。</blockquote></p><p> As such, my feeling is that investors can pick up BioNTech stock at current price and be optimistic of ~30% near-term upside, based on recent developments with Comirnaty, and the introduction of booster shots.</p><p><blockquote>因此，我的感觉是，根据 Comirnaty 的最新进展以及加强注射的引入，投资者可以以当前价格买入 BioNTech 股票，并对近期约 30% 的上涨空间持乐观态度。</blockquote></p><p> A dip may follow if COVID revenues begin to slide after 2022, which I expect to happen, and be pronounced, but this ought to be offset by pipeline progress, which suggests to me that BioNTech could maintain a &gt;$100bn market cap, which may even be at the lower end of expectations.</p><p><blockquote>如果 2022 年后 COVID 收入开始下滑（我预计这种情况会发生），并且很明显，那么接下来可能会出现下滑，但这应该会被管道进展所抵消，这表明 BioNTech 可以保持超过 1000 亿美元的市值，甚至可能处于预期的低端。</blockquote></p><p> <b>Outlook for Comirnaty</b></p><p><blockquote><b>Comirnaty 展望</b></blockquote></p><p> Pfizer/BioNTech'sCovid vaccine - now known as Comirnaty, is fully approved by the FDA, and used in &gt;130 countries in the fight against Coronavirus.</p><p><blockquote>辉瑞/BioNTech的COVID疫苗——现在被称为Comirnaty，得到了FDA的完全批准，并在130多个国家用于抗击冠状病毒。</blockquote></p><p> In the first 6 months of 2021, BioNTech and Pfizer shipped &gt;1bn doses of Comirnaty, signed supply contracts to deliver another 2.2bn doses by the end of the year, and committed to supply a further 2bn doses to low and middle-income nations, according to a summation in BioNTech's Q2'21&nbsp;earnings presentation.</p><p><blockquote>2021 年前 6 个月，BioNTech 和辉瑞运送了超过 10 亿剂 Comirnaty，签署了供应合同，将在年底前再交付 22 亿剂，并承诺再向低收入和中等收入国家供应 20 亿剂。 BioNTech 21 年第二季度收益报告中的总结。</blockquote></p><p> Alongside an agreement signed with the EU to provide 900m doses, and potentially another 900m - doses that had been earmarked for fulfilment by CureVac before its vaccine&nbsp;failed to achieve&nbsp;the required efficacy in its pivotal trial, with just 47% versus Pfizer / BioNTech's &gt;95% - there are 90m doses going to the US, and potentially 90m more in 2022.</p><p><blockquote>除了与欧盟签署的提供 9 亿剂疫苗的协议外，CureVac 还可能提供另外 9 亿剂疫苗，这些疫苗在其关键试验中未能达到所需的功效（仅达到 47%，而辉瑞/BioNTech 的功效超过 95%）还有 9000 万剂疫苗将运往美国，2022 年可能还会有 9000 万剂疫苗。</blockquote></p><p> Since August, however, Comirnaty has&nbsp;received&nbsp;an Emergency Use Authorisation (\"EUA\") for use as a booster vaccine, for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups, based on data suggesting that the vaccine \"elicits high neutralization titers against SARS-CoV-2 and all currently tested variants\".</p><p><blockquote>然而，自8月以来，Comirnaty已获得紧急使用授权（“EUA”），可用作加强疫苗，用于65岁及以上的个人以及某些高危人群中18至64岁的个人，其依据是该疫苗“对新型冠状病毒和所有当前测试的变种产生高中和滴度”。</blockquote></p><p> Covid is simply refusing to go away, with a significant spike in infections, hospitalizations and deaths reported across the past 2 months, according to data from the&nbsp;New York Times.</p><p><blockquote>根据《纽约时报》的数据，Covid只是拒绝消失，过去两个月报告的感染、住院和死亡人数大幅增加。</blockquote></p><p> Just as it was the first vaccine approved in the US for COVID, Comirnaty is now the first to be approved as a booster shot, and it seems logical that, in time, booster shots will be extended to the entire US population, and populations worldwide. Looking further ahead, it also seems likely that annual or biannual shots will be required as COVID becomes an endemic disease.</p><p><blockquote>正如它是美国批准的第一个COVID疫苗一样，Comirnaty现在是第一个被批准作为加强注射的疫苗，随着时间的推移，加强注射将扩展到整个美国人口和世界各地的人口，这似乎是合乎逻辑的。展望未来，随着COVID成为地方病，似乎也可能需要每年或每两年注射一次。</blockquote></p><p> With that said, I would argue that it is unlikely that BioNTech will replicate its $18bn of sales - which works out at just under 1bn doses - in 2021 in future years.</p><p><blockquote>话虽如此，我认为 BioNTech 在未来几年不太可能在 2021 年复制其 180 亿美元的销售额（相当于略低于 10 亿剂）。</blockquote></p><p> At maximum capacity, Pfizer/BioNTech can manufacture ~2bn doses per annum, so we can be fairly sure that each firms' sales are capped at &gt;$20bn per annum, but it is also likely that both companies average selling price will decrease after 2021, as the vaccine rollout switches from developed, to developing nations.</p><p><blockquote>辉瑞/BioNTech 在最大产能下每年可以生产约 20 亿剂疫苗，因此我们可以相当肯定每家公司的年销售额上限都在 200 亿美元以上，但两家公司的平均销售价格也有可能在 2021 年后下降，随着疫苗的推出从发达国家转向发展中国家。</blockquote></p><p> Arguably, if every global citizen receives 2 vaccinations per annum, there is demand for ~16bn doses per annum, and as a key supplier, BioNTech would have no issues selling 1bn doses per annum. The deals recently done with the EU are not far short of such figures, but they may not be repeatable, and logistically speaking there is little or no chance that any population globally will be able to achieve &gt;50% population vaccination in a single year in my view.</p><p><blockquote>可以说，如果每个全球公民每年接种两次疫苗，每年的需求约为160亿剂，作为主要供应商，BioNTech每年销售10亿剂疫苗不会有问题。最近与欧盟达成的协议与这样的数字相差不远，但它们可能不可重复，从逻辑上讲，在我看来，全球任何人口都不太可能在一年内实现超过50%的人口疫苗接种率。</blockquote></p><p> As such, I would not expect to see BioNTech earn double-digit billions from Comirnaty sales in any year after 2021, and its profit margins may well narrow after this year - the near 80% profit margin achieved across the first 6 months of 2021 is also simply unsustainable from an economic or ethical viewpoint.</p><p><blockquote>因此，我预计 BioNTech 在 2021 年之后的任何一年都不会从 Comirnaty 销售中赚取两位数的数十亿美元，而且今年之后其利润率很可能会缩小——2021 年前 6 个月实现的近 80% 的利润率从经济或道德角度来看也是根本不可持续的。</blockquote></p><p> I would put forward an average figure of ~$8bn per annum for BioNTech's earnings from Comirnaty between 2022 - 2025, for the reasons discussed above, and a profit margin average of ~50%.</p><p><blockquote>出于上述原因，我预计 2022 年至 2025 年间 BioNTech 从 Comirnaty 获得的平均收入约为 80 亿美元，平均利润率约为 50%。</blockquote></p><p></p><p> That gives me a price to sales ratio of ~9.4x and price to earnings ratio of ~19x - not especially attractive, but realistic, and for a company with as much promise as BioNTech, perhaps a strong value proposition, given what may come from its pipeline.</p><p><blockquote>这给我的市销率约为 9.4 倍，市盈率约为 19 倍——这不是特别有吸引力，但很现实，对于一家像 BioNTech 这样有前途的公司来说，考虑到它的产品线，也许是一个强大的价值主张。</blockquote></p><p> <b>Outlook for Pipeline</b></p><p><blockquote><b>管道展望</b></blockquote></p><p> When we think about the fact that neither BioNTech nor Moderna can realistically rely on revenues or profit margins from its COVID vaccine sales being sustained over the long term at current levels, their valuations - $75bn and $153bn respectively - may look too high.</p><p><blockquote>当我们考虑到 BioNTech 和 Moderna 都无法现实地依赖其 COVID 疫苗销售的收入或利润率长期维持在当前水平时，它们的估值（分别为 750 亿美元和 1530 亿美元）可能看起来太高了。</blockquote></p><p> But believers in mRNA technology - and why wouldn't anyone be excited by a technology as powerful as mRNA, which can effectively instruct cells to manufacture literally any protein - may feel that both companies are significantly undervalued.</p><p><blockquote>但 mRNA 技术的信徒——以及为什么没有人会对像 mRNA 这样强大的技术感到兴奋，这种技术可以有效地指导细胞制造任何蛋白质——可能会觉得这两家公司都被严重低估了。</blockquote></p><p> The key question, however, is whether each company is able to deliver the hoped for revolution in medicine - personalized vaccines for many/all disease types, tailored to the patients' specific genetic profile - how long it will take, what the risk of failure is, and what will happen to each company's share price in the interim period.</p><p><blockquote>然而，关键问题是每家公司是否能够提供人们所希望的医学革命——针对许多/所有疾病类型的个性化疫苗，根据患者的特定基因特征量身定制——需要多长时间，失败的风险是多少，以及在过渡时期内，每家公司的股价会发生什么变化。</blockquote></p><p> The first and most obvious targets are infectious diseases - then oncology, CAR-T cell therapy, immuno-therapies, and then expansion into multiple modalities, covering most disease types that any investor can care to think of.</p><p><blockquote>第一个也是最明显的目标是传染病——然后是肿瘤学、CAR-T细胞疗法、免疫疗法，然后扩展到多种模式，涵盖任何投资者都能想到的大多数疾病类型。</blockquote></p><p> 12 months ago even, BioNTech's infectious disease pipeline went largely under the radar but emboldened by its success with Comirnaty, BioNTech now boasts vaccines in development for Malaria, Tuberculosis and HIV, 10 mRNA vaccines in clinical development targeting infectious diseases, and an influenza vaccine, jointly developed with Pfizer, which implies that the 2 companies are willing to work together over the long term - perhaps a merger is even a possibility.</p><p><blockquote>甚至在 12 个月前，BioNTech 的传染病产品线在很大程度上还不为人知，但受到 Comirnaty 成功的鼓舞，BioNTech 现在拥有正在开发的疟疾、结核病和艾滋病毒疫苗、正在临床开发的 10 种针对传染病的 mRNA 疫苗，以及与辉瑞联合开发的流感疫苗，这意味着两家公司愿意长期合作——也许合并甚至是一种可能性。</blockquote></p><p> By the end of this year, BioNTech will deliver 5 trial updates from vaccines targeting solid tumors, leveraging bi-specifics, CD40, and CAR-T cell therapy, and largely targeting solid tumors, initiate 3 Phase 2 trials, targeting melanoma, head and neck cancer, and colorectal cancer, as well as 7 Phase 1 trials, including its influenza vaccine program.</p><p><blockquote>到今年年底，BioNTech 将提供 5 项针对实体瘤的疫苗试验更新，利用双特异性、CD40 和 CAR-T 细胞疗法，主要针对实体瘤，启动 3 项针对黑色素瘤、头颈癌和结直肠癌的 2 期试验，以及 7 项 1 期试验，包括其流感疫苗计划。</blockquote></p><p> All of the company's plans are laid out in its latest&nbsp;investor presentation- collaborations with Pharma powerhouses such as Regeneron (REGN), Genentech (a Roche subsidiary), and Sanofi, as well as Pfizer.</p><p><blockquote>该公司的所有计划都在其最新的投资者演示中有所阐述——与再生元（REGN）、基因泰克（罗氏子公司）、赛诺菲以及辉瑞等制药巨头合作。</blockquote></p><p> There are 15 oncology programs in total, 6 infectious disease vaccines (admittedly still at the preclinical stage), therapies targeting PD-1 / PDL1, the targets of cancer blockbuster drugs such as Bristol Myers Squibb's (BMY) Opdivo and Merck's (MRK) Keytruda, cell therapies, and cytokine inhibitors.</p><p><blockquote>共有15个肿瘤学项目，6个传染病疫苗（公认仍处于临床前阶段），靶向PD-1/PDL1的疗法，百时美施贵宝（BMY）的Opdivo和默沙东（MRK）的Keytruda等癌症重磅药物的靶点，细胞疗法，以及细胞因子抑制剂。</blockquote></p><p> <b>Conclusion</b></p><p><blockquote><b>结论</b></blockquote></p><p> My point in relation to both BioNTech and Moderna is that both are increasingly beginning to behave more and more like Big Pharma firms - anticipating that their revenue-generating assets may not have a lengthy shelf life, and understanding that they must deliver new medicines in order to support current valuations over the longer term.</p><p><blockquote>我对 BioNTech 和 Moderna 的看法是，两家公司的行为越来越像大型制药公司——预计它们的创收资产可能不会有很长的保质期，并且明白它们必须提供新药以支持当前的长期估值。</blockquote></p><p> Reviewing BioNtech's latest investor presentation - which I encourage all prospective investors to do - I was struck by the amount of progress BioNTech has made in a single year, and not just from a development perspective - the company has always had grand ambitions - but from an organisational, and PR perspective also.</p><p><blockquote>回顾 BioNTech 最新的投资者演示（我鼓励所有潜在投资者这样做），我对 BioNTech 在一年内取得的巨大进步感到震惊，不仅仅是从发展的角度来看——该公司一直有远大的抱负——但从组织和公关的角度来看也是如此。</blockquote></p><p> There's no question in my mind that the market still values BioNTech as if it were a pure COVID vaccine play, and any company with a single, $18bn per annum selling asset is highly unlikely to be able to distract investor's attention away from that asset.</p><p><blockquote>在我看来，毫无疑问，市场仍然将 BioNTech 视为纯粹的新冠疫苗，任何每年出售 180 亿美元资产的公司都不太可能将投资者的注意力从该资产上转移开。</blockquote></p><p> But BioNtech and its management team are smarter than most, in my view, just like their technology, and it is planning for the long term.</p><p><blockquote>但在我看来，BioNtech 及其管理团队比大多数人都聪明，就像他们的技术一样，而且它正在进行长远规划。</blockquote></p><p> Data readouts in oncology - and there ought to be 5 before the end of this year - and progress towards commercialisation of a new infectious disease vaccine - will rapidly become the key yardsticks for assessing the true value of BioNTech shares.</p><p><blockquote>肿瘤学领域的数据读数（今年年底前应该有 5 个）以及新传染病疫苗商业化的进展将迅速成为评估 BioNTech 股票真实价值的关键标准。</blockquote></p><p> There is currently no need for investors to be concerned about BioNtech's share price crashing on negative data readouts from these programs - when there are double-digit billion annual revenues in play - but these programs will increasingly replace Comirnaty sales as the stock markets' weighing machine, and that ought to be good news for fans of mRNA science - of which I am one.</p><p><blockquote>目前，投资者无需担心 BioNtech 的股价因这些项目的负面数据读数而暴跌——当时年收入达到了两位数十亿美元——但这些项目将越来越多地取代 Comirnaty 销售成为股市的称重机器，这对于 mRNA 科学的粉丝来说应该是个好消息——我就是其中之一。</blockquote></p><p> It may take time, but BioNTech represents an exciting buy and hold opportunity for biotech enthusiasts, in my view.</p><p><blockquote>这可能需要时间，但在我看来，BioNTech 代表着生物技术爱好者令人兴奋的买入和持有机会。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://seekingalpha.com/article/4457813-biontech-stock-price-buoyancy-depends-on-comirnaty-sales-but-long-term-value-on-pipeline-bntx\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/article/4457813-biontech-stock-price-buoyancy-depends-on-comirnaty-sales-but-long-term-value-on-pipeline-bntx","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149815025","content_text":"Summary\n\nBioNTech has been a phenomenal success story for investors, delivering a ~1,900% gain on investment since its 2019 IPO.\nSales of its mRNA vaccine Comirnaty will earn the company in excess of $18bn in 2021, management believes - firmly ahead of expectations.\nThese revenues are likely not sustainable, however - I expect them to dip below $10bn from 2022.\nNevertheless, BioNTech has never been about a single vaccine and the pipeline excites.\nmRNA technology is here to stay and BioNTech's pipeline will soon become the key measure for valuing the company. It may take time but a triple-digit billion valuation is a distinct possibility in my view.\n\nPM Images/DigitalVision via Getty Images\nInvestment Thesis\nBioNTech (BNTX) shareholders who backed the messenger-RNA pioneer at the time of the Germany based company's IPO, which raised ~$150m at a price of $15, can be well satisfied with a >1,900% gain on investment to date - but is the company still worth backing at current price of $277 per share?\nWhen I last covered BioNTech back in February, I set a share price forecast of ~$200 for BioNTech stock, but that was based on sales of its Comirnaty COVID vaccine - jointly developed with Pfizer (PFE) - reaching ~$7.5bn in 2021.\nReleasing its Q2'21 results in early August, the company reported 6-month revenues of $8.56bn - shattering my expectations - and its share price reached a stunning peak of $388.\nAt the time of writing, shares have fallen back to a price of $277 - discounted by ~29% from their August peak, but with full-year revenues forecast by management to be in the region of $18.5bn, and net profits perhaps reaching >$13.5bn (if we take 6-month net profit figure of $6.8bn and double it), investors will likely look at a forward price to sales ratio of 4x, and forward price to earnings ratio of ~5x, and feel that BioNTech stock continues to look great value.\nEssentially, two factors will determine whether BioNTech shares are worth buying at current price, and also how long investors should think about holding them.\nThe first is the scale of ongoing demand for its COVID vaccine Comirnaty. Sadly, revenues from this source have probably exceeded the market's wildest expectations, with the pandemic refusing to die down, and with booster shots now approved to be administered to over-65's in the US, and to over-50's in the UK, and under consideration for all people over the age of 16 in Europe, there appears to be no set limit to how many Comirnaty shots BioNTech will eventually sell.\nThe second is the migration of the use of messenger-RNA technologies into other therapeutic modalities, to target a broad range of diseases, where it can potentially challenge current standards of care on efficacy and safety.\nOnly in a nightmare scenario will vaccine demand remain at current levels beyond the next 2-3 years, and therefore BioNTech's revenues will not remain at 2021 levels over the long term, unless it can launch new vaccine products targeting e.g. other infectious diseases, oncology, auto-immune, inflammation, regenerative medicines, etc.\nTo that end, BioNTech recently released a 70-slide presentation highlighting its development pipeline, and reporting progress across all the above treatment fields. Not one single mention of its COVID vaccine can be found, illustrating that BioNTech has never, and will never think of itself as a pure COVID vaccine company.\nEven so, it will take time to successfully develop new mRNA therapies in other indications, and success is not guaranteed.\nNew challengers are emerging in the mRNA field, with strong investor backing and ambitious goals - China-based pharma Abogen Biosciences, for example,recently raised > $700m of funding to develop an mRNA COVID vaccine whilst Sanofi (SNY), the French Pharma company with a >$120bn market cap valuation recently splashed out $3.2bn to acquire Translate Bio, and its messenger RNA Technology targeting Cystic Fibrosis and other genetic diseases.\n6 months ago, Moderna (MRNA), BioNTech and CureVac were probably considered the \"Big 3\" mRNA pioneers, but CureVac's failure to successfully develop a COVID vaccine has wiped >50% off of its market value whilst Moderna stock has realized unprecedented highs, trading at a price of $390 at the time of writing, with a market valuation of $157bn.\nThat is a staggeringly high valuation, but as I argued in my last post on BioNTech and in other posts on Moderna itself, that valuation could potentially double again if the company can prove that mRNA technology will work in any therapeutic setting - as it is striving to do.\nI would certainly argue that BioNTech has more in common with Moderna than it does with CureVac - the company will earn a similar volume of revenues in FY21 as Moderna, and yet its market cap of $75bn is half that of Moderna's.\nThat may be due firstly to the market's perception that BioNTech owes much of its success to Pfizer, whilst Moderna is not reliant on a Big Pharma partner, and secondly on the strength of Moderna's non-COVID programs.\nIn the rest of this post I will take a closer look at BioNTech's Covid earnings, and its longer-term development pipeline in order to highlight the short and long-term investment cases.\nMy thesis is that BioNTech is not worth less than half Moderna, and that Moderna itself is potentially undervalued relative to its opportunities to develop mRNA vaccines and therapies in other therapeutic modalities.\nAs such, my feeling is that investors can pick up BioNTech stock at current price and be optimistic of ~30% near-term upside, based on recent developments with Comirnaty, and the introduction of booster shots.\nA dip may follow if COVID revenues begin to slide after 2022, which I expect to happen, and be pronounced, but this ought to be offset by pipeline progress, which suggests to me that BioNTech could maintain a >$100bn market cap, which may even be at the lower end of expectations.\nOutlook for Comirnaty\nPfizer/BioNTech'sCovid vaccine - now known as Comirnaty, is fully approved by the FDA, and used in >130 countries in the fight against Coronavirus.\nIn the first 6 months of 2021, BioNTech and Pfizer shipped >1bn doses of Comirnaty, signed supply contracts to deliver another 2.2bn doses by the end of the year, and committed to supply a further 2bn doses to low and middle-income nations, according to a summation in BioNTech's Q2'21 earnings presentation.\nAlongside an agreement signed with the EU to provide 900m doses, and potentially another 900m - doses that had been earmarked for fulfilment by CureVac before its vaccine failed to achieve the required efficacy in its pivotal trial, with just 47% versus Pfizer / BioNTech's >95% - there are 90m doses going to the US, and potentially 90m more in 2022.\nSince August, however, Comirnaty has received an Emergency Use Authorisation (\"EUA\") for use as a booster vaccine, for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups, based on data suggesting that the vaccine \"elicits high neutralization titers against SARS-CoV-2 and all currently tested variants\".\nCovid is simply refusing to go away, with a significant spike in infections, hospitalizations and deaths reported across the past 2 months, according to data from the New York Times.\nJust as it was the first vaccine approved in the US for COVID, Comirnaty is now the first to be approved as a booster shot, and it seems logical that, in time, booster shots will be extended to the entire US population, and populations worldwide. Looking further ahead, it also seems likely that annual or biannual shots will be required as COVID becomes an endemic disease.\nWith that said, I would argue that it is unlikely that BioNTech will replicate its $18bn of sales - which works out at just under 1bn doses - in 2021 in future years.\nAt maximum capacity, Pfizer/BioNTech can manufacture ~2bn doses per annum, so we can be fairly sure that each firms' sales are capped at >$20bn per annum, but it is also likely that both companies average selling price will decrease after 2021, as the vaccine rollout switches from developed, to developing nations.\nArguably, if every global citizen receives 2 vaccinations per annum, there is demand for ~16bn doses per annum, and as a key supplier, BioNTech would have no issues selling 1bn doses per annum. The deals recently done with the EU are not far short of such figures, but they may not be repeatable, and logistically speaking there is little or no chance that any population globally will be able to achieve >50% population vaccination in a single year in my view.\nAs such, I would not expect to see BioNTech earn double-digit billions from Comirnaty sales in any year after 2021, and its profit margins may well narrow after this year - the near 80% profit margin achieved across the first 6 months of 2021 is also simply unsustainable from an economic or ethical viewpoint.\nI would put forward an average figure of ~$8bn per annum for BioNTech's earnings from Comirnaty between 2022 - 2025, for the reasons discussed above, and a profit margin average of ~50%.\nThat gives me a price to sales ratio of ~9.4x and price to earnings ratio of ~19x - not especially attractive, but realistic, and for a company with as much promise as BioNTech, perhaps a strong value proposition, given what may come from its pipeline.\nOutlook for Pipeline\nWhen we think about the fact that neither BioNTech nor Moderna can realistically rely on revenues or profit margins from its COVID vaccine sales being sustained over the long term at current levels, their valuations - $75bn and $153bn respectively - may look too high.\nBut believers in mRNA technology - and why wouldn't anyone be excited by a technology as powerful as mRNA, which can effectively instruct cells to manufacture literally any protein - may feel that both companies are significantly undervalued.\nThe key question, however, is whether each company is able to deliver the hoped for revolution in medicine - personalized vaccines for many/all disease types, tailored to the patients' specific genetic profile - how long it will take, what the risk of failure is, and what will happen to each company's share price in the interim period.\nThe first and most obvious targets are infectious diseases - then oncology, CAR-T cell therapy, immuno-therapies, and then expansion into multiple modalities, covering most disease types that any investor can care to think of.\n12 months ago even, BioNTech's infectious disease pipeline went largely under the radar but emboldened by its success with Comirnaty, BioNTech now boasts vaccines in development for Malaria, Tuberculosis and HIV, 10 mRNA vaccines in clinical development targeting infectious diseases, and an influenza vaccine, jointly developed with Pfizer, which implies that the 2 companies are willing to work together over the long term - perhaps a merger is even a possibility.\nBy the end of this year, BioNTech will deliver 5 trial updates from vaccines targeting solid tumors, leveraging bi-specifics, CD40, and CAR-T cell therapy, and largely targeting solid tumors, initiate 3 Phase 2 trials, targeting melanoma, head and neck cancer, and colorectal cancer, as well as 7 Phase 1 trials, including its influenza vaccine program.\nAll of the company's plans are laid out in its latest investor presentation- collaborations with Pharma powerhouses such as Regeneron (REGN), Genentech (a Roche subsidiary), and Sanofi, as well as Pfizer.\nThere are 15 oncology programs in total, 6 infectious disease vaccines (admittedly still at the preclinical stage), therapies targeting PD-1 / PDL1, the targets of cancer blockbuster drugs such as Bristol Myers Squibb's (BMY) Opdivo and Merck's (MRK) Keytruda, cell therapies, and cytokine inhibitors.\nConclusion\nMy point in relation to both BioNTech and Moderna is that both are increasingly beginning to behave more and more like Big Pharma firms - anticipating that their revenue-generating assets may not have a lengthy shelf life, and understanding that they must deliver new medicines in order to support current valuations over the longer term.\nReviewing BioNtech's latest investor presentation - which I encourage all prospective investors to do - I was struck by the amount of progress BioNTech has made in a single year, and not just from a development perspective - the company has always had grand ambitions - but from an organisational, and PR perspective also.\nThere's no question in my mind that the market still values BioNTech as if it were a pure COVID vaccine play, and any company with a single, $18bn per annum selling asset is highly unlikely to be able to distract investor's attention away from that asset.\nBut BioNtech and its management team are smarter than most, in my view, just like their technology, and it is planning for the long term.\nData readouts in oncology - and there ought to be 5 before the end of this year - and progress towards commercialisation of a new infectious disease vaccine - will rapidly become the key yardsticks for assessing the true value of BioNTech shares.\nThere is currently no need for investors to be concerned about BioNtech's share price crashing on negative data readouts from these programs - when there are double-digit billion annual revenues in play - but these programs will increasingly replace Comirnaty sales as the stock markets' weighing machine, and that ought to be good news for fans of mRNA science - of which I am one.\nIt may take time, but BioNTech represents an exciting buy and hold opportunity for biotech enthusiasts, in my view.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1306,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865054353,"gmtCreate":1632926008796,"gmtModify":1632926008994,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574428256060280","authorIdStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/865054353","repostId":"1190233990","repostType":4,"repost":{"id":"1190233990","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632925635,"share":"https://www.laohunote.com/m/news/1190233990?lang=zh_CN&edition=full","pubTime":"2021-09-29 22:27","market":"us","language":"en","title":"Pharmaceutical stocks rallied in morning trading<blockquote>医药股早盘上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1190233990","media":"Tiger Newspress","summary":"Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZen","content":"<p>Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca&nbsp;and&nbsp;Sanofi&nbsp;climbed&nbsp;between 0.5% and 3%.</p><p><blockquote>制药股早盘上涨.辉瑞、BioNTech SE、礼来、默克、Moderna、阿斯利康和赛诺菲上涨0.5%至3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/30e27c112e85fc577e71ea58a8ac6216\" tg-width=\"407\" tg-height=\"716\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Pfizer’s covid-19 vaccine for kids may not be FDA authorized before november.</p><p><blockquote>辉瑞公司的儿童 covid-19 疫苗可能要到 11 月才能获得 FDA 的批准。</blockquote></p><p> Citi analyst Andrew Baum upgraded shares of Ely Lilly and Co&nbsp;to Buy and raised the price target.</p><p><blockquote>花旗分析师安德鲁·鲍姆将礼来公司的股票上调至买入，并上调了目标价。</blockquote></p><p> Merck says its covid-19 antiviral pill is cctive against variants.</p><p><blockquote>默克公司表示，其 covid-19 抗病毒药丸对变异株有效。</blockquote></p><p> AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.</p><p><blockquote>阿斯利康以 5 亿美元的潜在交易收购罕见病制药商 Caelum。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaceutical stocks rallied in morning trading<blockquote>医药股早盘上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaceutical stocks rallied in morning trading<blockquote>医药股早盘上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-29 22:27</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca&nbsp;and&nbsp;Sanofi&nbsp;climbed&nbsp;between 0.5% and 3%.</p><p><blockquote>制药股早盘上涨.辉瑞、BioNTech SE、礼来、默克、Moderna、阿斯利康和赛诺菲上涨0.5%至3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/30e27c112e85fc577e71ea58a8ac6216\" tg-width=\"407\" tg-height=\"716\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Pfizer’s covid-19 vaccine for kids may not be FDA authorized before november.</p><p><blockquote>辉瑞公司的儿童 covid-19 疫苗可能要到 11 月才能获得 FDA 的批准。</blockquote></p><p> Citi analyst Andrew Baum upgraded shares of Ely Lilly and Co&nbsp;to Buy and raised the price target.</p><p><blockquote>花旗分析师安德鲁·鲍姆将礼来公司的股票上调至买入，并上调了目标价。</blockquote></p><p> Merck says its covid-19 antiviral pill is cctive against variants.</p><p><blockquote>默克公司表示，其 covid-19 抗病毒药丸对变异株有效。</blockquote></p><p> AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.</p><p><blockquote>阿斯利康以 5 亿美元的潜在交易收购罕见病制药商 Caelum。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190233990","content_text":"Pharmaceutical stocks rallied in morning trading.Pfizer,BioNTech SE,Eli Lilly,Merck,Moderna,AstraZeneca and Sanofi climbed between 0.5% and 3%.\n\nPfizer’s covid-19 vaccine for kids may not be FDA authorized before november.\nCiti analyst Andrew Baum upgraded shares of Ely Lilly and Co to Buy and raised the price target.\nMerck says its covid-19 antiviral pill is cctive against variants.\nAstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":104281718,"gmtCreate":1620393921634,"gmtModify":1634205564111,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Pls like &amp; comment Thank you","listText":"Pls like &amp; comment Thank you","text":"Pls like & comment Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":10,"repostSize":0,"link":"https://laohu8.com/post/104281718","repostId":"2133520488","repostType":4,"isVote":1,"tweetType":1,"viewCount":884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377326329,"gmtCreate":1619498671861,"gmtModify":1634212252854,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Boom.!","listText":"Boom.!","text":"Boom.!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/377326329","repostId":"1190086074","repostType":4,"repost":{"id":"1190086074","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619480390,"share":"https://www.laohunote.com/m/news/1190086074?lang=zh_CN&edition=full","pubTime":"2021-04-27 07:39","market":"us","language":"en","title":"Tesla posts record net income of $438 million, revenue surges by 74%<blockquote>特斯拉净利润创历史新高 4.38 亿美元，收入激增 74%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1190086074","media":"Tiger Newspress","summary":"Tesla reported record net income of $438 million during the quarter, as well as earnings of 93 cents per share on $10.39 billion in revenue.In its earnings release, the company said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.”On an earnings call, CEO Elon Musk said the delayed new version of the company’s Model S sedan will be deliv","content":"<p><b>KEY POINTS</b></p><p><blockquote><b>要点</b></blockquote></p><p><ul><li>Tesla reported record net income of $438 million during the quarter, as well as earnings of 93 cents per share on $10.39 billion in revenue.</li><li>In its earnings release, the company said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.”</li><li>On an earnings call, CEO Elon Musk said the delayed new version of the company’s Model S sedan will be delivered starting in May 2021, and Model X deliveries will begin in the third quarter of the year.</li></ul>Tesla&nbsp;reported first-quarter results after the bell on Monday. The company beat expectations handily, buoyed by sales of bitcoin and regulatory credits, but the stock dipped as much as 2.5% after hours as investors digested the numbers.</p><p><blockquote><ul><li>特斯拉公布本季度净利润为创纪录的 4.38 亿美元，每股收益为 93 美分，营收为 103.9 亿美元。</li><li>该公司在财报发布中表示，它已经度过了困扰汽车行业的芯片短缺问题，部分原因是 “迅速转向新型微控制器，同时为新供应商生产的新芯片开发固件”。</li><li>首席执行官埃隆-马斯克（Elon Musk）在财报看涨期权上表示，公司推迟推出的 Model S 轿车新版本将于 2021 年 5 月开始交付，Model X 将于今年第三季度开始交付。</li></ul>特斯拉周一盘后公布了第一季度业绩。在比特币出售和监管信贷的提振下，该公司轻松超出预期，但随着投资者消化这些数据，该股盘后下跌了 2.5%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/fec5c52f391c1077b749edc13b7b3417\" tg-width=\"1302\" tg-height=\"833\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>Here’s how the company fared in the quarter, compared with analyst estimates compiled by Refinitiv:</p><p><blockquote>以下是该公司本季度的表现与 Refinitiv 编制的分析师预期的比较：</blockquote></p><p><ul><li><b>Earnings:</b>93 cents per share vs. 79 cents per share expected</li><li><b>Revenue:</b>$10.39 billion vs. $10.29 billion expected, up 74% from a year ago</li></ul>Net profit reached a quarterly record of $438 million on a GAAP basis, and the company recorded $518 million in revenue from sales of regulatory credits during the period. It also recorded a $101 million positive impact from&nbsp;sales of bitcoin&nbsp;during the quarter.</p><p><blockquote><ul><li><b>收益：</b>每股 93 美分，预计每股 79 美分</li><li><b>收入：</b>103.9 亿美元，而预期为 102.9 亿美元，同比增长 74%</li></ul>按公认会计准则计算，季度净利润达到创纪录的 4.38 亿美元，该公司在此期间从监管信用销售收入中获得 5.18 亿美元。本季度比特币销售额还带来了 1.01 亿美元的积极影响。</blockquote></p><p><img src=\"https://static.tigerbbs.com/107ab1e725bed375ea106bdf3024ec6a\" tg-width=\"1910\" tg-height=\"1097\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>CEO Elon Musk’s electric vehicle business reported in the first quarter&nbsp;vehicle deliveries of 184,800&nbsp;Model 3 and Model Y cars, beating expectations and setting a record for Tesla. However, the company also said it produced none of its higher-end Model S sedans or Model X SUVs for the period ending March. It delivered2,020 older Model S sedans and Model X SUVs from inventory.</p><p><blockquote>首席执行官埃隆-马斯克（Elon Musk）的电动汽车业务第一季度交付了 18.48 万辆 Model 3 和 Model Y 汽车，超出预期，创下了特斯拉的纪录。不过，该公司还表示，截至 3 月份，它没有生产任何高端 Model S 轿车或 Model X SUV。它从库存中交付了 2,020 辆旧款 Model S 轿车和 Model X SUV。</blockquote></p><p>On Monday’s earnings call, Musk said the new version of the company’s Model S sedans will finally be delivered to customers starting in May 2021, with Model X deliveries to begin in the third quarter of the year. Musk and CFO Zachary Kirkhorn both said supply chain issues are likely to remain a challenge for Tesla this year.</p><p><blockquote>在周一的财报看涨期权上，马斯克表示，公司新版 Model S 轿车最终将于 2021 年 5 月开始交付给客户，Model X 将于今年第三季度开始交付。马斯克和首席财务官扎卡里·柯克霍恩都表示，供应链问题今年可能仍然是特斯拉面临的挑战。</blockquote></p><p>In January 2021 (during a fourth-quarter 2020 earnings update) Musk had said that the Model S Plaid was already in production would be delivered starting in February 2021. But he admitted on Monday, “There were more challenges than expected,” in producing the refreshed version of these vehicles. He did not elaborate.</p><p><blockquote>2021 年 1 月（在 2020 年第四季度收益更新期间），马斯克曾表示 Model S Plaid 已经投入生产，将于 2021 年 2 月开始交付。但他在周一承认，在生产这些车辆的更新版本时，“面临的挑战比预期的要多”。他没有详细说明。</blockquote></p><p>Tesla is now aiming to produce 2,000 Model S and X vehicles per week later this year.</p><p><blockquote>特斯拉目前的目标是在今年晚些时候每周生产 2,000 辆 Model S 和 X 汽车。</blockquote></p><p>The company said Monday it expects more than 50% vehicle delivery growth in 2021 overall, which implies minimum deliveries around 750,000 vehicles this year.</p><p><blockquote>该公司周一表示，预计 2021 年整体汽车交付量将增长 50% 以上，这意味着今年的最低交付量约为 75 万辆。</blockquote></p><p>The fact Tesla grew vehicle unit sales by more than 100% year over year but grew service centers by only 28% and its mobile service fleet by only 22% explains why some Tesla customers face frustratingly long wait times for repairs. Service expansion is not keeping pace with the volume of vehicles sold.</p><p><blockquote>事实上，特斯拉的汽车销量同比增长超过 100%，但服务中心仅增长 28%，移动服务车队仅增长 22%，这解释了为什么一些特斯拉客户面临令人沮丧的漫长维修等待时间。服务扩展跟不上车辆销量。</blockquote></p><p>Tesla said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.” It did not disclose the names of its new suppliers.</p><p><blockquote>特斯拉表示，该公司已经度过了困扰汽车行业的芯片短缺问题，部分原因是 “迅速转向新型微控制器，同时为新供应商生产的新芯片开发固件”。它没有透露新供应商的名字。</blockquote></p><p>It also reiterated Musk’s frequent claim that cameras, not radar, are a better path toward autonomous vehicles. “Our AI-based software architecture has been increasingly reliant on cameras, to the point where radar is becoming unnecessary earlier than expected. As a result, our FSD [Full Self-Driving] team is fully focused on evolving to a vision-based autonomous system and we are nearly ready to switch the US market to Tesla Vision,” the company said in its earnings release.</p><p><blockquote>它还重申了马斯克经常说的，即摄像头而不是雷达是自动驾驶汽车的更好途径。“我们基于人工智能的软件架构越来越依赖摄像头，以至于雷达比预期更早变得不必要。因此，我们的 FSD（全自动驾驶）团队正全力致力于发展基于视觉的自主系统，我们几乎准备好将美国市场转向特斯拉视觉，”该公司在财报发布会上说。</blockquote></p><p>Revenue for its energy generation and storage business nearly doubled for Tesla versus the same period in 2020, when Musk said Covid, then an emerging pandemic, had slowed its energy business to a crawl. But energy revenue declined from $787 million in the fourth quarter to $595 million in the first quarter of 2021.</p><p><blockquote>与 2020 年同期相比，特斯拉的能源发电和存储业务收入几乎翻了一番，当时马斯克表示，当时新兴的新冠疫情使其能源业务大幅放缓。但能源收入从第四季度的7.87亿美元下降至2021年第一季度的5.95亿美元。</blockquote></p><p>Recently, Tesla increased prices for its solar rooftops by 50%, and now requires anyone ordering solar photovoltaics (including Tesla solar roof tiles) to also order the Powerwall, Tesla’s home energy storage system. The sudden price change applied retroactively to some&nbsp;vexed customers.</p><p><blockquote>最近，特斯拉将太阳能屋顶的价格提高了 50%，现在要求任何订购太阳能光伏（包括特斯拉太阳能屋顶瓦）的人也必须订购特斯拉的家庭储能系统 Powerwall。突然的价格变化追溯适用于一些烦恼的顾客。</blockquote></p><p>Musk said on the Q1 2021 call that he is aiming for homes with solar rooftops and batteries from Tesla to function as a “giant distributed utility” that can help incumbent electrical utilities supply customers with all the electricity they need as demand and extreme weather events increase.</p><p><blockquote>马斯克在 2021 年第一季度看涨期权上表示，他的目标是让拥有太阳能屋顶和特斯拉电池的家庭成为 “巨型分布式公用事业公司”，随着需求和极端天气事件的增加，帮助现有电力公司为客户提供所需的所有电力。</blockquote></p><p></p><p>Executives did not say how they would change their production or mix of battery cells from suppliers in order to make a higher volume of vehicles and energy storage products in 2021.</p><p><blockquote>高管们没有透露他们将如何改变供应商电池的生产或组合，以便在 2021 年生产更多的汽车和储能产品。</blockquote></p><p>Musk said the company’s 4680 cells, which it developed independently and makes at a pilot plant in Fremont, California, are not yet reliable enough to be shipped in Tesla vehicles. He said Tesla would probably “achieve volume production” of these cells in 12 to 18 months.</p><p><blockquote>马斯克说，该公司自主研发并在加州弗里蒙特的一个试点工厂生产的 4680 电池还不够可靠，无法在特斯拉汽车上运输。他说，特斯拉可能会在 12 到 18 个月内 “实现这些电池的量产 ”。</blockquote></p><p>The company revealed in February it purchased&nbsp;$1.5 billion in bitcoin&nbsp;and would potentially invest in other cryptocurrencies in the future. By April, bitcoin rose to record levels before pulling back. In its statement of cash flows, Tesla revealed that it had sold $272 million worth of “digital assets,” presumably bitcoin, during the quarter.</p><p><blockquote>该公司在2月份透露，它在比特币购买了15亿美元，未来可能会投资其他加密货币。到四月份，比特币升至创纪录水平，然后回落。特斯拉在现金流量表中透露，该公司在本季度出售了价值 2.72 亿美元的 “数字资产”，大概是比特币。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla posts record net income of $438 million, revenue surges by 74%<blockquote>特斯拉净利润创历史新高 4.38 亿美元，收入激增 74%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla posts record net income of $438 million, revenue surges by 74%<blockquote>特斯拉净利润创历史新高 4.38 亿美元，收入激增 74%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-04-27 07:39</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>KEY POINTS</b></p><p><blockquote><b>要点</b></blockquote></p><p><ul><li>Tesla reported record net income of $438 million during the quarter, as well as earnings of 93 cents per share on $10.39 billion in revenue.</li><li>In its earnings release, the company said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.”</li><li>On an earnings call, CEO Elon Musk said the delayed new version of the company’s Model S sedan will be delivered starting in May 2021, and Model X deliveries will begin in the third quarter of the year.</li></ul>Tesla&nbsp;reported first-quarter results after the bell on Monday. The company beat expectations handily, buoyed by sales of bitcoin and regulatory credits, but the stock dipped as much as 2.5% after hours as investors digested the numbers.</p><p><blockquote><ul><li>特斯拉公布本季度净利润为创纪录的 4.38 亿美元，每股收益为 93 美分，营收为 103.9 亿美元。</li><li>该公司在财报发布中表示，它已经度过了困扰汽车行业的芯片短缺问题，部分原因是 “迅速转向新型微控制器，同时为新供应商生产的新芯片开发固件”。</li><li>首席执行官埃隆-马斯克（Elon Musk）在财报看涨期权上表示，公司推迟推出的 Model S 轿车新版本将于 2021 年 5 月开始交付，Model X 将于今年第三季度开始交付。</li></ul>特斯拉周一盘后公布了第一季度业绩。在比特币出售和监管信贷的提振下，该公司轻松超出预期，但随着投资者消化这些数据，该股盘后下跌了 2.5%。</blockquote></p><p><img src=\"https://static.tigerbbs.com/fec5c52f391c1077b749edc13b7b3417\" tg-width=\"1302\" tg-height=\"833\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>Here’s how the company fared in the quarter, compared with analyst estimates compiled by Refinitiv:</p><p><blockquote>以下是该公司本季度的表现与 Refinitiv 编制的分析师预期的比较：</blockquote></p><p><ul><li><b>Earnings:</b>93 cents per share vs. 79 cents per share expected</li><li><b>Revenue:</b>$10.39 billion vs. $10.29 billion expected, up 74% from a year ago</li></ul>Net profit reached a quarterly record of $438 million on a GAAP basis, and the company recorded $518 million in revenue from sales of regulatory credits during the period. It also recorded a $101 million positive impact from&nbsp;sales of bitcoin&nbsp;during the quarter.</p><p><blockquote><ul><li><b>收益：</b>每股 93 美分，预计每股 79 美分</li><li><b>收入：</b>103.9 亿美元，而预期为 102.9 亿美元，同比增长 74%</li></ul>按公认会计准则计算，季度净利润达到创纪录的 4.38 亿美元，该公司在此期间从监管信用销售收入中获得 5.18 亿美元。本季度比特币销售额还带来了 1.01 亿美元的积极影响。</blockquote></p><p><img src=\"https://static.tigerbbs.com/107ab1e725bed375ea106bdf3024ec6a\" tg-width=\"1910\" tg-height=\"1097\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p>CEO Elon Musk’s electric vehicle business reported in the first quarter&nbsp;vehicle deliveries of 184,800&nbsp;Model 3 and Model Y cars, beating expectations and setting a record for Tesla. However, the company also said it produced none of its higher-end Model S sedans or Model X SUVs for the period ending March. It delivered2,020 older Model S sedans and Model X SUVs from inventory.</p><p><blockquote>首席执行官埃隆-马斯克（Elon Musk）的电动汽车业务第一季度交付了 18.48 万辆 Model 3 和 Model Y 汽车，超出预期，创下了特斯拉的纪录。不过，该公司还表示，截至 3 月份，它没有生产任何高端 Model S 轿车或 Model X SUV。它从库存中交付了 2,020 辆旧款 Model S 轿车和 Model X SUV。</blockquote></p><p>On Monday’s earnings call, Musk said the new version of the company’s Model S sedans will finally be delivered to customers starting in May 2021, with Model X deliveries to begin in the third quarter of the year. Musk and CFO Zachary Kirkhorn both said supply chain issues are likely to remain a challenge for Tesla this year.</p><p><blockquote>在周一的财报看涨期权上，马斯克表示，公司新版 Model S 轿车最终将于 2021 年 5 月开始交付给客户，Model X 将于今年第三季度开始交付。马斯克和首席财务官扎卡里·柯克霍恩都表示，供应链问题今年可能仍然是特斯拉面临的挑战。</blockquote></p><p>In January 2021 (during a fourth-quarter 2020 earnings update) Musk had said that the Model S Plaid was already in production would be delivered starting in February 2021. But he admitted on Monday, “There were more challenges than expected,” in producing the refreshed version of these vehicles. He did not elaborate.</p><p><blockquote>2021 年 1 月（在 2020 年第四季度收益更新期间），马斯克曾表示 Model S Plaid 已经投入生产，将于 2021 年 2 月开始交付。但他在周一承认，在生产这些车辆的更新版本时，“面临的挑战比预期的要多”。他没有详细说明。</blockquote></p><p>Tesla is now aiming to produce 2,000 Model S and X vehicles per week later this year.</p><p><blockquote>特斯拉目前的目标是在今年晚些时候每周生产 2,000 辆 Model S 和 X 汽车。</blockquote></p><p>The company said Monday it expects more than 50% vehicle delivery growth in 2021 overall, which implies minimum deliveries around 750,000 vehicles this year.</p><p><blockquote>该公司周一表示，预计 2021 年整体汽车交付量将增长 50% 以上，这意味着今年的最低交付量约为 75 万辆。</blockquote></p><p>The fact Tesla grew vehicle unit sales by more than 100% year over year but grew service centers by only 28% and its mobile service fleet by only 22% explains why some Tesla customers face frustratingly long wait times for repairs. Service expansion is not keeping pace with the volume of vehicles sold.</p><p><blockquote>事实上，特斯拉的汽车销量同比增长超过 100%，但服务中心仅增长 28%，移动服务车队仅增长 22%，这解释了为什么一些特斯拉客户面临令人沮丧的漫长维修等待时间。服务扩展跟不上车辆销量。</blockquote></p><p>Tesla said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.” It did not disclose the names of its new suppliers.</p><p><blockquote>特斯拉表示，该公司已经度过了困扰汽车行业的芯片短缺问题，部分原因是 “迅速转向新型微控制器，同时为新供应商生产的新芯片开发固件”。它没有透露新供应商的名字。</blockquote></p><p>It also reiterated Musk’s frequent claim that cameras, not radar, are a better path toward autonomous vehicles. “Our AI-based software architecture has been increasingly reliant on cameras, to the point where radar is becoming unnecessary earlier than expected. As a result, our FSD [Full Self-Driving] team is fully focused on evolving to a vision-based autonomous system and we are nearly ready to switch the US market to Tesla Vision,” the company said in its earnings release.</p><p><blockquote>它还重申了马斯克经常说的，即摄像头而不是雷达是自动驾驶汽车的更好途径。“我们基于人工智能的软件架构越来越依赖摄像头，以至于雷达比预期更早变得不必要。因此，我们的 FSD（全自动驾驶）团队正全力致力于发展基于视觉的自主系统，我们几乎准备好将美国市场转向特斯拉视觉，”该公司在财报发布会上说。</blockquote></p><p>Revenue for its energy generation and storage business nearly doubled for Tesla versus the same period in 2020, when Musk said Covid, then an emerging pandemic, had slowed its energy business to a crawl. But energy revenue declined from $787 million in the fourth quarter to $595 million in the first quarter of 2021.</p><p><blockquote>与 2020 年同期相比，特斯拉的能源发电和存储业务收入几乎翻了一番，当时马斯克表示，当时新兴的新冠疫情使其能源业务大幅放缓。但能源收入从第四季度的7.87亿美元下降至2021年第一季度的5.95亿美元。</blockquote></p><p>Recently, Tesla increased prices for its solar rooftops by 50%, and now requires anyone ordering solar photovoltaics (including Tesla solar roof tiles) to also order the Powerwall, Tesla’s home energy storage system. The sudden price change applied retroactively to some&nbsp;vexed customers.</p><p><blockquote>最近，特斯拉将太阳能屋顶的价格提高了 50%，现在要求任何订购太阳能光伏（包括特斯拉太阳能屋顶瓦）的人也必须订购特斯拉的家庭储能系统 Powerwall。突然的价格变化追溯适用于一些烦恼的顾客。</blockquote></p><p>Musk said on the Q1 2021 call that he is aiming for homes with solar rooftops and batteries from Tesla to function as a “giant distributed utility” that can help incumbent electrical utilities supply customers with all the electricity they need as demand and extreme weather events increase.</p><p><blockquote>马斯克在 2021 年第一季度看涨期权上表示，他的目标是让拥有太阳能屋顶和特斯拉电池的家庭成为 “巨型分布式公用事业公司”，随着需求和极端天气事件的增加，帮助现有电力公司为客户提供所需的所有电力。</blockquote></p><p></p><p>Executives did not say how they would change their production or mix of battery cells from suppliers in order to make a higher volume of vehicles and energy storage products in 2021.</p><p><blockquote>高管们没有透露他们将如何改变供应商电池的生产或组合，以便在 2021 年生产更多的汽车和储能产品。</blockquote></p><p>Musk said the company’s 4680 cells, which it developed independently and makes at a pilot plant in Fremont, California, are not yet reliable enough to be shipped in Tesla vehicles. He said Tesla would probably “achieve volume production” of these cells in 12 to 18 months.</p><p><blockquote>马斯克说，该公司自主研发并在加州弗里蒙特的一个试点工厂生产的 4680 电池还不够可靠，无法在特斯拉汽车上运输。他说，特斯拉可能会在 12 到 18 个月内 “实现这些电池的量产 ”。</blockquote></p><p>The company revealed in February it purchased&nbsp;$1.5 billion in bitcoin&nbsp;and would potentially invest in other cryptocurrencies in the future. By April, bitcoin rose to record levels before pulling back. In its statement of cash flows, Tesla revealed that it had sold $272 million worth of “digital assets,” presumably bitcoin, during the quarter.</p><p><blockquote>该公司在2月份透露，它在比特币购买了15亿美元，未来可能会投资其他加密货币。到四月份，比特币升至创纪录水平，然后回落。特斯拉在现金流量表中透露，该公司在本季度出售了价值 2.72 亿美元的 “数字资产”，大概是比特币。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190086074","content_text":"KEY POINTSTesla reported record net income of $438 million during the quarter, as well as earnings of 93 cents per share on $10.39 billion in revenue.In its earnings release, the company said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.”On an earnings call, CEO Elon Musk said the delayed new version of the company’s Model S sedan will be delivered starting in May 2021, and Model X deliveries will begin in the third quarter of the year.Tesla reported first-quarter results after the bell on Monday. The company beat expectations handily, buoyed by sales of bitcoin and regulatory credits, but the stock dipped as much as 2.5% after hours as investors digested the numbers.Here’s how the company fared in the quarter, compared with analyst estimates compiled by Refinitiv:Earnings:93 cents per share vs. 79 cents per share expectedRevenue:$10.39 billion vs. $10.29 billion expected, up 74% from a year agoNet profit reached a quarterly record of $438 million on a GAAP basis, and the company recorded $518 million in revenue from sales of regulatory credits during the period. It also recorded a $101 million positive impact from sales of bitcoin during the quarter.CEO Elon Musk’s electric vehicle business reported in the first quarter vehicle deliveries of 184,800 Model 3 and Model Y cars, beating expectations and setting a record for Tesla. However, the company also said it produced none of its higher-end Model S sedans or Model X SUVs for the period ending March. It delivered2,020 older Model S sedans and Model X SUVs from inventory.On Monday’s earnings call, Musk said the new version of the company’s Model S sedans will finally be delivered to customers starting in May 2021, with Model X deliveries to begin in the third quarter of the year. Musk and CFO Zachary Kirkhorn both said supply chain issues are likely to remain a challenge for Tesla this year.In January 2021 (during a fourth-quarter 2020 earnings update) Musk had said that the Model S Plaid was already in production would be delivered starting in February 2021. But he admitted on Monday, “There were more challenges than expected,” in producing the refreshed version of these vehicles. He did not elaborate.Tesla is now aiming to produce 2,000 Model S and X vehicles per week later this year.The company said Monday it expects more than 50% vehicle delivery growth in 2021 overall, which implies minimum deliveries around 750,000 vehicles this year.The fact Tesla grew vehicle unit sales by more than 100% year over year but grew service centers by only 28% and its mobile service fleet by only 22% explains why some Tesla customers face frustratingly long wait times for repairs. Service expansion is not keeping pace with the volume of vehicles sold.Tesla said it has weathered chip shortages that have plagued the auto industry in part by “pivoting extremely quickly to new microcontrollers, while simultaneously developing firmware for new chips made by new suppliers.” It did not disclose the names of its new suppliers.It also reiterated Musk’s frequent claim that cameras, not radar, are a better path toward autonomous vehicles. “Our AI-based software architecture has been increasingly reliant on cameras, to the point where radar is becoming unnecessary earlier than expected. As a result, our FSD [Full Self-Driving] team is fully focused on evolving to a vision-based autonomous system and we are nearly ready to switch the US market to Tesla Vision,” the company said in its earnings release.Revenue for its energy generation and storage business nearly doubled for Tesla versus the same period in 2020, when Musk said Covid, then an emerging pandemic, had slowed its energy business to a crawl. But energy revenue declined from $787 million in the fourth quarter to $595 million in the first quarter of 2021.Recently, Tesla increased prices for its solar rooftops by 50%, and now requires anyone ordering solar photovoltaics (including Tesla solar roof tiles) to also order the Powerwall, Tesla’s home energy storage system. The sudden price change applied retroactively to some vexed customers.Musk said on the Q1 2021 call that he is aiming for homes with solar rooftops and batteries from Tesla to function as a “giant distributed utility” that can help incumbent electrical utilities supply customers with all the electricity they need as demand and extreme weather events increase.Executives did not say how they would change their production or mix of battery cells from suppliers in order to make a higher volume of vehicles and energy storage products in 2021.Musk said the company’s 4680 cells, which it developed independently and makes at a pilot plant in Fremont, California, are not yet reliable enough to be shipped in Tesla vehicles. He said Tesla would probably “achieve volume production” of these cells in 12 to 18 months.The company revealed in February it purchased $1.5 billion in bitcoin and would potentially invest in other cryptocurrencies in the future. By April, bitcoin rose to record levels before pulling back. In its statement of cash flows, Tesla revealed that it had sold $272 million worth of “digital assets,” presumably bitcoin, during the quarter.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":525,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166475181,"gmtCreate":1624024072343,"gmtModify":1631887210343,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Get your post featured? What’s that means.?","listText":"Get your post featured? What’s that means.?","text":"Get your post featured? What’s that means.?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/166475181","repostId":"1118271544","repostType":4,"repost":{"id":"1118271544","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624023029,"share":"https://www.laohunote.com/m/news/1118271544?lang=zh_CN&edition=full","pubTime":"2021-06-18 21:30","market":"us","language":"en","title":"Dow drops 400 points at the open, extending losses in its worst week since January<blockquote>道琼斯指数开盘下跌 400 点，扩大自 1 月份以来最糟糕的一周跌幅</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1118271544","media":"Tiger Newspress","summary":"U.S. stocks fell on Friday with the Dow Jones Industrial Average on pace to post its worst week sinc","content":"<p>U.S. stocks fell on Friday with the Dow Jones Industrial Average on pace to post its worst week since January, as bank shares led the market sell-off after the Federal Reserve's latest policy update.</p><p><blockquote>美国股市周五下跌，道琼斯工业平均指数有望创下 1 月份以来最糟糕的一周，美联储最新政策更新后，银行股领跌市场。</blockquote></p><p> The blue-chip average dropped 400 points, bringing its week-to-date losses to 2.8% The S&amp;P 500 fell 0.8%, pushing its loss this week to more than 1%. The tech-heavy Nasdaq Composite dipped 0.5%.</p><p><blockquote>蓝筹股平均指数下跌 400 点，本周迄今跌幅达 2.8%，标普500下跌 0.8%，本周跌幅超过 1%。以科技股为主的纳斯达克综合指数下跌 0.5%。</blockquote></p><p> Stocks extended their losses asSt. Louis Fed President Jim Bullard said on CNBCthat it was natural for the Fed to tilt a little \"hawkish\" this week and that the first rate increase from the central bank would likely come in 2022.</p><p><blockquote>股市扩大跌幅。路易斯联储主席吉姆·布拉德在 CNBC 上表示，美联储本周采取一点“鹰派”立场是很自然的，央行首次加息可能会在 2022 年进行。</blockquote></p><p> Wall Street registered losses as the Federal Reserve on Wednesday afternoon added two rate hikes to its 2023 forecast and increased its inflation projection for the year.</p><p><blockquote>由于美联储周三下午在 2023 年预测中增加了两次加息，并上调了今年的通胀预测，华尔街出现亏损。</blockquote></p><p> The decline in stocks came as the Fed's actions caused a drastic flattening of the so-called Treasury yield curve&nbsp;where the yields of shorter-duration Treasurys, like the&nbsp;2-year note, rose, while longer duration yields, such as the benchmark 10-year, fell.&nbsp;The retreat in long-dated bonds reflects less optimism toward economic growth, while the jump in short-end yields shows the expectations of the Fed raising rates.</p><p><blockquote>股市下跌之际，美联储的行动导致所谓的国债收益率曲线急剧变平，短期国债（如2年期国债）的收益率上升，而长期国债（如基准10年期国债）的收益率下降。长期债券的回落反映出人们对经济增长的乐观情绪有所下降，而短期国债收益率的上升则显示了美联储加息的预期。</blockquote></p><p> This phenomenon is hurting bank stocks particularly as bank earnings could take a hit when the spread between short-term and long-term rates narrows. Goldman Sachs shares fell more than 1% Friday, while JPMorgan and Morgan Stanley also traded in the red.</p><p><blockquote>这种现象尤其损害了银行股，因为当短期和长期利差收窄时，银行盈利可能会受到打击。高盛股价周五下跌超过1%，摩根大通和摩根士丹利也出现亏损。</blockquote></p><p> Fed Chairman Jerome Powell said on Wednesday that officials have discussed tapering bond buying and would at some point begin slowing the asset purchases.</p><p><blockquote>美联储主席杰罗姆·鲍威尔周三表示，官员们已经讨论了缩减债券购买规模，并将在某个时候开始放缓资产购买速度。</blockquote></p><p> \"Investors may be interpreting the Fed's hawkish tilt Wednesday as a sign that an extended US post-pandemic economic expansion may be a bit harder to achieve in a potentially emerging environment of less accommodative monetary policy,\" said Goldman Sachs' Chris Hussey in a note.</p><p><blockquote>高盛 (Goldman Sachs) 的克里斯·赫西 (Chris Hussey) 在一份报告中表示：“投资者可能将美联储周三的鹰派倾向解读为一个迹象，表明在可能出现的货币政策不太宽松的环境下，美国大流行后的经济扩张可能更难实现。”</blockquote></p><p> Most commodities prices rebounded a bit on Friday followingsharp declines this week&nbsp;as China attempts to cool rising prices and the U.S. dollar strengthens. Futures prices for copper, gold, and platinum rebounded Friday, but were still down big for the week.</p><p><blockquote>由于中国试图冷却物价上涨和美元走强，大多数大宗商品价格在本周大幅下跌后，周五小幅反弹。铜、黄金和铂金期货价格周五反弹，但本周仍大幅下跌。</blockquote></p><p> Chip stocks, which have had a good week, looked set to continue their run on Friday with shares of Nvidia higher by about 1%.</p><p><blockquote>本周表现良好的芯片股似乎将在周五继续上涨，英伟达股价上涨约 1%。</blockquote></p><p> Adobe shares gained about 3% after earnings and revenue topped estimates.</p><p><blockquote>盈利和收入超出预期后，Adobe 股价上涨约 3%。</blockquote></p><p> Friday also coincides with the quarterly \"quadruple witching\" where options and futures on indexes and equities expire. Many expect trading to be more volatile in light of this event.</p><p><blockquote>周五也恰逢季度“四重巫术”，指数和股票的期权和期货到期。许多人预计，鉴于这一事件，交易将更加波动。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow drops 400 points at the open, extending losses in its worst week since January<blockquote>道琼斯指数开盘下跌 400 点，扩大自 1 月份以来最糟糕的一周跌幅</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow drops 400 points at the open, extending losses in its worst week since January<blockquote>道琼斯指数开盘下跌 400 点，扩大自 1 月份以来最糟糕的一周跌幅</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-06-18 21:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stocks fell on Friday with the Dow Jones Industrial Average on pace to post its worst week since January, as bank shares led the market sell-off after the Federal Reserve's latest policy update.</p><p><blockquote>美国股市周五下跌，道琼斯工业平均指数有望创下 1 月份以来最糟糕的一周，美联储最新政策更新后，银行股领跌市场。</blockquote></p><p> The blue-chip average dropped 400 points, bringing its week-to-date losses to 2.8% The S&amp;P 500 fell 0.8%, pushing its loss this week to more than 1%. The tech-heavy Nasdaq Composite dipped 0.5%.</p><p><blockquote>蓝筹股平均指数下跌 400 点，本周迄今跌幅达 2.8%，标普500下跌 0.8%，本周跌幅超过 1%。以科技股为主的纳斯达克综合指数下跌 0.5%。</blockquote></p><p> Stocks extended their losses asSt. Louis Fed President Jim Bullard said on CNBCthat it was natural for the Fed to tilt a little \"hawkish\" this week and that the first rate increase from the central bank would likely come in 2022.</p><p><blockquote>股市扩大跌幅。路易斯联储主席吉姆·布拉德在 CNBC 上表示，美联储本周采取一点“鹰派”立场是很自然的，央行首次加息可能会在 2022 年进行。</blockquote></p><p> Wall Street registered losses as the Federal Reserve on Wednesday afternoon added two rate hikes to its 2023 forecast and increased its inflation projection for the year.</p><p><blockquote>由于美联储周三下午在 2023 年预测中增加了两次加息，并上调了今年的通胀预测，华尔街出现亏损。</blockquote></p><p> The decline in stocks came as the Fed's actions caused a drastic flattening of the so-called Treasury yield curve&nbsp;where the yields of shorter-duration Treasurys, like the&nbsp;2-year note, rose, while longer duration yields, such as the benchmark 10-year, fell.&nbsp;The retreat in long-dated bonds reflects less optimism toward economic growth, while the jump in short-end yields shows the expectations of the Fed raising rates.</p><p><blockquote>股市下跌之际，美联储的行动导致所谓的国债收益率曲线急剧变平，短期国债（如2年期国债）的收益率上升，而长期国债（如基准10年期国债）的收益率下降。长期债券的回落反映出人们对经济增长的乐观情绪有所下降，而短期国债收益率的上升则显示了美联储加息的预期。</blockquote></p><p> This phenomenon is hurting bank stocks particularly as bank earnings could take a hit when the spread between short-term and long-term rates narrows. Goldman Sachs shares fell more than 1% Friday, while JPMorgan and Morgan Stanley also traded in the red.</p><p><blockquote>这种现象尤其损害了银行股，因为当短期和长期利差收窄时，银行盈利可能会受到打击。高盛股价周五下跌超过1%，摩根大通和摩根士丹利也出现亏损。</blockquote></p><p> Fed Chairman Jerome Powell said on Wednesday that officials have discussed tapering bond buying and would at some point begin slowing the asset purchases.</p><p><blockquote>美联储主席杰罗姆·鲍威尔周三表示，官员们已经讨论了缩减债券购买规模，并将在某个时候开始放缓资产购买速度。</blockquote></p><p> \"Investors may be interpreting the Fed's hawkish tilt Wednesday as a sign that an extended US post-pandemic economic expansion may be a bit harder to achieve in a potentially emerging environment of less accommodative monetary policy,\" said Goldman Sachs' Chris Hussey in a note.</p><p><blockquote>高盛 (Goldman Sachs) 的克里斯·赫西 (Chris Hussey) 在一份报告中表示：“投资者可能将美联储周三的鹰派倾向解读为一个迹象，表明在可能出现的货币政策不太宽松的环境下，美国大流行后的经济扩张可能更难实现。”</blockquote></p><p> Most commodities prices rebounded a bit on Friday followingsharp declines this week&nbsp;as China attempts to cool rising prices and the U.S. dollar strengthens. Futures prices for copper, gold, and platinum rebounded Friday, but were still down big for the week.</p><p><blockquote>由于中国试图冷却物价上涨和美元走强，大多数大宗商品价格在本周大幅下跌后，周五小幅反弹。铜、黄金和铂金期货价格周五反弹，但本周仍大幅下跌。</blockquote></p><p> Chip stocks, which have had a good week, looked set to continue their run on Friday with shares of Nvidia higher by about 1%.</p><p><blockquote>本周表现良好的芯片股似乎将在周五继续上涨，英伟达股价上涨约 1%。</blockquote></p><p> Adobe shares gained about 3% after earnings and revenue topped estimates.</p><p><blockquote>盈利和收入超出预期后，Adobe 股价上涨约 3%。</blockquote></p><p> Friday also coincides with the quarterly \"quadruple witching\" where options and futures on indexes and equities expire. Many expect trading to be more volatile in light of this event.</p><p><blockquote>周五也恰逢季度“四重巫术”，指数和股票的期权和期货到期。许多人预计，鉴于这一事件，交易将更加波动。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118271544","content_text":"U.S. stocks fell on Friday with the Dow Jones Industrial Average on pace to post its worst week since January, as bank shares led the market sell-off after the Federal Reserve's latest policy update.\nThe blue-chip average dropped 400 points, bringing its week-to-date losses to 2.8% The S&P 500 fell 0.8%, pushing its loss this week to more than 1%. The tech-heavy Nasdaq Composite dipped 0.5%.\nStocks extended their losses asSt. Louis Fed President Jim Bullard said on CNBCthat it was natural for the Fed to tilt a little \"hawkish\" this week and that the first rate increase from the central bank would likely come in 2022.\nWall Street registered losses as the Federal Reserve on Wednesday afternoon added two rate hikes to its 2023 forecast and increased its inflation projection for the year.\nThe decline in stocks came as the Fed's actions caused a drastic flattening of the so-called Treasury yield curve where the yields of shorter-duration Treasurys, like the 2-year note, rose, while longer duration yields, such as the benchmark 10-year, fell. The retreat in long-dated bonds reflects less optimism toward economic growth, while the jump in short-end yields shows the expectations of the Fed raising rates.\nThis phenomenon is hurting bank stocks particularly as bank earnings could take a hit when the spread between short-term and long-term rates narrows. Goldman Sachs shares fell more than 1% Friday, while JPMorgan and Morgan Stanley also traded in the red.\nFed Chairman Jerome Powell said on Wednesday that officials have discussed tapering bond buying and would at some point begin slowing the asset purchases.\n\"Investors may be interpreting the Fed's hawkish tilt Wednesday as a sign that an extended US post-pandemic economic expansion may be a bit harder to achieve in a potentially emerging environment of less accommodative monetary policy,\" said Goldman Sachs' Chris Hussey in a note.\nMost commodities prices rebounded a bit on Friday followingsharp declines this week as China attempts to cool rising prices and the U.S. dollar strengthens. Futures prices for copper, gold, and platinum rebounded Friday, but were still down big for the week.\nChip stocks, which have had a good week, looked set to continue their run on Friday with shares of Nvidia higher by about 1%.\nAdobe shares gained about 3% after earnings and revenue topped estimates.\nFriday also coincides with the quarterly \"quadruple witching\" where options and futures on indexes and equities expire. Many expect trading to be more volatile in light of this event.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":196915679,"gmtCreate":1621004490291,"gmtModify":1634194608009,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Buy buy buy","listText":"Buy buy buy","text":"Buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/196915679","repostId":"1185220705","repostType":4,"isVote":1,"tweetType":1,"viewCount":882,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109577559,"gmtCreate":1619707492371,"gmtModify":1634210534329,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Need ur like &amp; comment","listText":"Need ur like &amp; comment","text":"Need ur like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/109577559","repostId":"1183966356","repostType":4,"repost":{"id":"1183966356","kind":"news","pubTimestamp":1619665696,"share":"https://www.laohunote.com/m/news/1183966356?lang=zh_CN&edition=full","pubTime":"2021-04-29 11:08","market":"us","language":"en","title":"NIO Q1 2021 Earnings Report Preview: What to Look For<blockquote>蔚来 2021 年第一季度收益报告预览：看点</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1183966356","media":"InvestoPedia","summary":"Analysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.Revenue is expected to soar on expanding vehicle sales.NIO Inc. , like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles . NIO's production stoppage in late March had little impact on the company's record ve","content":"<p>Focus on NIO vehicle deliveries</p><p><blockquote>专注于蔚来汽车交付</blockquote></p><p> <b>KEY TAKEAWAYS</b></p><p><blockquote><b>主要要点</b></blockquote></p><p> <ul>  <li>Analysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.</li>  <li>Vehicle deliveries, already announced, rose dramatically YOY.</li>  <li>Revenue is expected to soar on expanding vehicle sales.</li> </ul> NIO Inc. (NIO), like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles (EVs). NIO's production stoppage in late March had little impact on the company's record vehicle deliveries in Q1, but it could affect future production numbers.</p><p><blockquote><ul><li>分析师预计 2020 财年第一季度每股美国存托凭证收益为 -0.72 元，而 -1.66 元。</li><li>已经宣布的汽车交付量同比大幅增长。</li><li>随着汽车销量的扩大，收入预计将飙升。</li></ul>与许多其他汽车制造商一样，由于全球半导体短缺，蔚来（蔚来）今年被迫停产。半导体芯片广泛用于智能手机、计算机和其他电子设备，对于高端电动汽车 (EV) 制造商蔚来来说尤为重要。蔚来汽车3月下旬的停产对该公司第一季度创纪录的汽车交付量影响不大，但可能会影响未来的产量。</blockquote></p><p> Investors will focus on how these forces affect NIO's immediate results, as well as its financial outlook, when the company reports earnings on April 29, 2021 for Q1 FY 2021.Analysts are expecting the company's loss per American depositary share (ADS) to narrow significantly as revenue expands at a rapid pace.</p><p><blockquote>当蔚来汽车于 2021 年 4 月 29 日公布 2021 财年第一季度收益时，投资者将关注这些力量如何影响蔚来汽车的近期业绩及其财务前景。分析师预计，随着收入的快速增长，该公司每股美国存托股 (ADS) 的亏损将大幅缩小。</blockquote></p><p> Vehicle deliveries are another key metric investors watch in order to gauge the company's productive capacity. NIO already reported vehicle deliveries for the first quarter earlier this month, achieving a new quarterly record despite total deliveries coming in slightly below expectations.</p><p><blockquote>汽车交付量是投资者衡量公司生产能力的另一个关键指标。蔚来本月早些时候已经公布了第一季度的汽车交付量，尽管总交付量略低于预期，但仍创下了新的季度记录。</blockquote></p><p> Shares of NIO have dramatically outperformed the broader market over the past year. But after reaching all-time highs earlier this year, the stock has fallen considerably and has been trading mostly sideways since early March. NIO's shares have provided investors with an astronomic total return of 1,171.9% over the past year, well above the S&amp;P 500's total return of 45.5%.</p><p><blockquote>过去一年，蔚来股价的表现大幅优于大盘。但在今年早些时候触及历史高点后，该股大幅下跌，自 3 月初以来大部分时间横盘整理。过去一年，蔚来汽车的股票为投资者提供了1,171.9%的天文数字总回报率，远高于标准普尔500指数45.5%的总回报率。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a11e1a915810ccbc7f07ec2adf16865b\" tg-width=\"3004\" tg-height=\"1798\"><span>Source: TradingView.</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：TradingView。</span></p></blockquote></p><p> <b>NIO Earnings History</b></p><p><blockquote><b>蔚来盈利历史</b></blockquote></p><p> The stock, which had been gathering downward momentum after peaking around mid-February, plunged following NIO's&nbsp;Q4 FY 2020 earnings&nbsp;report released at the beginning of March. The company reported a much larger loss per ADS than analysts expected and revenue also missed estimates. However, NIO's loss narrowed considerably compared to the year-ago quarter and revenue was still up 133.2%.The company was optimistic about its performance, noting that its&nbsp;gross margin&nbsp;rose to 17.2% compared to negative 8.9% in the year-ago quarter.</p><p><blockquote>该股在 2 月中旬左右见顶后一直在积聚下跌动力，但在蔚来汽车 3 月初发布 2020 财年第四季度收益报告后暴跌。该公司报告的每股美国存托凭证亏损远高于分析师预期，收入也低于预期。不过，蔚来汽车的亏损较去年同期大幅收窄，收入仍增长133.2%。该公司对其业绩持乐观态度，指出其毛利率从去年同期的负8.9%升至17.2%。</blockquote></p><p> In Q3 FY 2020, NIO posted a loss per ADS of 0.98 yuan ($0.15 as of the CNY/USD exchange rate on April 27, 2021).It was the smallest loss in at least 11 quarters. Revenue rose 146.4%, maintaining the pace of growth achieved in the second quarter.NIO said it delivered a record number of vehicles and saw improvements in its average selling price. The company also said that it was the second straight quarter of positive cash flow from operating activities.</p><p><blockquote>2020财年第三季度，蔚来公布每股美国存托凭证亏损0.98元（按2021年4月27日人民币/美元汇率计算为0.15美元）。这是至少11个季度以来最小的损失。收入增长146.4%，保持了第二季度的增长速度。蔚来表示，交付的车辆数量创历史新高，平均售价有所提高。该公司还表示，这是连续第二个季度经营活动现金流为正。</blockquote></p><p> Analysts expect continued improvement in NIO's financial results in Q1 FY 2021. While NIO is still expected to post another loss per ADS, it is estimated to be the lowest in at least 14 quarters. Revenue for the quarter is forecast to rise 446.1%, which would be the fastest pace since Q2 FY 2019. For full-year FY 2021, analysts are currently expecting NIO to achieve a loss of 2.72 yuan per ADS, which would be the smallest loss in at least five years. Revenue is expected to rise 109.7%, a faster pace than in each of the last two years.</p><p><blockquote>分析师预计蔚来汽车2021财年第一季度的财务业绩将继续改善。虽然预计蔚来每股广告仍将出现另一次亏损，但预计这是至少 14 个季度以来的最低水平。该季度收入预计将增长 446.1%，这将是自 2019 财年第二季度以来的最快增速。对于2021财年全年，分析师目前预计蔚来每股ADS亏损2.72元，这将是至少五年来的最小亏损。收入预计将增长 109.7%，增速快于过去两年的每一年。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d412a9c0aea28621f713f5afbfba444c\" tg-width=\"885\" tg-height=\"352\"><span>Source: Visible Alpha; NIO Inc.</span></p><p><blockquote><p class=\"t-img-caption\"><span>来源：可见阿尔法；蔚来</span></p></blockquote></p><p> <b>The Key Metric</b></p><p><blockquote><b>关键指标</b></blockquote></p><p> As mentioned above, investors are also watching the number of vehicles NIO delivers each quarter. NIO generates some revenue from various services it provides, but the majority of revenue is derived from vehicle sales.Currently, the company makes deliveries of three types of vehicles: the ES8, the company's 6-seater and 7-seater flagship premium smart electric SUV; the ES6, the company’s 5-seater high-performance premium smart electric SUV; and the EC6, the company’s 5-seater premium electric coupe SUV.The number of vehicle deliveries provides an indication of the demand for NIO's vehicles as well as the company's ability to scale production.</p><p><blockquote>如上所述，投资者也在关注蔚来每个季度交付的汽车数量。蔚来从其提供的各种服务中产生一些收入，但大部分收入来自汽车销售。目前，该公司交付三种类型的车辆：ES8，该公司的6座和7座旗舰高端智能电动SUV；ES6，该公司的5座高性能高端智能电动SUV；以及该公司的 5 座高端电动轿跑车 EC6。车辆交付数量表明了蔚来汽车的需求以及该公司扩大生产的能力。</blockquote></p><p></p><p> NIO has significantly ramped up its production over the past few years. The company delivered 11,350 vehicles in FY 2018. In FY 2020, it had nearly quadrupled that figure, delivering 43,730 vehicles. Despite a slowdown in Q1 FY 2020 amid the COVID-19 pandemic, NIO quickly made up for the Q1 drop in deliveries with a 190.8% year-over-year increase in Q2 FY 2020. Total vehicle delivery growth decelerated to 154.3% in Q3 and then to 111.0% in Q4. However, vehicle deliveries rose 423.0% in Q1 FY 2021, hitting a new quarterly record, as mentioned above. For full-year FY 2021, analysts are forecasting NIO to deliver 88,280 vehicles, which would be more than double last year's total deliveries. However, NIO warned investors in early March that the global chip shortage is likely to cut its production capacity, at least in the second quarter.</p><p><blockquote>蔚来在过去几年中大幅增加了产量。该公司在2018财年交付了11,350辆汽车。2020 财年，这一数字几乎翻了两番，交付了 43,730 辆汽车。尽管2020财年第一季度因新冠肺炎疫情而放缓，但蔚来迅速弥补了第一季度交付量的下降，2020财年第二季度交付量同比增长190.8%。第三季度汽车总交付量增长率放缓至 154.3%，第四季度又放缓至 111.0%。然而，如上所述，2021 财年第一季度汽车交付量增长了 423.0%，创下了新的季度记录。对于2021财年全年，分析师预测蔚来将交付88,280辆汽车，这将是去年总交付量的两倍多。然而，蔚来在3月初警告投资者，全球芯片短缺可能会削减其产能，至少在第二季度如此。</blockquote></p><p></p>","source":"lsy1606203311635","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO Q1 2021 Earnings Report Preview: What to Look For<blockquote>蔚来 2021 年第一季度收益报告预览：看点</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO Q1 2021 Earnings Report Preview: What to Look For<blockquote>蔚来 2021 年第一季度收益报告预览：看点</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">InvestoPedia</strong><span class=\"h-time small\">2021-04-29 11:08</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Focus on NIO vehicle deliveries</p><p><blockquote>专注于蔚来汽车交付</blockquote></p><p> <b>KEY TAKEAWAYS</b></p><p><blockquote><b>主要要点</b></blockquote></p><p> <ul>  <li>Analysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.</li>  <li>Vehicle deliveries, already announced, rose dramatically YOY.</li>  <li>Revenue is expected to soar on expanding vehicle sales.</li> </ul> NIO Inc. (NIO), like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles (EVs). NIO's production stoppage in late March had little impact on the company's record vehicle deliveries in Q1, but it could affect future production numbers.</p><p><blockquote><ul><li>分析师预计 2020 财年第一季度每股美国存托凭证收益为 -0.72 元，而 -1.66 元。</li><li>已经宣布的汽车交付量同比大幅增长。</li><li>随着汽车销量的扩大，收入预计将飙升。</li></ul>与许多其他汽车制造商一样，由于全球半导体短缺，蔚来（蔚来）今年被迫停产。半导体芯片广泛用于智能手机、计算机和其他电子设备，对于高端电动汽车 (EV) 制造商蔚来来说尤为重要。蔚来汽车3月下旬的停产对该公司第一季度创纪录的汽车交付量影响不大，但可能会影响未来的产量。</blockquote></p><p> Investors will focus on how these forces affect NIO's immediate results, as well as its financial outlook, when the company reports earnings on April 29, 2021 for Q1 FY 2021.Analysts are expecting the company's loss per American depositary share (ADS) to narrow significantly as revenue expands at a rapid pace.</p><p><blockquote>当蔚来汽车于 2021 年 4 月 29 日公布 2021 财年第一季度收益时，投资者将关注这些力量如何影响蔚来汽车的近期业绩及其财务前景。分析师预计，随着收入的快速增长，该公司每股美国存托股 (ADS) 的亏损将大幅缩小。</blockquote></p><p> Vehicle deliveries are another key metric investors watch in order to gauge the company's productive capacity. NIO already reported vehicle deliveries for the first quarter earlier this month, achieving a new quarterly record despite total deliveries coming in slightly below expectations.</p><p><blockquote>汽车交付量是投资者衡量公司生产能力的另一个关键指标。蔚来本月早些时候已经公布了第一季度的汽车交付量，尽管总交付量略低于预期，但仍创下了新的季度记录。</blockquote></p><p> Shares of NIO have dramatically outperformed the broader market over the past year. But after reaching all-time highs earlier this year, the stock has fallen considerably and has been trading mostly sideways since early March. NIO's shares have provided investors with an astronomic total return of 1,171.9% over the past year, well above the S&amp;P 500's total return of 45.5%.</p><p><blockquote>过去一年，蔚来股价的表现大幅优于大盘。但在今年早些时候触及历史高点后，该股大幅下跌，自 3 月初以来大部分时间横盘整理。过去一年，蔚来汽车的股票为投资者提供了1,171.9%的天文数字总回报率，远高于标准普尔500指数45.5%的总回报率。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a11e1a915810ccbc7f07ec2adf16865b\" tg-width=\"3004\" tg-height=\"1798\"><span>Source: TradingView.</span></p><p><blockquote><p class=\"t-img-caption\"><span>资料来源：TradingView。</span></p></blockquote></p><p> <b>NIO Earnings History</b></p><p><blockquote><b>蔚来盈利历史</b></blockquote></p><p> The stock, which had been gathering downward momentum after peaking around mid-February, plunged following NIO's&nbsp;Q4 FY 2020 earnings&nbsp;report released at the beginning of March. The company reported a much larger loss per ADS than analysts expected and revenue also missed estimates. However, NIO's loss narrowed considerably compared to the year-ago quarter and revenue was still up 133.2%.The company was optimistic about its performance, noting that its&nbsp;gross margin&nbsp;rose to 17.2% compared to negative 8.9% in the year-ago quarter.</p><p><blockquote>该股在 2 月中旬左右见顶后一直在积聚下跌动力，但在蔚来汽车 3 月初发布 2020 财年第四季度收益报告后暴跌。该公司报告的每股美国存托凭证亏损远高于分析师预期，收入也低于预期。不过，蔚来汽车的亏损较去年同期大幅收窄，收入仍增长133.2%。该公司对其业绩持乐观态度，指出其毛利率从去年同期的负8.9%升至17.2%。</blockquote></p><p> In Q3 FY 2020, NIO posted a loss per ADS of 0.98 yuan ($0.15 as of the CNY/USD exchange rate on April 27, 2021).It was the smallest loss in at least 11 quarters. Revenue rose 146.4%, maintaining the pace of growth achieved in the second quarter.NIO said it delivered a record number of vehicles and saw improvements in its average selling price. The company also said that it was the second straight quarter of positive cash flow from operating activities.</p><p><blockquote>2020财年第三季度，蔚来公布每股美国存托凭证亏损0.98元（按2021年4月27日人民币/美元汇率计算为0.15美元）。这是至少11个季度以来最小的损失。收入增长146.4%，保持了第二季度的增长速度。蔚来表示，交付的车辆数量创历史新高，平均售价有所提高。该公司还表示，这是连续第二个季度经营活动现金流为正。</blockquote></p><p> Analysts expect continued improvement in NIO's financial results in Q1 FY 2021. While NIO is still expected to post another loss per ADS, it is estimated to be the lowest in at least 14 quarters. Revenue for the quarter is forecast to rise 446.1%, which would be the fastest pace since Q2 FY 2019. For full-year FY 2021, analysts are currently expecting NIO to achieve a loss of 2.72 yuan per ADS, which would be the smallest loss in at least five years. Revenue is expected to rise 109.7%, a faster pace than in each of the last two years.</p><p><blockquote>分析师预计蔚来汽车2021财年第一季度的财务业绩将继续改善。虽然预计蔚来每股广告仍将出现另一次亏损，但预计这是至少 14 个季度以来的最低水平。该季度收入预计将增长 446.1%，这将是自 2019 财年第二季度以来的最快增速。对于2021财年全年，分析师目前预计蔚来每股ADS亏损2.72元，这将是至少五年来的最小亏损。收入预计将增长 109.7%，增速快于过去两年的每一年。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d412a9c0aea28621f713f5afbfba444c\" tg-width=\"885\" tg-height=\"352\"><span>Source: Visible Alpha; NIO Inc.</span></p><p><blockquote><p class=\"t-img-caption\"><span>来源：可见阿尔法；蔚来</span></p></blockquote></p><p> <b>The Key Metric</b></p><p><blockquote><b>关键指标</b></blockquote></p><p> As mentioned above, investors are also watching the number of vehicles NIO delivers each quarter. NIO generates some revenue from various services it provides, but the majority of revenue is derived from vehicle sales.Currently, the company makes deliveries of three types of vehicles: the ES8, the company's 6-seater and 7-seater flagship premium smart electric SUV; the ES6, the company’s 5-seater high-performance premium smart electric SUV; and the EC6, the company’s 5-seater premium electric coupe SUV.The number of vehicle deliveries provides an indication of the demand for NIO's vehicles as well as the company's ability to scale production.</p><p><blockquote>如上所述，投资者也在关注蔚来每个季度交付的汽车数量。蔚来从其提供的各种服务中产生一些收入，但大部分收入来自汽车销售。目前，该公司交付三种类型的车辆：ES8，该公司的6座和7座旗舰高端智能电动SUV；ES6，该公司的5座高性能高端智能电动SUV；以及该公司的 5 座高端电动轿跑车 EC6。车辆交付数量表明了蔚来汽车的需求以及该公司扩大生产的能力。</blockquote></p><p></p><p> NIO has significantly ramped up its production over the past few years. The company delivered 11,350 vehicles in FY 2018. In FY 2020, it had nearly quadrupled that figure, delivering 43,730 vehicles. Despite a slowdown in Q1 FY 2020 amid the COVID-19 pandemic, NIO quickly made up for the Q1 drop in deliveries with a 190.8% year-over-year increase in Q2 FY 2020. Total vehicle delivery growth decelerated to 154.3% in Q3 and then to 111.0% in Q4. However, vehicle deliveries rose 423.0% in Q1 FY 2021, hitting a new quarterly record, as mentioned above. For full-year FY 2021, analysts are forecasting NIO to deliver 88,280 vehicles, which would be more than double last year's total deliveries. However, NIO warned investors in early March that the global chip shortage is likely to cut its production capacity, at least in the second quarter.</p><p><blockquote>蔚来在过去几年中大幅增加了产量。该公司在2018财年交付了11,350辆汽车。2020 财年，这一数字几乎翻了两番，交付了 43,730 辆汽车。尽管2020财年第一季度因新冠肺炎疫情而放缓，但蔚来迅速弥补了第一季度交付量的下降，2020财年第二季度交付量同比增长190.8%。第三季度汽车总交付量增长率放缓至 154.3%，第四季度又放缓至 111.0%。然而，如上所述，2021 财年第一季度汽车交付量增长了 423.0%，创下了新的季度记录。对于2021财年全年，分析师预测蔚来将交付88,280辆汽车，这将是去年总交付量的两倍多。然而，蔚来在3月初警告投资者，全球芯片短缺可能会削减其产能，至少在第二季度如此。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.investopedia.com/nio-q1-2021-earnings-report-preview-5180991\">InvestoPedia</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"source_url":"https://www.investopedia.com/nio-q1-2021-earnings-report-preview-5180991","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183966356","content_text":"Focus on NIO vehicle deliveries\nKEY TAKEAWAYS\n\nAnalysts estimate earnings per ADS of -0.72 yuan vs. -1.66 yuan in Q1 FY 2020.\nVehicle deliveries, already announced, rose dramatically YOY.\nRevenue is expected to soar on expanding vehicle sales.\n\nNIO Inc. (NIO), like many other automakers, was forced to halt production this year due to the global semiconductor shortage. Semiconductor chips, widely used in smartphones, computers, and other electronic devices, are especially important to NIO, a maker of premium electric vehicles (EVs). NIO's production stoppage in late March had little impact on the company's record vehicle deliveries in Q1, but it could affect future production numbers.\nInvestors will focus on how these forces affect NIO's immediate results, as well as its financial outlook, when the company reports earnings on April 29, 2021 for Q1 FY 2021.Analysts are expecting the company's loss per American depositary share (ADS) to narrow significantly as revenue expands at a rapid pace.\nVehicle deliveries are another key metric investors watch in order to gauge the company's productive capacity. NIO already reported vehicle deliveries for the first quarter earlier this month, achieving a new quarterly record despite total deliveries coming in slightly below expectations.\nShares of NIO have dramatically outperformed the broader market over the past year. But after reaching all-time highs earlier this year, the stock has fallen considerably and has been trading mostly sideways since early March. NIO's shares have provided investors with an astronomic total return of 1,171.9% over the past year, well above the S&P 500's total return of 45.5%.\nSource: TradingView.\nNIO Earnings History\nThe stock, which had been gathering downward momentum after peaking around mid-February, plunged following NIO's Q4 FY 2020 earnings report released at the beginning of March. The company reported a much larger loss per ADS than analysts expected and revenue also missed estimates. However, NIO's loss narrowed considerably compared to the year-ago quarter and revenue was still up 133.2%.The company was optimistic about its performance, noting that its gross margin rose to 17.2% compared to negative 8.9% in the year-ago quarter.\nIn Q3 FY 2020, NIO posted a loss per ADS of 0.98 yuan ($0.15 as of the CNY/USD exchange rate on April 27, 2021).It was the smallest loss in at least 11 quarters. Revenue rose 146.4%, maintaining the pace of growth achieved in the second quarter.NIO said it delivered a record number of vehicles and saw improvements in its average selling price. The company also said that it was the second straight quarter of positive cash flow from operating activities.\nAnalysts expect continued improvement in NIO's financial results in Q1 FY 2021. While NIO is still expected to post another loss per ADS, it is estimated to be the lowest in at least 14 quarters. Revenue for the quarter is forecast to rise 446.1%, which would be the fastest pace since Q2 FY 2019. For full-year FY 2021, analysts are currently expecting NIO to achieve a loss of 2.72 yuan per ADS, which would be the smallest loss in at least five years. Revenue is expected to rise 109.7%, a faster pace than in each of the last two years.\nSource: Visible Alpha; NIO Inc.\nThe Key Metric\nAs mentioned above, investors are also watching the number of vehicles NIO delivers each quarter. NIO generates some revenue from various services it provides, but the majority of revenue is derived from vehicle sales.Currently, the company makes deliveries of three types of vehicles: the ES8, the company's 6-seater and 7-seater flagship premium smart electric SUV; the ES6, the company’s 5-seater high-performance premium smart electric SUV; and the EC6, the company’s 5-seater premium electric coupe SUV.The number of vehicle deliveries provides an indication of the demand for NIO's vehicles as well as the company's ability to scale production.\nNIO has significantly ramped up its production over the past few years. The company delivered 11,350 vehicles in FY 2018. In FY 2020, it had nearly quadrupled that figure, delivering 43,730 vehicles. Despite a slowdown in Q1 FY 2020 amid the COVID-19 pandemic, NIO quickly made up for the Q1 drop in deliveries with a 190.8% year-over-year increase in Q2 FY 2020. Total vehicle delivery growth decelerated to 154.3% in Q3 and then to 111.0% in Q4. However, vehicle deliveries rose 423.0% in Q1 FY 2021, hitting a new quarterly record, as mentioned above. For full-year FY 2021, analysts are forecasting NIO to deliver 88,280 vehicles, which would be more than double last year's total deliveries. However, NIO warned investors in early March that the global chip shortage is likely to cut its production capacity, at least in the second quarter.","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":821,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":600765168,"gmtCreate":1638198782315,"gmtModify":1638198822415,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/600765168","repostId":"1180693909","repostType":4,"repost":{"id":"1180693909","kind":"news","pubTimestamp":1638198357,"share":"https://www.laohunote.com/m/news/1180693909?lang=zh_CN&edition=full","pubTime":"2021-11-29 23:05","market":"us","language":"en","title":"Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify 股票：逢低买入至 10 月初水平？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1180693909","media":"TheStreet","summary":"Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the","content":"<p>Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.</p><p><blockquote>继第三季度后盈利飙升后，Spotify 股价在 11 月份大幅下跌。一些人可能认为这一举动是看跌的，而另一些人则可能认为这是一个以更低价格购买现货的机会。</blockquote></p><p> In late October, Spotify&nbsp;announced third quarter results. The numbers excited investors and sent Spotify stock&nbsp;up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.</p><p><blockquote>10月下旬，Spotify公布了第三季度业绩。这些数字让投资者兴奋不已，Spotify 股价迅速上涨近 15%。支撑乐观情绪的关键指标是该平台的 MAU（月活跃用户）比上一年大幅增长，随后收入同比增长近 30%。</blockquote></p><p> However, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.</p><p><blockquote>然而，在财报公布近一个月后，股价下跌了10%，回到了10月初的水平。如今，MavenFlix 试图了解 SPOT 的情况，并讨论最近的下跌是否可以被视为买入机会。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1a76b6dc048e3702eb0b6ef48bbc0409\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Spotify app icon.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Spotify应用程序图标。</span></p></blockquote></p><p> <b>Recent downfall and a future opportunity</b></p><p><blockquote><b>最近的失败和未来的机会</b></blockquote></p><p> SPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.</p><p><blockquote>SPOT 在 8 月份触及每股 205 美元，此后开始强劲看涨，升至六个月高点。然而，11 月，在该公司第三季度业绩公布后不久，Spotify 股价从 300 美元的高点跌至 250 美元以下。</blockquote></p><p> One of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.</p><p><blockquote>这种下降的可能原因之一是获利了结。如果是这样的话，对于那些喜欢该公司基本面的人来说，可能存在逢低买入的机会，但认为该现货可能过于昂贵或被高估。如今，Spotify 的交易价格为过去 3 个月来的最低价格。</blockquote></p><p> <b>Podcast growth and ad revenue</b></p><p><blockquote><b>播客增长和广告收入</b></blockquote></p><p> Unlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.</p><p><blockquote>与许多人的想法不同，Spotify不仅仅是一个音乐平台，而是一个音频平台。因此，在计算股票的公允价值时，人们不应只考虑音乐流媒体领域的增长。</blockquote></p><p> As we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&amp;L in the foreseeable future.</p><p><blockquote>正如我们在 “Spotify 财报： 为什么第三季度业绩导致股价飙升 ”中讨论的那样，播客是当今 Spotify 最相关的增长动力之一。流媒体音频的这一细分市场正在快速扩张，并可能在可预见的未来成为公司损益的重要组成部分。</blockquote></p><p> With ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.</p><p><blockquote>随着广告支持的帐户以与付费用户相同的速度增长，播客货币化是Spotify下一步的关键。我们认为这可能是推动 Spotify 股价在未来走高的催化剂——即使不是在未来几周或几个月内。</blockquote></p><p> <b>Spotify dominates audio streaming</b></p><p><blockquote><b>Spotify 主导音频流媒体</b></blockquote></p><p> Spotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.</p><p><blockquote>Spotify拥有最大的音乐库之一。然而，我们并不认为这使该公司有别于竞争对手。例如，苹果和亚马逊也在继续投入大量现金，以提高其平台的内容产品。</blockquote></p><p> What makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.</p><p><blockquote>在我们看来，让Spotify脱颖而出的是它在音频流媒体领域的足迹。尽管有增长前景，但市场仍然集中在少数参与者手中，这与视频流不同。如下图所示，Spotify 拥有明显的市场主导地位。</blockquote></p><p> The investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.</p><p><blockquote>对播客的投资只会帮助Spotify在未来几年确立自己的领先地位。目前，该平台上大约有260万个播客标题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab561adf751b756fe06b8fa8d2bff0ee\" tg-width=\"609\" tg-height=\"458\" width=\"100%\" height=\"auto\"><span>Figure 2: Music streaming market share.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：音乐流媒体市场份额。</span></p></blockquote></p><p> <b>Our view</b></p><p><blockquote><b>我们的观点</b></blockquote></p><p> After Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.</p><p><blockquote>自 11 月初以来，Spotify 股价下跌超过 10%，对于那些欣赏 Spotify 商业模式的人来说，机会之窗可能已经打开。然而，今天购买现货可能只会被证明是一个好的长期策略，因为短期内的波动性不太可能消退。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Spotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify 股票：逢低买入至 10 月初水平？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpotify Stock: Buy the Dip to Early-October Levels?<blockquote>Spotify 股票：逢低买入至 10 月初水平？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-11-29 23:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.</p><p><blockquote>继第三季度后盈利飙升后，Spotify 股价在 11 月份大幅下跌。一些人可能认为这一举动是看跌的，而另一些人则可能认为这是一个以更低价格购买现货的机会。</blockquote></p><p> In late October, Spotify&nbsp;announced third quarter results. The numbers excited investors and sent Spotify stock&nbsp;up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.</p><p><blockquote>10月下旬，Spotify公布了第三季度业绩。这些数字让投资者兴奋不已，Spotify 股价迅速上涨近 15%。支撑乐观情绪的关键指标是该平台的 MAU（月活跃用户）比上一年大幅增长，随后收入同比增长近 30%。</blockquote></p><p> However, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.</p><p><blockquote>然而，在财报公布近一个月后，股价下跌了10%，回到了10月初的水平。如今，MavenFlix 试图了解 SPOT 的情况，并讨论最近的下跌是否可以被视为买入机会。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1a76b6dc048e3702eb0b6ef48bbc0409\" tg-width=\"1240\" tg-height=\"698\" width=\"100%\" height=\"auto\"><span>Figure 1: Spotify app icon.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：Spotify应用程序图标。</span></p></blockquote></p><p> <b>Recent downfall and a future opportunity</b></p><p><blockquote><b>最近的失败和未来的机会</b></blockquote></p><p> SPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.</p><p><blockquote>SPOT 在 8 月份触及每股 205 美元，此后开始强劲看涨，升至六个月高点。然而，11 月，在该公司第三季度业绩公布后不久，Spotify 股价从 300 美元的高点跌至 250 美元以下。</blockquote></p><p> One of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.</p><p><blockquote>这种下降的可能原因之一是获利了结。如果是这样的话，对于那些喜欢该公司基本面的人来说，可能存在逢低买入的机会，但认为该现货可能过于昂贵或被高估。如今，Spotify 的交易价格为过去 3 个月来的最低价格。</blockquote></p><p> <b>Podcast growth and ad revenue</b></p><p><blockquote><b>播客增长和广告收入</b></blockquote></p><p> Unlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.</p><p><blockquote>与许多人的想法不同，Spotify不仅仅是一个音乐平台，而是一个音频平台。因此，在计算股票的公允价值时，人们不应只考虑音乐流媒体领域的增长。</blockquote></p><p> As we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&amp;L in the foreseeable future.</p><p><blockquote>正如我们在 “Spotify 财报： 为什么第三季度业绩导致股价飙升 ”中讨论的那样，播客是当今 Spotify 最相关的增长动力之一。流媒体音频的这一细分市场正在快速扩张，并可能在可预见的未来成为公司损益的重要组成部分。</blockquote></p><p> With ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.</p><p><blockquote>随着广告支持的帐户以与付费用户相同的速度增长，播客货币化是Spotify下一步的关键。我们认为这可能是推动 Spotify 股价在未来走高的催化剂——即使不是在未来几周或几个月内。</blockquote></p><p> <b>Spotify dominates audio streaming</b></p><p><blockquote><b>Spotify 主导音频流媒体</b></blockquote></p><p> Spotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.</p><p><blockquote>Spotify拥有最大的音乐库之一。然而，我们并不认为这使该公司有别于竞争对手。例如，苹果和亚马逊也在继续投入大量现金，以提高其平台的内容产品。</blockquote></p><p> What makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.</p><p><blockquote>在我们看来，让Spotify脱颖而出的是它在音频流媒体领域的足迹。尽管有增长前景，但市场仍然集中在少数参与者手中，这与视频流不同。如下图所示，Spotify 拥有明显的市场主导地位。</blockquote></p><p> The investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.</p><p><blockquote>对播客的投资只会帮助Spotify在未来几年确立自己的领先地位。目前，该平台上大约有260万个播客标题。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ab561adf751b756fe06b8fa8d2bff0ee\" tg-width=\"609\" tg-height=\"458\" width=\"100%\" height=\"auto\"><span>Figure 2: Music streaming market share.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：音乐流媒体市场份额。</span></p></blockquote></p><p> <b>Our view</b></p><p><blockquote><b>我们的观点</b></blockquote></p><p> After Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.</p><p><blockquote>自 11 月初以来，Spotify 股价下跌超过 10%，对于那些欣赏 Spotify 商业模式的人来说，机会之窗可能已经打开。然而，今天购买现货可能只会被证明是一个好的长期策略，因为短期内的波动性不太可能消退。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/streaming/spot/buy-spotify-stock-at-pre-q3-earnings-levels\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPOT":"Spotify Technology S.A."},"source_url":"https://www.thestreet.com/streaming/spot/buy-spotify-stock-at-pre-q3-earnings-levels","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180693909","content_text":"Spotify stock lost plenty of steam in November, following a post-Q3 earnings spike. Some may see the move as bearish, while others could find it an opportunity to buy SPOT cheaper.\nIn late October, Spotify announced third quarter results. The numbers excited investors and sent Spotify stock up nearly 15% quickly. The key metric supporting bullishness was the large increase in the platform's MAUs (monthly active users) over the previous year, followed by an almost 30% YoY growth in revenue.\nHowever, almost a month after the earnings announcement, shares have dipped 10% and returned to the same levels of early October. Today, MavenFlix tries to make sense of what is happening with SPOT, and debates whether the recent drop can be considered a buying opportunity.\nFigure 1: Spotify app icon.\nRecent downfall and a future opportunity\nSPOT hit $205 per share in August and, since then, embarked on a strong bullish ride to six-month highs. However, in November, not long after the announcement of the company's third quarter results, Spotify stock dropped from a high of $300 to less than $250.\nOne of the possible causes for such decline is profit taking. If so, an opportunity to buy the dip could exist for those who like the fundamentals of the company, but that believed SPOT may have been too expensive or overvalued. Today, Spotify is trading at the lowest price in the last 3 months.\nPodcast growth and ad revenue\nUnlike what many might think, Spotify is not merely a music platform, but an audio one. Therefore, one should not only consider growth in the music streaming space when calculating the fair value of the stock.\nAs we discussed in “Spotify Earnings: Why The Stock Spiked On Q3 Results”, one of the most relevant growth drivers for Spotify today is podcast. This sub-segment of streaming audio is expanding fast and could become a substantial part of the company's P&L in the foreseeable future.\nWith ad-supported accounts growing at the same rate as paid users, monetizing on podcasts is a key next step for Spotify. We think that this could be a catalyst pushing Spotify stock higher in the future – even if not in the next few weeks or months.\nSpotify dominates audio streaming\nSpotify has one of the largest music libraries. However, we do not think that this sets the company apart from its competitors. Apple and Amazon, for example, continue to invest their bottomless piles of cash to boost their platforms’ content offerings as well.\nWhat makes Spotify stand out, in our view, is its footprint in audio streaming. Despite the growth prospects, the market is still concentrated in the hands of few players, unlike what happens in video streaming. Spotify has clear market dominance, as the chart below depicts.\nThe investments in podcasts should only help Spotify to establish itself at the top for years to come. Currently, there are about 2.6 million podcast titles available on the platform.\nFigure 2: Music streaming market share.\nOur view\nAfter Spotify stock dropped more than 10% since the beginning of November, a window of opportunity may have opened for those who appreciate Spotify's business model. Buying SPOT today, however, may only prove to be a good long-term strategy, since volatility in the short term in unlikely to subside.","news_type":1,"symbols_score_info":{"SPOT":0.9}},"isVote":1,"tweetType":1,"viewCount":4999,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866693672,"gmtCreate":1632758526196,"gmtModify":1632798023770,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/866693672","repostId":"1143307489","repostType":4,"repost":{"id":"1143307489","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632757396,"share":"https://www.laohunote.com/m/news/1143307489?lang=zh_CN&edition=full","pubTime":"2021-09-27 23:43","market":"us","language":"en","title":"Cannabis stocks jumped in Monday morning trading<blockquote>周一早盘交易中大麻股票上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1143307489","media":"Tiger Newspress","summary":"Cannabis stocks jumped in Monday morning trading as U.S. House approved bill to ease banking for can","content":"<p>Cannabis stocks jumped in Monday morning trading&nbsp;as&nbsp;U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers&nbsp;and&nbsp;OrganiGram&nbsp;climbed between 2% and 6%.</p><p><blockquote>由于美国众议院批准了放宽大麻公司银行业务的法案。 Canopy Growth、Tilray、Aurora Cannabis、Cronos、Sundial Growers 和 OrganiGram 的股价上涨了 2% 至 6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b7d7c6db300ed6a9e7a2699a1884e853\" tg-width=\"399\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The U.S. House of Representatives late last&nbsp;Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.</p><p><blockquote>美国众议院上周二深夜批准了一项法案，允许银行与大麻公司开展业务，而不必担心受到处罚，这为不断发展的行业所寻求的争议最少的改革提供了动力。</blockquote></p><p> The so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.</p><p><blockquote>所谓的《安全银行法》是不断发展的银行业所寻求的争议最少的改革，它作为更广泛立法的一部分被接受，周二晚间，该法案被纳入《国防授权法》以口头投票的方式获得批准。该法案是否会在参议院获得通过还有待观察，但众议院的行动给了它更好的机会。</blockquote></p><p> The act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.</p><p><blockquote>该法案对大麻公司来说将是一个福音，由于联邦限制，大麻公司迄今为止一直受到现金交易需求的阻碍。这意味着他们有额外的安全成本和后勤问题，即使大麻越来越合法。根据大麻研究公司New Frontier Data的数据，现在大约有36个州允许医疗或娱乐使用。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/94634a1c93ee67a96440d95391009461\" tg-width=\"748\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Representative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said&nbsp;that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.</p><p><blockquote>重新提出该法案的科罗拉多州民主党众议员埃德·珀尔穆特表示，允许大麻企业进入银行系统将为经济带来更多资金，并提供创造高薪就业机会的机会。根据New Frontier的数据，2020年美国大麻行业的合法销售额为203亿美元。</blockquote></p><p> The initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.</p><p><blockquote>该倡议此前已在两党支持下在众议院获得通过，但从未提交参议院，与该行业寻求的法律改革愿望清单相去甚远，其中包括全面合法化和减轻税收负担。</blockquote></p><p> The U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.</p><p><blockquote>贸易组织美国大麻委员会称，目前要求大麻公司全现金的规定是一种安全隐患。</blockquote></p><p> “Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.</p><p><blockquote>“去年，美国共售出超过 170 亿美元的合法大麻，其中绝大多数是通过现金交易。强迫合法、监管良好的大麻企业以现金交易进行大部分业务是不合时宜的，显然是对公共安全的威胁，”该委员会首席执行官史蒂文-霍金斯（Steven Hawkins）在法案通过前的一份声明中说。</blockquote></p><p> “Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.</p><p><blockquote>“BTIGA分析师卡米洛-里昂（Camilo Lyon）在周三的一份研究报告中说：”每向前迈出一步，对大麻产业来说都是积极的一步。他说，目前还不清楚参议员查克-舒默（Chuck Schumer）是否会将该法案纳入参议院 NDAA 法案。</blockquote></p><p> “Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.</p><p><blockquote>“里昂写道：”与我们在华盛顿的联系人进行的讨论表明，该法案在参议院获得通过的途径更容易，这主要是因为没有参议员愿意仅仅因为银行安全而被视为搁置长达 1700 页的必须通过的 NDAA。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cannabis stocks jumped in Monday morning trading<blockquote>周一早盘交易中大麻股票上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCannabis stocks jumped in Monday morning trading<blockquote>周一早盘交易中大麻股票上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-27 23:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Cannabis stocks jumped in Monday morning trading&nbsp;as&nbsp;U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers&nbsp;and&nbsp;OrganiGram&nbsp;climbed between 2% and 6%.</p><p><blockquote>由于美国众议院批准了放宽大麻公司银行业务的法案。 Canopy Growth、Tilray、Aurora Cannabis、Cronos、Sundial Growers 和 OrganiGram 的股价上涨了 2% 至 6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/b7d7c6db300ed6a9e7a2699a1884e853\" tg-width=\"399\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The U.S. House of Representatives late last&nbsp;Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.</p><p><blockquote>美国众议院上周二深夜批准了一项法案，允许银行与大麻公司开展业务，而不必担心受到处罚，这为不断发展的行业所寻求的争议最少的改革提供了动力。</blockquote></p><p> The so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.</p><p><blockquote>所谓的《安全银行法》是不断发展的银行业所寻求的争议最少的改革，它作为更广泛立法的一部分被接受，周二晚间，该法案被纳入《国防授权法》以口头投票的方式获得批准。该法案是否会在参议院获得通过还有待观察，但众议院的行动给了它更好的机会。</blockquote></p><p> The act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.</p><p><blockquote>该法案对大麻公司来说将是一个福音，由于联邦限制，大麻公司迄今为止一直受到现金交易需求的阻碍。这意味着他们有额外的安全成本和后勤问题，即使大麻越来越合法。根据大麻研究公司New Frontier Data的数据，现在大约有36个州允许医疗或娱乐使用。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/94634a1c93ee67a96440d95391009461\" tg-width=\"748\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Representative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said&nbsp;that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.</p><p><blockquote>重新提出该法案的科罗拉多州民主党众议员埃德·珀尔穆特表示，允许大麻企业进入银行系统将为经济带来更多资金，并提供创造高薪就业机会的机会。根据New Frontier的数据，2020年美国大麻行业的合法销售额为203亿美元。</blockquote></p><p> The initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.</p><p><blockquote>该倡议此前已在两党支持下在众议院获得通过，但从未提交参议院，与该行业寻求的法律改革愿望清单相去甚远，其中包括全面合法化和减轻税收负担。</blockquote></p><p> The U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.</p><p><blockquote>贸易组织美国大麻委员会称，目前要求大麻公司全现金的规定是一种安全隐患。</blockquote></p><p> “Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.</p><p><blockquote>“去年，美国共售出超过 170 亿美元的合法大麻，其中绝大多数是通过现金交易。强迫合法、监管良好的大麻企业以现金交易进行大部分业务是不合时宜的，显然是对公共安全的威胁，”该委员会首席执行官史蒂文-霍金斯（Steven Hawkins）在法案通过前的一份声明中说。</blockquote></p><p> “Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.</p><p><blockquote>“BTIGA分析师卡米洛-里昂（Camilo Lyon）在周三的一份研究报告中说：”每向前迈出一步，对大麻产业来说都是积极的一步。他说，目前还不清楚参议员查克-舒默（Chuck Schumer）是否会将该法案纳入参议院 NDAA 法案。</blockquote></p><p> “Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.</p><p><blockquote>“里昂写道：”与我们在华盛顿的联系人进行的讨论表明，该法案在参议院获得通过的途径更容易，这主要是因为没有参议员愿意仅仅因为银行安全而被视为搁置长达 1700 页的必须通过的 NDAA。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGC":"Canopy Growth Corporation","CRON":"Cronos Group Inc.","ACB":"奥罗拉大麻公司","MJ":"Amplify Alternative Harvest ETF","SNDL":"SNDL Inc.","OGI":"ORGANIGRAM HOLD","TLRY":"Tilray Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143307489","content_text":"Cannabis stocks jumped in Monday morning trading as U.S. House approved bill to ease banking for cannabis companies.Canopy Growth,Tilray, Aurora Cannabis, Cronos, Sundial Growers and OrganiGram climbed between 2% and 6%.\n\nThe U.S. House of Representatives late last Tuesday night approved a bill that would let banks to do business with cannabis companies without fear of penalty, giving traction to the least-disputed reform sought by the growing industry.\nThe so-called SAFE Banking Act, which is the least disputed reform sought by the growing industry, got picked up as part of broader legislation, and its inclusion in the National Defense Authorization Act was approved by voice vote late Tuesday. It remains to be seen whether the bill will pass the Senate, but the House action gives it a better shot.\nThe act would be a boon for marijuana companies, which have so far been stymied by the need to deal in cash because of federal restrictions. That has meant they have extra security costs and logistical problems, even as marijuana increasingly becomes legal. Some three dozen states now allow medical or recreational use, according to New Frontier Data, a cannabis research firm.\n\nRepresentative Ed Perlmutter, a Colorado Democrat, who had re-introduced the bill,has said that allowing cannabis businesses to access the banking system would bring more money into the economy and offer the opportunity to create good-paying jobs. The American cannabis industry had $20.3 billion in legal sales in 2020, according New Frontier Data.\nThe initiative, which has been passed by the House before with bipartisan support but never advanced to the Senate, is still a far cry from the wish list of legal reforms sought by the industry, which include all-out legalization and relief from tax burdens.\nThe U.S. Cannabis Council, a trade group, called the current rules that require marijuana firms to be all-cash a security hazard.\n“Over $17 billion in legal cannabis was sold in the United States last year, overwhelmingly through cash transactions. Forcing legitimate, well-regulated cannabis businesses to conduct most of their business in cash is anachronistic and a clear threat to public safety,” the council’s chief executive officer, Steven Hawkins, said in a statement before the bill passed.\n“Every step forward is a positive one for the cannabis industry,”BTIGanalyst Camilo Lyon said in a research note Wednesday. He said it isn’t clear whether Senator Chuck Schumer will include the act in the Senate NDAA bill.\n“Discussions with our D.C. contacts suggest it has an easier pathway of getting through the Senate, largely because no senator wants to be viewed as holding up the massive 1,700 page must-pass NDAA simply because of SAFE banking,” Lyon wrote.","news_type":1,"symbols_score_info":{"MJ":0.9,"TLRY":0.9,"CGC":0.9,"ACB":0.9,"CRON":0.9,"OGI":0.9,"SNDL":0.9}},"isVote":1,"tweetType":1,"viewCount":1010,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":196212133,"gmtCreate":1621056356122,"gmtModify":1634194222243,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Pls like &amp; comment","listText":"Pls like &amp; comment","text":"Pls like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/196212133","repostId":"1163454382","repostType":4,"repost":{"id":"1163454382","kind":"news","pubTimestamp":1621004581,"share":"https://www.laohunote.com/m/news/1163454382?lang=zh_CN&edition=full","pubTime":"2021-05-14 23:03","market":"us","language":"en","title":"Why AMC Entertainment Stock Jumped Again Friday<blockquote>为什么AMC院线股价周五再次上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1163454382","media":"Motley Fool","summary":"AMC investors have reason for more optimism on the heels of another capital raise.Yesterday's jump came after the company announcedit raised $428 million. First, the Centers for Disease Control and Prevention  issued a new statement on current health and safety protocols saying that fully vaccinated people can resume activities without wearing a mask or physically distancing, including indoors.This should allow theaters to open back up at full capacity and be a desirable destination for vaccinat","content":"<p>  <b>AMC investors have reason for more optimism on the heels of another capital raise.</b>  <b>What happened</b></p><p><blockquote><b>AMC 投资者有理由在再次融资后更加乐观。</b><b>发生了什么事</b></blockquote></p><p> A day after<b>AMC Entertainment Holdings</b>(NYSE:AMC)</p><p><blockquote>一天后<b>AMC院线控股</b>（纽约证券交易所代码：AMC）</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yesterday's jump came after the company announcedit raised $428 million</p><p><blockquote>昨天的上涨是在该公司宣布筹集 4.28 亿美元之后发生的</blockquote></p><p> First, the Centers for Disease Control and Prevention (CDC) issued a new statement on current health and safety protocols saying that fully vaccinated people can resume activities without wearing a mask or physically distancing, including indoors.</p><p><blockquote>首先，疾病控制和预防中心（CDC）就当前的健康和安全协议发表了一份新声明，称完全接种疫苗的人可以在不戴口罩或保持物理距离的情况下恢复活动，包括在室内。</blockquote></p><p> This should allow theaters to open back up at full capacity and be a desirable destination for vaccinated movie patrons. Also yesterday,<b>Walt Disney</b>(NYSE:DIS)announced its quarterly earnings report, and CEO Bob Chapek noted \"increased production at our studios.\" While that is a positive for theater operators, Disney also reported disappointing subscriber growth in itsstreaming services.</p><p><blockquote>这应该可以让电影院满负荷重新开放，并成为接种疫苗的电影观众的理想目的地。也是昨天，<b>华特·迪士尼</b>（纽约证券交易所代码：DIS）公布了季度收益报告，首席执行官鲍勃·查佩克 (Bob Chapek) 指出“我们工作室的产量有所增加”。虽然这对影院运营商来说是个好消息，但迪士尼也报告了其流媒体服务的用户增长令人失望。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> Lower streaming subscriptions could be a positive sign for the theater business. As vaccinations continue to roll out, and with the CDC now officially giving its approval to gather indoors with crowds and without masks, theater attendance may resume quickly.</p><p><blockquote>较低的流媒体订阅可能是影院业务的一个积极迹象。随着疫苗接种的继续推广，随着疾病预防控制中心现在正式批准在室内聚集人群，不戴口罩，剧院上座率可能会很快恢复。</blockquote></p><p> Vaccinations are going to drive people back to activities outside the home. Movie theaters are likely to be a favorite destination after more than a year of mostly watching at home. On the heels of another capital raise, AMC investors may be thinking this company finally has a promising path ahead.</p><p><blockquote>疫苗接种将促使人们回到户外活动中。经过一年多的在家观看，电影院可能会成为最受欢迎的目的地。在再次融资之后，AMC 投资者可能认为这家公司终于有了一条充满希望的道路。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AMC Entertainment Stock Jumped Again Friday<blockquote>为什么AMC院线股价周五再次上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AMC Entertainment Stock Jumped Again Friday<blockquote>为什么AMC院线股价周五再次上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-05-14 23:03</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  <b>AMC investors have reason for more optimism on the heels of another capital raise.</b>  <b>What happened</b></p><p><blockquote><b>AMC 投资者有理由在再次融资后更加乐观。</b><b>发生了什么事</b></blockquote></p><p> A day after<b>AMC Entertainment Holdings</b>(NYSE:AMC)</p><p><blockquote>一天后<b>AMC院线控股</b>（纽约证券交易所代码：AMC）</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yesterday's jump came after the company announcedit raised $428 million</p><p><blockquote>昨天的上涨是在该公司宣布筹集 4.28 亿美元之后发生的</blockquote></p><p> First, the Centers for Disease Control and Prevention (CDC) issued a new statement on current health and safety protocols saying that fully vaccinated people can resume activities without wearing a mask or physically distancing, including indoors.</p><p><blockquote>首先，疾病控制和预防中心（CDC）就当前的健康和安全协议发表了一份新声明，称完全接种疫苗的人可以在不戴口罩或保持物理距离的情况下恢复活动，包括在室内。</blockquote></p><p> This should allow theaters to open back up at full capacity and be a desirable destination for vaccinated movie patrons. Also yesterday,<b>Walt Disney</b>(NYSE:DIS)announced its quarterly earnings report, and CEO Bob Chapek noted \"increased production at our studios.\" While that is a positive for theater operators, Disney also reported disappointing subscriber growth in itsstreaming services.</p><p><blockquote>这应该可以让电影院满负荷重新开放，并成为接种疫苗的电影观众的理想目的地。也是昨天，<b>华特·迪士尼</b>（纽约证券交易所代码：DIS）公布了季度收益报告，首席执行官鲍勃·查佩克 (Bob Chapek) 指出“我们工作室的产量有所增加”。虽然这对影院运营商来说是个好消息，但迪士尼也报告了其流媒体服务的用户增长令人失望。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在呢</b></blockquote></p><p> Lower streaming subscriptions could be a positive sign for the theater business. As vaccinations continue to roll out, and with the CDC now officially giving its approval to gather indoors with crowds and without masks, theater attendance may resume quickly.</p><p><blockquote>较低的流媒体订阅可能是影院业务的一个积极迹象。随着疫苗接种的继续推广，随着疾病预防控制中心现在正式批准在室内聚集人群，不戴口罩，剧院上座率可能会很快恢复。</blockquote></p><p> Vaccinations are going to drive people back to activities outside the home. Movie theaters are likely to be a favorite destination after more than a year of mostly watching at home. On the heels of another capital raise, AMC investors may be thinking this company finally has a promising path ahead.</p><p><blockquote>疫苗接种将促使人们回到户外活动中。经过一年多的在家观看，电影院可能会成为最受欢迎的目的地。在再次融资之后，AMC 投资者可能认为这家公司终于有了一条充满希望的道路。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/05/14/why-amc-entertainment-stock-jumped-again-friday/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/05/14/why-amc-entertainment-stock-jumped-again-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163454382","content_text":"AMC investors have reason for more optimism on the heels of another capital raise.\n\nWhat happened\nA day afterAMC Entertainment Holdings(NYSE:AMC)\nSo what\nYesterday's jump came after the company announcedit raised $428 million\nFirst, the Centers for Disease Control and Prevention (CDC) issued a new statement on current health and safety protocols saying that fully vaccinated people can resume activities without wearing a mask or physically distancing, including indoors.\nThis should allow theaters to open back up at full capacity and be a desirable destination for vaccinated movie patrons. Also yesterday,Walt Disney(NYSE:DIS)announced its quarterly earnings report, and CEO Bob Chapek noted \"increased production at our studios.\" While that is a positive for theater operators, Disney also reported disappointing subscriber growth in itsstreaming services.\nNow what\nLower streaming subscriptions could be a positive sign for the theater business. As vaccinations continue to roll out, and with the CDC now officially giving its approval to gather indoors with crowds and without masks, theater attendance may resume quickly.\nVaccinations are going to drive people back to activities outside the home. Movie theaters are likely to be a favorite destination after more than a year of mostly watching at home. On the heels of another capital raise, AMC investors may be thinking this company finally has a promising path ahead.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":576,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":180001149,"gmtCreate":1623162897981,"gmtModify":1634036264623,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Pls comment. Thank you&nbsp;","listText":"Pls comment. Thank you&nbsp;","text":"Pls comment. Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/180001149","repostId":"1136550999","repostType":4,"isVote":1,"tweetType":1,"viewCount":983,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":196212297,"gmtCreate":1621056370919,"gmtModify":1634194221904,"author":{"id":"3574428256060280","authorId":"3574428256060280","name":"KinKin","avatar":"https://static.tigerbbs.com/b4f58c29c0c165071cb594bd19ce588a","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574428256060280","idStr":"3574428256060280"},"themes":[],"title":"","htmlText":"Pls like &amp; comment","listText":"Pls like &amp; comment","text":"Pls like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/196212297","repostId":"1174509827","repostType":4,"repost":{"id":"1174509827","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1621004388,"share":"https://www.laohunote.com/m/news/1174509827?lang=zh_CN&edition=full","pubTime":"2021-05-14 22:59","market":"us","language":"en","title":"Delta Mandates All New Employees Must Have COVID-19 Vaccinations<blockquote>达美航空要求所有新员工必须接种 COVID-19 疫苗</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1174509827","media":"Benzinga Earnings","summary":"Delta Air Lines, Inc. DAL 4.24% has announced a new corporate mandate requiring all future employees to be vaccinated against COVID-19 before joining the company.What Happened: The Atlanta-headquartered carrier issued a statement praising the vaccines for protecting individuals and speeding the end of the pandemic, adding that the new mandate will ensure its employees will not face a reprise of the health crisis.“Delta people have made great progress to achieve herd immunity within our workforce","content":"<p><b>Delta Air Lines, Inc.</b>&nbsp;DAL 4.24%&nbsp;has announced a new corporate mandate requiring all future employees to be vaccinated against COVID-19 before joining the company.</p><p><blockquote><b>达美航空公司。</b>DAL 4.24% 宣布了一项新的公司规定，要求所有未来的员工在加入公司前接种 COVID-19 疫苗。</blockquote></p><p> <b>What Happened:</b>&nbsp;The Atlanta-headquartered carrier issued a statement praising the vaccines for protecting individuals and speeding the end of the pandemic, adding that&nbsp;the new mandate will ensure its employees will not face a reprise of the health crisis.</p><p><blockquote><b>发生了什么：</b>这家总部位于亚特兰大的航空公司发表声明，称赞疫苗可以保护个人并加速疫情的结束，并补充说，新的授权将确保其员工不会面临健康危机的重演。</blockquote></p><p> “Delta people have made great progress to achieve herd immunity within our workforce, so to help us maintain that trajectory, we will be requiring all new hires in the U.S. to be vaccinated against COVID-19 unless they qualify for an accommodation,” said Elizabeth Ninomiya, manager of strategic communications. “This is an important move to protect our workforce and our customers as our business recovers and demand for air travel continues to rise.”</p><p><blockquote>“战略传播经理伊丽莎白-二宫（Elizabeth Ninomiya）说：”达美航空在实现员工队伍群体免疫方面取得了巨大进步，因此，为了帮助我们保持这一势头，我们将要求美国所有新员工接种 COVID-19 疫苗，除非他们有资格获得住宿。“随着我们业务的复苏和航空旅行需求的持续增长，这是保护我们员工和客户的重要举措”。</blockquote></p><p> Speaking on&nbsp;CNN, Delta CEO Ed Bastian clarified this mandate won't apply to current employees.</p><p><blockquote>达美航空首席执行官埃德·巴斯蒂安在接受美国有线电视新闻网采访时澄清说，这项规定不适用于现有员工。</blockquote></p><p> “I am not going to mandate and force people if they have some specific reason why they don’t want to get vaccinated,” he said. “I am going to strongly encourage them that they understand the risks of not getting vaccinated.”</p><p><blockquote>“他说：”如果人们有特定的理由不想接种疫苗，我不会强迫他们接种疫苗。“我将强烈鼓励他们了解不接种疫苗的风险”。</blockquote></p><p> However, he noted&nbsp;employees who are not vaccinated may be excluded from certain assignments, including international flights. He added that 60% of Delta’s workforce has at least one vaccine shot.</p><p><blockquote>然而，他指出，未接种疫苗的员工可能会被排除在某些任务之外，包括国际航班。他补充说，达美航空 60% 的员工至少接种过一次疫苗。</blockquote></p><p> <i>Related Link:CDC Says Fully Vaccinated People Can Mostly Stop Wearing Masks</i></p><p><blockquote><i>相关链接：疾病预防控制中心表示，完全接种疫苗的人大多可以停止戴口罩</i></blockquote></p><p> <b>Why It Matters:</b>&nbsp;Delta is the first U.S. carrier to announce it will only hire vaccinated individuals.The New York Timesreported&nbsp;<b>United Airlines Holdings&nbsp;Inc.</b>UAL 4.73%CEO Scott Kirby voiced his support for the idea in a video forum in January, but decided not to go forward because the carrier could not “realistically be the only company” to take this action.</p><p><blockquote><b>为什么重要：</b>达美航空是第一家宣布只雇用接种疫苗的个人的美国航空公司。《纽约时报》报道<b>联合航空控股公司。</b>UAL 4.73% 首席执行官斯科特-柯比（Scott Kirby）在 1 月份的一个视频论坛上表示支持这一想法，但决定不再推进，因为该航空公司不可能 “实际上是唯一一家 ”采取这一行动的公司。</blockquote></p><p> Although most schools in the U.S. require children to have certain vaccinations, there is no precedent for companies refusing to hire people based on their vaccination status.</p><p><blockquote>虽然美国大多数学校都要求孩子接种某些疫苗，但公司根据疫苗接种情况拒绝雇用员工的先例并没有。</blockquote></p><p> Current&nbsp;federal policy on employer-mandated vaccinations is focused on the rights of current employees, not potential hires.</p><p><blockquote>目前关于雇主强制接种疫苗的联邦政策侧重于现有雇员的权利，而不是潜在雇员的权利。</blockquote></p><p> The Equal Employment Opportunity Commission (EEOC) issued&nbsp;guidancelast December stating companies “may encourage or possibly require COVID-19 vaccinations” of its workforce, provided their policies are in compliance with workplace laws including the Americans with Disabilities Act and Title VII of the Civil Rights Act of 1964 (Title VII).</p><p><blockquote>平等就业机会委员会（EEOC）去年 12 月发布了指导意见，指出公司 “可以鼓励或可能要求 ”其员工接种 COVID-19 疫苗，前提是其政策符合工作场所法律，包括《美国残疾人法》和 1964 年民权法案第七章（第七章）。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Delta Mandates All New Employees Must Have COVID-19 Vaccinations<blockquote>达美航空要求所有新员工必须接种 COVID-19 疫苗</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDelta Mandates All New Employees Must Have COVID-19 Vaccinations<blockquote>达美航空要求所有新员工必须接种 COVID-19 疫苗</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2021-05-14 22:59</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><b>Delta Air Lines, Inc.</b>&nbsp;DAL 4.24%&nbsp;has announced a new corporate mandate requiring all future employees to be vaccinated against COVID-19 before joining the company.</p><p><blockquote><b>达美航空公司。</b>DAL 4.24% 宣布了一项新的公司规定，要求所有未来的员工在加入公司前接种 COVID-19 疫苗。</blockquote></p><p> <b>What Happened:</b>&nbsp;The Atlanta-headquartered carrier issued a statement praising the vaccines for protecting individuals and speeding the end of the pandemic, adding that&nbsp;the new mandate will ensure its employees will not face a reprise of the health crisis.</p><p><blockquote><b>发生了什么：</b>这家总部位于亚特兰大的航空公司发表声明，称赞疫苗可以保护个人并加速疫情的结束，并补充说，新的授权将确保其员工不会面临健康危机的重演。</blockquote></p><p> “Delta people have made great progress to achieve herd immunity within our workforce, so to help us maintain that trajectory, we will be requiring all new hires in the U.S. to be vaccinated against COVID-19 unless they qualify for an accommodation,” said Elizabeth Ninomiya, manager of strategic communications. “This is an important move to protect our workforce and our customers as our business recovers and demand for air travel continues to rise.”</p><p><blockquote>“战略传播经理伊丽莎白-二宫（Elizabeth Ninomiya）说：”达美航空在实现员工队伍群体免疫方面取得了巨大进步，因此，为了帮助我们保持这一势头，我们将要求美国所有新员工接种 COVID-19 疫苗，除非他们有资格获得住宿。“随着我们业务的复苏和航空旅行需求的持续增长，这是保护我们员工和客户的重要举措”。</blockquote></p><p> Speaking on&nbsp;CNN, Delta CEO Ed Bastian clarified this mandate won't apply to current employees.</p><p><blockquote>达美航空首席执行官埃德·巴斯蒂安在接受美国有线电视新闻网采访时澄清说，这项规定不适用于现有员工。</blockquote></p><p> “I am not going to mandate and force people if they have some specific reason why they don’t want to get vaccinated,” he said. “I am going to strongly encourage them that they understand the risks of not getting vaccinated.”</p><p><blockquote>“他说：”如果人们有特定的理由不想接种疫苗，我不会强迫他们接种疫苗。“我将强烈鼓励他们了解不接种疫苗的风险”。</blockquote></p><p> However, he noted&nbsp;employees who are not vaccinated may be excluded from certain assignments, including international flights. He added that 60% of Delta’s workforce has at least one vaccine shot.</p><p><blockquote>然而，他指出，未接种疫苗的员工可能会被排除在某些任务之外，包括国际航班。他补充说，达美航空 60% 的员工至少接种过一次疫苗。</blockquote></p><p> <i>Related Link:CDC Says Fully Vaccinated People Can Mostly Stop Wearing Masks</i></p><p><blockquote><i>相关链接：疾病预防控制中心表示，完全接种疫苗的人大多可以停止戴口罩</i></blockquote></p><p> <b>Why It Matters:</b>&nbsp;Delta is the first U.S. carrier to announce it will only hire vaccinated individuals.The New York Timesreported&nbsp;<b>United Airlines Holdings&nbsp;Inc.</b>UAL 4.73%CEO Scott Kirby voiced his support for the idea in a video forum in January, but decided not to go forward because the carrier could not “realistically be the only company” to take this action.</p><p><blockquote><b>为什么重要：</b>达美航空是第一家宣布只雇用接种疫苗的个人的美国航空公司。《纽约时报》报道<b>联合航空控股公司。</b>UAL 4.73% 首席执行官斯科特-柯比（Scott Kirby）在 1 月份的一个视频论坛上表示支持这一想法，但决定不再推进，因为该航空公司不可能 “实际上是唯一一家 ”采取这一行动的公司。</blockquote></p><p> Although most schools in the U.S. require children to have certain vaccinations, there is no precedent for companies refusing to hire people based on their vaccination status.</p><p><blockquote>虽然美国大多数学校都要求孩子接种某些疫苗，但公司根据疫苗接种情况拒绝雇用员工的先例并没有。</blockquote></p><p> Current&nbsp;federal policy on employer-mandated vaccinations is focused on the rights of current employees, not potential hires.</p><p><blockquote>目前关于雇主强制接种疫苗的联邦政策侧重于现有雇员的权利，而不是潜在雇员的权利。</blockquote></p><p> The Equal Employment Opportunity Commission (EEOC) issued&nbsp;guidancelast December stating companies “may encourage or possibly require COVID-19 vaccinations” of its workforce, provided their policies are in compliance with workplace laws including the Americans with Disabilities Act and Title VII of the Civil Rights Act of 1964 (Title VII).</p><p><blockquote>平等就业机会委员会（EEOC）去年 12 月发布了指导意见，指出公司 “可以鼓励或可能要求 ”其员工接种 COVID-19 疫苗，前提是其政策符合工作场所法律，包括《美国残疾人法》和 1964 年民权法案第七章（第七章）。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DAL":"达美航空"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174509827","content_text":"Delta Air Lines, Inc. DAL 4.24% has announced a new corporate mandate requiring all future employees to be vaccinated against COVID-19 before joining the company.\nWhat Happened: The Atlanta-headquartered carrier issued a statement praising the vaccines for protecting individuals and speeding the end of the pandemic, adding that the new mandate will ensure its employees will not face a reprise of the health crisis.\n“Delta people have made great progress to achieve herd immunity within our workforce, so to help us maintain that trajectory, we will be requiring all new hires in the U.S. to be vaccinated against COVID-19 unless they qualify for an accommodation,” said Elizabeth Ninomiya, manager of strategic communications. “This is an important move to protect our workforce and our customers as our business recovers and demand for air travel continues to rise.”\nSpeaking on CNN, Delta CEO Ed Bastian clarified this mandate won't apply to current employees.\n“I am not going to mandate and force people if they have some specific reason why they don’t want to get vaccinated,” he said. “I am going to strongly encourage them that they understand the risks of not getting vaccinated.”\nHowever, he noted employees who are not vaccinated may be excluded from certain assignments, including international flights. He added that 60% of Delta’s workforce has at least one vaccine shot.\nRelated Link:CDC Says Fully Vaccinated People Can Mostly Stop Wearing Masks\nWhy It Matters: Delta is the first U.S. carrier to announce it will only hire vaccinated individuals.The New York Timesreported United Airlines Holdings Inc.UAL 4.73%CEO Scott Kirby voiced his support for the idea in a video forum in January, but decided not to go forward because the carrier could not “realistically be the only company” to take this action.\nAlthough most schools in the U.S. require children to have certain vaccinations, there is no precedent for companies refusing to hire people based on their vaccination status.\nCurrent federal policy on employer-mandated vaccinations is focused on the rights of current employees, not potential hires.\nThe Equal Employment Opportunity Commission (EEOC) issued guidancelast December stating companies “may encourage or possibly require COVID-19 vaccinations” of its workforce, provided their policies are in compliance with workplace laws including the Americans with Disabilities Act and Title VII of the Civil Rights Act of 1964 (Title VII).","news_type":1,"symbols_score_info":{"DAL":0.9}},"isVote":1,"tweetType":1,"viewCount":721,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}